id	sid	tid	token	lemma	pos
aiua-7778	1	1	archivio	archivio	PROPN
aiua-7778	1	2	italiano	italiano	X
aiua-7778	1	3	di	di	X
aiua-7778	1	4	urologia	urologia	PROPN
aiua-7778	1	5	e	e	PROPN
aiua-7778	1	6	andrologia	andrologia	NOUN
aiua-7778	1	7	2018	2018	NUM
aiua-7778	1	8	;	;	PUNCT
aiua-7778	1	9	90	90	NUM
aiua-7778	1	10	,	,	PUNCT
aiua-7778	1	11	4270	4270	NUM
aiua-7778	1	12	original	original	ADJ
aiua-7778	1	13	paper	paper	NOUN
aiua-7778	1	14	lymphocyte	lymphocyte	NOUN
aiua-7778	1	15	-	-	PUNCT
aiua-7778	1	16	to	to	ADP
aiua-7778	1	17	-	-	PUNCT
aiua-7778	1	18	monocyte	monocyte	NOUN
aiua-7778	1	19	ratio	ratio	NOUN
aiua-7778	1	20	is	be	AUX
aiua-7778	1	21	a	a	DET
aiua-7778	1	22	valuable	valuable	ADJ
aiua-7778	1	23	marker	marker	NOUN
aiua-7778	1	24	to	to	PART
aiua-7778	1	25	predict	predict	VERB
aiua-7778	1	26	prostate	prostate	NOUN
aiua-7778	1	27	cancer	cancer	NOUN
aiua-7778	1	28	in	in	ADP
aiua-7778	1	29	patients	patient	NOUN
aiua-7778	1	30	with	with	ADP
aiua-7778	1	31	prostate	prostate	NOUN
aiua-7778	1	32	specific	specific	ADJ
aiua-7778	1	33	antigen	antigen	NOUN
aiua-7778	1	34	between	between	ADP
aiua-7778	1	35	4	4	NUM
aiua-7778	1	36	and	and	CCONJ
aiua-7778	1	37	10	10	NUM
aiua-7778	1	38	ng	ng	PROPN
aiua-7778	1	39	/	/	SYM
aiua-7778	1	40	dl	dl	PROPN
aiua-7778	1	41	volkan	volkan	PROPN
aiua-7778	1	42	caglayan	caglayan	PROPN
aiua-7778	1	43	,	,	PUNCT
aiua-7778	1	44	efe	efe	PROPN
aiua-7778	1	45	onen	onen	PROPN
aiua-7778	1	46	,	,	PUNCT
aiua-7778	1	47	sinan	sinan	PROPN
aiua-7778	1	48	avci	avci	PROPN
aiua-7778	1	49	,	,	PUNCT
aiua-7778	1	50	murat	murat	PROPN
aiua-7778	1	51	sambel	sambel	PROPN
aiua-7778	1	52	,	,	PUNCT
aiua-7778	1	53	metin	metin	PROPN
aiua-7778	1	54	kilic	kilic	PROPN
aiua-7778	1	55	,	,	PUNCT
aiua-7778	1	56	sedat	sedat	PROPN
aiua-7778	1	57	oner	oner	PROPN
aiua-7778	1	58	,	,	PUNCT
aiua-7778	1	59	mustafa	mustafa	PROPN
aiua-7778	1	60	murat	murat	PROPN
aiua-7778	1	61	aydos	aydos	PROPN
aiua-7778	1	62	,	,	PUNCT
aiua-7778	1	63	halil	halil	PROPN
aiua-7778	1	64	emre	emre	PROPN
aiua-7778	1	65	yıldız	yıldız	PROPN
aiua-7778	1	66	university	university	PROPN
aiua-7778	1	67	of	of	ADP
aiua-7778	1	68	health	health	PROPN
aiua-7778	1	69	sciences	sciences	PROPN
aiua-7778	1	70	,	,	PUNCT
aiua-7778	1	71	bursa	bursa	NOUN
aiua-7778	1	72	yuksek	yuksek	PROPN
aiua-7778	1	73	ihtisas	ihtisa	VERB
aiua-7778	1	74	training	training	NOUN
aiua-7778	1	75	and	and	CCONJ
aiua-7778	1	76	research	research	NOUN
aiua-7778	1	77	hospital	hospital	NOUN
aiua-7778	1	78	,	,	PUNCT
aiua-7778	1	79	bursa	bursa	NOUN
aiua-7778	1	80	,	,	PUNCT
aiua-7778	1	81	turkey	turkey	PROPN
aiua-7778	1	82	.	.	PUNCT
aiua-7778	2	1	objective	objective	NOUN
aiua-7778	2	2	:	:	PUNCT
aiua-7778	2	3	to	to	PART
aiua-7778	2	4	evaluate	evaluate	VERB
aiua-7778	2	5	the	the	DET
aiua-7778	2	6	diagnostic	diagnostic	ADJ
aiua-7778	2	7	value	value	NOUN
aiua-7778	2	8	of	of	ADP
aiua-7778	2	9	serum	serum	NOUN
aiua-7778	2	10	inflammation	inflammation	NOUN
aiua-7778	2	11	markers	marker	NOUN
aiua-7778	2	12	derived	derive	VERB
aiua-7778	2	13	from	from	ADP
aiua-7778	2	14	complete	complete	ADJ
aiua-7778	2	15	blood	blood	NOUN
aiua-7778	2	16	count	count	NOUN
aiua-7778	2	17	in	in	ADP
aiua-7778	2	18	diagnosis	diagnosis	NOUN
aiua-7778	2	19	of	of	ADP
aiua-7778	2	20	prostate	prostate	NOUN
aiua-7778	2	21	cancer	cancer	NOUN
aiua-7778	2	22	(	(	PUNCT
aiua-7778	2	23	pca	pca	PROPN
aiua-7778	2	24	)	)	PUNCT
aiua-7778	2	25	.	.	PUNCT
aiua-7778	3	1	methods	method	NOUN
aiua-7778	3	2	:	:	PUNCT
aiua-7778	3	3	we	we	PRON
aiua-7778	3	4	retrospectively	retrospectively	ADV
aiua-7778	3	5	analyzed	analyze	VERB
aiua-7778	3	6	the	the	DET
aiua-7778	3	7	data	datum	NOUN
aiua-7778	3	8	of	of	ADP
aiua-7778	3	9	621	621	NUM
aiua-7778	3	10	patients	patient	NOUN
aiua-7778	3	11	who	who	PRON
aiua-7778	3	12	underwent	undergo	VERB
aiua-7778	3	13	prostate	prostate	NOUN
aiua-7778	3	14	biopsy	biopsy	NOUN
aiua-7778	3	15	between	between	ADP
aiua-7778	3	16	march	march	PROPN
aiua-7778	3	17	2013	2013	NUM
aiua-7778	3	18	and	and	CCONJ
aiua-7778	3	19	april	april	PROPN
aiua-7778	3	20	2018	2018	NUM
aiua-7778	3	21	.	.	PUNCT
aiua-7778	4	1	age	age	NOUN
aiua-7778	4	2	,	,	PUNCT
aiua-7778	4	3	prostate	prostate	NOUN
aiua-7778	4	4	specific	specific	ADJ
aiua-7778	4	5	antigen	antigen	NOUN
aiua-7778	4	6	(	(	PUNCT
aiua-7778	4	7	psa	psa	NOUN
aiua-7778	4	8	)	)	PUNCT
aiua-7778	4	9	,	,	PUNCT
aiua-7778	4	10	free	free	ADJ
aiua-7778	4	11	psa	psa	NOUN
aiua-7778	4	12	,	,	PUNCT
aiua-7778	4	13	platelet	platelet	NOUN
aiua-7778	4	14	count	count	NOUN
aiua-7778	4	15	,	,	PUNCT
aiua-7778	4	16	neutrophil	neutrophil	ADJ
aiua-7778	4	17	count	count	NOUN
aiua-7778	4	18	,	,	PUNCT
aiua-7778	4	19	lymphocyte	lymphocyte	ADJ
aiua-7778	4	20	count	count	NOUN
aiua-7778	4	21	,	,	PUNCT
aiua-7778	4	22	monocyte	monocyte	NOUN
aiua-7778	4	23	count	count	NOUN
aiua-7778	4	24	,	,	PUNCT
aiua-7778	4	25	prostate	prostate	NOUN
aiua-7778	4	26	volume	volume	NOUN
aiua-7778	4	27	(	(	PUNCT
aiua-7778	4	28	pv	pv	NOUN
aiua-7778	4	29	)	)	PUNCT
aiua-7778	4	30	and	and	CCONJ
aiua-7778	4	31	pathology	pathology	NOUN
aiua-7778	4	32	result	result	NOUN
aiua-7778	4	33	of	of	ADP
aiua-7778	4	34	the	the	DET
aiua-7778	4	35	patients	patient	NOUN
aiua-7778	4	36	were	be	AUX
aiua-7778	4	37	recorded	record	VERB
aiua-7778	4	38	.	.	PUNCT
aiua-7778	5	1	patients	patient	NOUN
aiua-7778	5	2	were	be	AUX
aiua-7778	5	3	grouped	group	VERB
aiua-7778	5	4	as	as	ADP
aiua-7778	5	5	benign	benign	ADJ
aiua-7778	5	6	prostatic	prostatic	ADJ
aiua-7778	5	7	hyperplasia	hyperplasia	NOUN
aiua-7778	5	8	(	(	PUNCT
aiua-7778	5	9	bph	bph	NOUN
aiua-7778	5	10	)	)	PUNCT
aiua-7778	5	11	,	,	PUNCT
aiua-7778	5	12	prostatitis	prostatitis	NOUN
aiua-7778	5	13	and	and	CCONJ
aiua-7778	5	14	pca	pca	PROPN
aiua-7778	5	15	.	.	PUNCT
aiua-7778	6	1	patients	patient	NOUN
aiua-7778	6	2	were	be	AUX
aiua-7778	6	3	also	also	ADV
aiua-7778	6	4	grouped	group	VERB
aiua-7778	6	5	according	accord	VERB
aiua-7778	6	6	to	to	AUX
aiua-7778	6	7	psa	psa	VERB
aiua-7778	6	8	values	value	NOUN
aiua-7778	6	9	,	,	PUNCT
aiua-7778	6	10	as	as	SCONJ
aiua-7778	6	11	psa	psa	VERB
aiua-7778	6	12	<	<	X
aiua-7778	6	13	4	4	NUM
aiua-7778	6	14	,	,	PUNCT
aiua-7778	6	15	psa	psa	VERB
aiua-7778	6	16	4	4	NUM
aiua-7778	6	17	-	-	SYM
aiua-7778	6	18	10	10	NUM
aiua-7778	6	19	and	and	CCONJ
aiua-7778	6	20	psa	psa	VERB
aiua-7778	6	21	>	>	PROPN
aiua-7778	6	22	10	10	NUM
aiua-7778	6	23	ng	ng	PROPN
aiua-7778	6	24	/	/	SYM
aiua-7778	6	25	dl	dl	PROPN
aiua-7778	6	26	.	.	PROPN
aiua-7778	6	27	results	result	NOUN
aiua-7778	6	28	:	:	PUNCT
aiua-7778	6	29	the	the	DET
aiua-7778	6	30	mean	mean	ADJ
aiua-7778	6	31	lymphocyte	lymphocyte	NOUN
aiua-7778	6	32	-	-	PUNCT
aiua-7778	6	33	to	to	ADP
aiua-7778	6	34	-	-	PUNCT
aiua-7778	6	35	monocyte	monocyte	NOUN
aiua-7778	6	36	ratio	ratio	NOUN
aiua-7778	6	37	(	(	PUNCT
aiua-7778	6	38	lmr	lmr	PROPN
aiua-7778	6	39	)	)	PUNCT
aiua-7778	6	40	value	value	NOUN
aiua-7778	6	41	of	of	ADP
aiua-7778	6	42	the	the	DET
aiua-7778	6	43	patients	patient	NOUN
aiua-7778	6	44	with	with	ADP
aiua-7778	6	45	pca	pca	PROPN
aiua-7778	6	46	was	be	AUX
aiua-7778	6	47	significantly	significantly	ADV
aiua-7778	6	48	lower	low	ADJ
aiua-7778	6	49	in	in	ADP
aiua-7778	6	50	the	the	DET
aiua-7778	6	51	entire	entire	ADJ
aiua-7778	6	52	cohort	cohort	NOUN
aiua-7778	6	53	(	(	PUNCT
aiua-7778	6	54	p	p	X
aiua-7778	6	55	=	=	NOUN
aiua-7778	6	56	0.047	0.047	NUM
aiua-7778	6	57	)	)	PUNCT
aiua-7778	6	58	.	.	PUNCT
aiua-7778	7	1	in	in	ADP
aiua-7778	7	2	the	the	DET
aiua-7778	7	3	psa	psa	NOUN
aiua-7778	7	4	4	4	NUM
aiua-7778	7	5	-	-	SYM
aiua-7778	7	6	10	10	NUM
aiua-7778	7	7	ng	ng	PROPN
aiua-7778	7	8	/	/	SYM
aiua-7778	7	9	dl	dl	PROPN
aiua-7778	7	10	range	range	PROPN
aiua-7778	7	11	,	,	PUNCT
aiua-7778	7	12	lmr	lmr	PROPN
aiua-7778	7	13	value	value	NOUN
aiua-7778	7	14	wassignificantly	wassignificantly	ADV
aiua-7778	7	15	lower	low	ADJ
aiua-7778	7	16	in	in	ADP
aiua-7778	7	17	patients	patient	NOUN
aiua-7778	7	18	with	with	ADP
aiua-7778	7	19	pca	pca	PROPN
aiua-7778	7	20	than	than	ADP
aiua-7778	7	21	those	those	PRON
aiua-7778	7	22	with	with	ADP
aiua-7778	7	23	bph	bph	NOUN
aiua-7778	7	24	or	or	CCONJ
aiua-7778	7	25	prostatitis	prostatitis	NOUN
aiua-7778	7	26	(	(	PUNCT
aiua-7778	7	27	p	p	X
aiua-7778	7	28	=	=	PROPN
aiua-7778	7	29	0.012	0.012	NUM
aiua-7778	7	30	)	)	PUNCT
aiua-7778	7	31	.	.	PUNCT
aiua-7778	8	1	in	in	ADP
aiua-7778	8	2	this	this	DET
aiua-7778	8	3	psa	psa	NOUN
aiua-7778	8	4	range	range	NOUN
aiua-7778	8	5	,	,	PUNCT
aiua-7778	8	6	free	free	ADJ
aiua-7778	8	7	/	/	SYM
aiua-7778	8	8	total	total	ADJ
aiua-7778	8	9	psa	psa	NOUN
aiua-7778	8	10	ratio	ratio	NOUN
aiua-7778	8	11	and	and	CCONJ
aiua-7778	8	12	lmr	lmr	PROPN
aiua-7778	8	13	were	be	AUX
aiua-7778	8	14	significant	significant	ADJ
aiua-7778	8	15	factors	factor	NOUN
aiua-7778	8	16	to	to	PART
aiua-7778	8	17	predict	predict	VERB
aiua-7778	8	18	pca	pca	PROPN
aiua-7778	8	19	.	.	PUNCT
aiua-7778	9	1	the	the	DET
aiua-7778	9	2	cut	cut	VERB
aiua-7778	9	3	-	-	PUNCT
aiua-7778	9	4	off	off	ADP
aiua-7778	9	5	values	value	NOUN
aiua-7778	9	6	of	of	ADP
aiua-7778	9	7	lmr	lmr	PROPN
aiua-7778	9	8	,	,	PUNCT
aiua-7778	9	9	free	free	ADJ
aiua-7778	9	10	/	/	SYM
aiua-7778	9	11	total	total	ADJ
aiua-7778	9	12	psa	psa	NOUN
aiua-7778	9	13	were	be	AUX
aiua-7778	9	14	3.05	3.05	NUM
aiua-7778	9	15	and	and	CCONJ
aiua-7778	9	16	0.15	0.15	NUM
aiua-7778	9	17	respectively	respectively	ADV
aiua-7778	9	18	.	.	PUNCT
aiua-7778	10	1	the	the	DET
aiua-7778	10	2	sensitivities	sensitivity	NOUN
aiua-7778	10	3	,	,	PUNCT
aiua-7778	10	4	spesificities	spesificitie	NOUN
aiua-7778	10	5	,	,	PUNCT
aiua-7778	10	6	positive	positive	ADJ
aiua-7778	10	7	predictive	predictive	ADJ
aiua-7778	10	8	values	value	NOUN
aiua-7778	10	9	(	(	PUNCT
aiua-7778	10	10	ppv	ppv	NOUN
aiua-7778	10	11	)	)	PUNCT
aiua-7778	10	12	and	and	CCONJ
aiua-7778	10	13	negative	negative	ADJ
aiua-7778	10	14	predictive	predictive	ADJ
aiua-7778	10	15	values	value	NOUN
aiua-7778	10	16	using	use	VERB
aiua-7778	10	17	lmr	lmr	PROPN
aiua-7778	10	18	cut	cut	PROPN
aiua-7778	10	19	-	-	PUNCT
aiua-7778	10	20	off	off	NOUN
aiua-7778	10	21	,	,	PUNCT
aiua-7778	10	22	free	free	ADJ
aiua-7778	10	23	/	/	SYM
aiua-7778	10	24	total	total	ADJ
aiua-7778	10	25	psa	psa	NOUN
aiua-7778	10	26	cut	cut	NOUN
aiua-7778	10	27	-	-	PUNCT
aiua-7778	10	28	off	off	NOUN
aiua-7778	10	29	and	and	CCONJ
aiua-7778	10	30	their	their	PRON
aiua-7778	10	31	combination	combination	NOUN
aiua-7778	10	32	were	be	AUX
aiua-7778	10	33	assessed	assess	VERB
aiua-7778	10	34	.	.	PUNCT
aiua-7778	11	1	specificity	specificity	NOUN
aiua-7778	11	2	and	and	CCONJ
aiua-7778	11	3	ppv	ppv	NOUN
aiua-7778	11	4	of	of	ADP
aiua-7778	11	5	the	the	DET
aiua-7778	11	6	combination	combination	NOUN
aiua-7778	11	7	group	group	NOUN
aiua-7778	11	8	were	be	AUX
aiua-7778	11	9	higher	high	ADJ
aiua-7778	11	10	(	(	PUNCT
aiua-7778	11	11	97.2	97.2	NUM
aiua-7778	11	12	%	%	NOUN
aiua-7778	11	13	,	,	PUNCT
aiua-7778	11	14	83.3	83.3	NUM
aiua-7778	11	15	%	%	NOUN
aiua-7778	11	16	respectively	respectively	ADV
aiua-7778	11	17	)	)	PUNCT
aiua-7778	11	18	compared	compare	VERB
aiua-7778	11	19	to	to	ADP
aiua-7778	11	20	free	free	ADJ
aiua-7778	11	21	/	/	SYM
aiua-7778	11	22	total	total	ADJ
aiua-7778	11	23	psa	psa	NOUN
aiua-7778	11	24	cut	cut	VERB
aiua-7778	11	25	-	-	PUNCT
aiua-7778	11	26	off	off	ADP
aiua-7778	11	27	group	group	NOUN
aiua-7778	11	28	(	(	PUNCT
aiua-7778	11	29	91.6	91.6	NUM
aiua-7778	11	30	%	%	NOUN
aiua-7778	11	31	,	,	PUNCT
aiua-7778	11	32	76.6	76.6	NUM
aiua-7778	11	33	%	%	NOUN
aiua-7778	11	34	)	)	PUNCT
aiua-7778	11	35	and	and	CCONJ
aiua-7778	11	36	lmr	lmr	PROPN
aiua-7778	11	37	cut	cut	PROPN
aiua-7778	11	38	-	-	PUNCT
aiua-7778	11	39	off	off	ADP
aiua-7778	11	40	group	group	NOUN
aiua-7778	11	41	(	(	PUNCT
aiua-7778	11	42	67.8	67.8	NUM
aiua-7778	11	43	%	%	NOUN
aiua-7778	11	44	,	,	PUNCT
aiua-7778	11	45	43.7	43.7	NUM
aiua-7778	11	46	%	%	NOUN
aiua-7778	11	47	)	)	PUNCT
aiua-7778	11	48	.	.	PUNCT
aiua-7778	12	1	conclusions	conclusion	NOUN
aiua-7778	12	2	:	:	PUNCT
aiua-7778	12	3	lmr	lmr	PROPN
aiua-7778	12	4	is	be	AUX
aiua-7778	12	5	a	a	DET
aiua-7778	12	6	useful	useful	ADJ
aiua-7778	12	7	tool	tool	NOUN
aiua-7778	12	8	at	at	ADP
aiua-7778	12	9	detecting	detect	VERB
aiua-7778	12	10	pca	pca	NOUN
aiua-7778	12	11	especially	especially	ADV
aiua-7778	12	12	in	in	ADP
aiua-7778	12	13	patients	patient	NOUN
aiua-7778	12	14	with	with	ADP
aiua-7778	12	15	psa	psa	NOUN
aiua-7778	12	16	value	value	NOUN
aiua-7778	12	17	between	between	ADP
aiua-7778	12	18	4	4	NUM
aiua-7778	12	19	and	and	CCONJ
aiua-7778	12	20	10	10	NUM
aiua-7778	12	21	ng	ng	PROPN
aiua-7778	12	22	/	/	SYM
aiua-7778	12	23	dl	dl	PROPN
aiua-7778	12	24	.	.	PUNCT
aiua-7778	13	1	the	the	DET
aiua-7778	13	2	combination	combination	NOUN
aiua-7778	13	3	of	of	ADP
aiua-7778	13	4	free	free	ADJ
aiua-7778	13	5	/	/	SYM
aiua-7778	13	6	total	total	ADJ
aiua-7778	13	7	psa	psa	NOUN
aiua-7778	13	8	ratio	ratio	NOUN
aiua-7778	13	9	and	and	CCONJ
aiua-7778	13	10	lmr	lmr	PROPN
aiua-7778	13	11	improves	improve	VERB
aiua-7778	13	12	the	the	DET
aiua-7778	13	13	diagnostic	diagnostic	ADJ
aiua-7778	13	14	accuracy	accuracy	NOUN
aiua-7778	13	15	more	more	ADJ
aiua-7778	13	16	than	than	ADP
aiua-7778	13	17	the	the	DET
aiua-7778	13	18	use	use	NOUN
aiua-7778	13	19	of	of	ADP
aiua-7778	13	20	free	free	ADJ
aiua-7778	13	21	/	/	SYM
aiua-7778	13	22	total	total	ADJ
aiua-7778	13	23	psa	psa	NOUN
aiua-7778	13	24	ratio	ratio	NOUN
aiua-7778	13	25	alone	alone	ADV
aiua-7778	13	26	.	.	PUNCT
aiua-7778	14	1	key	key	ADJ
aiua-7778	14	2	words	word	NOUN
aiua-7778	14	3	:	:	PUNCT
aiua-7778	14	4	lymphocyte	lymphocyte	NOUN
aiua-7778	14	5	-	-	PUNCT
aiua-7778	14	6	to	to	ADP
aiua-7778	14	7	-	-	PUNCT
aiua-7778	14	8	monocyte	monocyte	NOUN
aiua-7778	14	9	ratio	ratio	NOUN
aiua-7778	14	10	;	;	PUNCT
aiua-7778	14	11	prostate	prostate	NOUN
aiua-7778	14	12	cancer	cancer	NOUN
aiua-7778	14	13	.	.	PUNCT
aiua-7778	14	14	aubmitted	aubmitte	VERB
aiua-7778	14	15	19	19	NUM
aiua-7778	14	16	august	august	PROPN
aiua-7778	14	17	2018	2018	NUM
aiua-7778	14	18	;	;	PUNCT
aiua-7778	14	19	accepted	accept	VERB
aiua-7778	14	20	19	19	NUM
aiua-7778	14	21	august	august	PROPN
aiua-7778	14	22	2018	2018	NUM
aiua-7778	14	23	summary	summary	NOUN
aiua-7778	14	24	no	no	DET
aiua-7778	14	25	conflict	conflict	NOUN
aiua-7778	14	26	of	of	ADP
aiua-7778	14	27	interest	interest	NOUN
aiua-7778	14	28	declared	declare	VERB
aiua-7778	14	29	.	.	PUNCT
aiua-7778	15	1	pca	pca	PROPN
aiua-7778	16	1	and	and	CCONJ
aiua-7778	17	1	reduced	reduce	VERB
aiua-7778	17	2	the	the	DET
aiua-7778	17	3	associated	associated	ADJ
aiua-7778	17	4	mortality	mortality	NOUN
aiua-7778	17	5	.	.	PUNCT
aiua-7778	18	1	however	however	ADV
aiua-7778	18	2	,	,	PUNCT
aiua-7778	18	3	the	the	DET
aiua-7778	18	4	low	low	ADJ
aiua-7778	18	5	specificity	specificity	NOUN
aiua-7778	18	6	of	of	ADP
aiua-7778	18	7	psa	psa	NOUN
aiua-7778	18	8	can	can	AUX
aiua-7778	18	9	lead	lead	VERB
aiua-7778	18	10	to	to	ADP
aiua-7778	18	11	unnecessary	unnecessary	ADJ
aiua-7778	18	12	biopsies	biopsy	NOUN
aiua-7778	18	13	,	,	PUNCT
aiua-7778	18	14	overdiagnosis	overdiagnosis	NOUN
aiua-7778	18	15	and	and	CCONJ
aiua-7778	18	16	overtreatment	overtreatment	NOUN
aiua-7778	18	17	(	(	PUNCT
aiua-7778	18	18	3	3	NUM
aiua-7778	18	19	)	)	PUNCT
aiua-7778	18	20	.	.	PUNCT
aiua-7778	19	1	psa	psa	VERB
aiua-7778	19	2	is	be	AUX
aiua-7778	19	3	organ	organ	ADJ
aiua-7778	19	4	but	but	CCONJ
aiua-7778	19	5	not	not	PART
aiua-7778	19	6	cancer	cancer	NOUN
aiua-7778	19	7	-	-	PUNCT
aiua-7778	19	8	specific	specific	ADJ
aiua-7778	19	9	,	,	PUNCT
aiua-7778	19	10	therefore	therefore	ADV
aiua-7778	19	11	it	it	PRON
aiua-7778	19	12	may	may	AUX
aiua-7778	19	13	be	be	AUX
aiua-7778	19	14	elevated	elevate	VERB
aiua-7778	19	15	in	in	ADP
aiua-7778	19	16	benign	benign	ADJ
aiua-7778	19	17	conditions	condition	NOUN
aiua-7778	19	18	such	such	ADJ
aiua-7778	19	19	as	as	ADP
aiua-7778	19	20	benign	benign	ADJ
aiua-7778	19	21	prostate	prostate	NOUN
aiua-7778	19	22	hyperplasia	hyperplasia	NOUN
aiua-7778	19	23	(	(	PUNCT
aiua-7778	19	24	bph	bph	NOUN
aiua-7778	19	25	)	)	PUNCT
aiua-7778	19	26	,	,	PUNCT
aiua-7778	19	27	prostatitis	prostatitis	NOUN
aiua-7778	19	28	,	,	PUNCT
aiua-7778	19	29	urinary	urinary	ADJ
aiua-7778	19	30	tract	tract	NOUN
aiua-7778	19	31	infections	infection	NOUN
aiua-7778	19	32	and	and	CCONJ
aiua-7778	19	33	trauma	trauma	NOUN
aiua-7778	19	34	.	.	PUNCT
aiua-7778	20	1	after	after	ADP
aiua-7778	20	2	detection	detection	NOUN
aiua-7778	20	3	of	of	ADP
aiua-7778	20	4	elevated	elevated	ADJ
aiua-7778	20	5	psa	psa	NOUN
aiua-7778	20	6	,	,	PUNCT
aiua-7778	20	7	it	it	PRON
aiua-7778	20	8	is	be	AUX
aiua-7778	20	9	recommended	recommend	VERB
aiua-7778	20	10	to	to	PART
aiua-7778	20	11	perform	perform	VERB
aiua-7778	20	12	prostate	prostate	NOUN
aiua-7778	20	13	biopsy	biopsy	NOUN
aiua-7778	20	14	(	(	PUNCT
aiua-7778	20	15	pbx	pbx	PROPN
aiua-7778	20	16	)	)	PUNCT
aiua-7778	20	17	which	which	PRON
aiua-7778	20	18	is	be	AUX
aiua-7778	20	19	still	still	ADV
aiua-7778	20	20	the	the	DET
aiua-7778	20	21	gold	gold	ADJ
aiua-7778	20	22	standard	standard	ADJ
aiua-7778	20	23	method	method	NOUN
aiua-7778	20	24	for	for	ADP
aiua-7778	20	25	diagnosis	diagnosis	NOUN
aiua-7778	20	26	of	of	ADP
aiua-7778	20	27	pca	pca	PROPN
aiua-7778	20	28	.	.	PUNCT
aiua-7778	21	1	however	however	ADV
aiua-7778	21	2	pbx	pbx	PROPN
aiua-7778	21	3	is	be	AUX
aiua-7778	21	4	associated	associate	VERB
aiua-7778	21	5	with	with	ADP
aiua-7778	21	6	several	several	ADJ
aiua-7778	21	7	complications	complication	NOUN
aiua-7778	21	8	,	,	PUNCT
aiua-7778	21	9	including	include	VERB
aiua-7778	21	10	pain	pain	NOUN
aiua-7778	21	11	,	,	PUNCT
aiua-7778	21	12	hematospermia	hematospermia	PROPN
aiua-7778	21	13	,	,	PUNCT
aiua-7778	21	14	haematuria	haematuria	PROPN
aiua-7778	21	15	,	,	PUNCT
aiua-7778	21	16	hematochezia	hematochezia	PROPN
aiua-7778	21	17	,	,	PUNCT
aiua-7778	21	18	and	and	CCONJ
aiua-7778	21	19	potentially	potentially	ADV
aiua-7778	21	20	severe	severe	ADJ
aiua-7778	21	21	infectious	infectious	ADJ
aiua-7778	21	22	complications	complication	NOUN
aiua-7778	21	23	,	,	PUNCT
aiua-7778	21	24	ranging	range	VERB
aiua-7778	21	25	from	from	ADP
aiua-7778	21	26	urinary	urinary	ADJ
aiua-7778	21	27	tract	tract	NOUN
aiua-7778	21	28	infections	infection	NOUN
aiua-7778	21	29	(	(	PUNCT
aiua-7778	21	30	utis	utis	NOUN
aiua-7778	21	31	)	)	PUNCT
aiua-7778	21	32	and	and	CCONJ
aiua-7778	21	33	prostatitis	prostatitis	NOUN
aiua-7778	21	34	to	to	ADP
aiua-7778	21	35	sepsis	sepsis	NOUN
aiua-7778	21	36	(	(	PUNCT
aiua-7778	21	37	4	4	NUM
aiua-7778	21	38	)	)	PUNCT
aiua-7778	21	39	.	.	PUNCT
aiua-7778	22	1	although	although	SCONJ
aiua-7778	22	2	psa	psa	NOUN
aiua-7778	22	3	is	be	AUX
aiua-7778	22	4	a	a	DET
aiua-7778	22	5	useful	useful	ADJ
aiua-7778	22	6	tool	tool	NOUN
aiua-7778	22	7	at	at	ADP
aiua-7778	22	8	detecting	detect	VERB
aiua-7778	22	9	pca	pca	PROPN
aiua-7778	22	10	,	,	PUNCT
aiua-7778	22	11	concern	concern	NOUN
aiua-7778	22	12	about	about	ADP
aiua-7778	22	13	performing	perform	VERB
aiua-7778	22	14	unnecessary	unnecessary	ADJ
aiua-7778	22	15	pbx	pbx	NOUN
aiua-7778	22	16	considering	consider	VERB
aiua-7778	22	17	overdiagnosis	overdiagnosis	NOUN
aiua-7778	22	18	and	and	CCONJ
aiua-7778	22	19	complications	complication	NOUN
aiua-7778	22	20	is	be	AUX
aiua-7778	22	21	the	the	DET
aiua-7778	22	22	crucial	crucial	ADJ
aiua-7778	22	23	problem	problem	NOUN
aiua-7778	22	24	for	for	ADP
aiua-7778	22	25	urologists	urologist	NOUN
aiua-7778	22	26	.	.	PUNCT
aiua-7778	23	1	some	some	DET
aiua-7778	23	2	psa	psa	NOUN
aiua-7778	23	3	-	-	PUNCT
aiua-7778	23	4	related	relate	VERB
aiua-7778	23	5	testing	testing	NOUN
aiua-7778	23	6	parameters	parameter	NOUN
aiua-7778	23	7	(	(	PUNCT
aiua-7778	23	8	e.g.	e.g.	ADV
aiua-7778	23	9	,	,	PUNCT
aiua-7778	23	10	psa	psa	VERB
aiua-7778	23	11	density	density	NOUN
aiua-7778	23	12	,	,	PUNCT
aiua-7778	23	13	free	free	ADJ
aiua-7778	23	14	/	/	SYM
aiua-7778	23	15	total	total	ADJ
aiua-7778	23	16	psa	psa	NOUN
aiua-7778	23	17	ratio	ratio	NOUN
aiua-7778	23	18	,	,	PUNCT
aiua-7778	23	19	psa	psa	VERB
aiua-7778	23	20	doubling	doubling	NOUN
aiua-7778	23	21	time	time	NOUN
aiua-7778	23	22	,	,	PUNCT
aiua-7778	23	23	and	and	CCONJ
aiua-7778	23	24	prostate	prostate	NOUN
aiua-7778	23	25	health	health	NOUN
aiua-7778	23	26	index	index	NOUN
aiua-7778	23	27	test	test	NOUN
aiua-7778	23	28	)	)	PUNCT
aiua-7778	23	29	have	have	AUX
aiua-7778	23	30	been	be	AUX
aiua-7778	23	31	used	use	VERB
aiua-7778	23	32	to	to	PART
aiua-7778	23	33	improve	improve	VERB
aiua-7778	23	34	the	the	DET
aiua-7778	23	35	accuracy	accuracy	NOUN
aiua-7778	23	36	of	of	ADP
aiua-7778	23	37	pca	pca	NOUN
aiua-7778	23	38	prediction	prediction	NOUN
aiua-7778	23	39	(	(	PUNCT
aiua-7778	23	40	5	5	NUM
aiua-7778	23	41	)	)	PUNCT
aiua-7778	23	42	.	.	PUNCT
aiua-7778	24	1	thus	thus	ADV
aiua-7778	24	2	,	,	PUNCT
aiua-7778	24	3	new	new	ADJ
aiua-7778	24	4	biomarkers	biomarker	NOUN
aiua-7778	24	5	may	may	AUX
aiua-7778	24	6	be	be	AUX
aiua-7778	24	7	needed	need	VERB
aiua-7778	24	8	to	to	PART
aiua-7778	24	9	improve	improve	VERB
aiua-7778	24	10	decision	decision	NOUN
aiua-7778	24	11	-	-	PUNCT
aiua-7778	24	12	making	making	NOUN
aiua-7778	24	13	regarding	regard	VERB
aiua-7778	24	14	initial	initial	ADJ
aiua-7778	24	15	management	management	NOUN
aiua-7778	24	16	,	,	PUNCT
aiua-7778	24	17	including	include	VERB
aiua-7778	24	18	whether	whether	SCONJ
aiua-7778	24	19	to	to	PART
aiua-7778	24	20	biopsy	biopsy	VERB
aiua-7778	24	21	.	.	PUNCT
aiua-7778	25	1	over	over	ADP
aiua-7778	25	2	the	the	DET
aiua-7778	25	3	last	last	ADJ
aiua-7778	25	4	decade	decade	NOUN
aiua-7778	25	5	,	,	PUNCT
aiua-7778	25	6	it	it	PRON
aiua-7778	25	7	has	have	AUX
aiua-7778	25	8	become	become	VERB
aiua-7778	25	9	clear	clear	ADJ
aiua-7778	25	10	that	that	SCONJ
aiua-7778	25	11	systemic	systemic	ADJ
aiua-7778	25	12	inflammation	inflammation	NOUN
aiua-7778	25	13	plays	play	VERB
aiua-7778	25	14	an	an	DET
aiua-7778	25	15	important	important	ADJ
aiua-7778	25	16	role	role	NOUN
aiua-7778	25	17	in	in	ADP
aiua-7778	25	18	the	the	DET
aiua-7778	25	19	development	development	NOUN
aiua-7778	25	20	and	and	CCONJ
aiua-7778	25	21	progression	progression	NOUN
aiua-7778	25	22	of	of	ADP
aiua-7778	25	23	cancer	cancer	NOUN
aiua-7778	25	24	.	.	PUNCT
aiua-7778	26	1	the	the	DET
aiua-7778	26	2	markers	marker	NOUN
aiua-7778	26	3	of	of	ADP
aiua-7778	26	4	the	the	DET
aiua-7778	26	5	systemic	systemic	ADJ
aiua-7778	26	6	inflammatory	inflammatory	ADJ
aiua-7778	26	7	response	response	NOUN
aiua-7778	26	8	are	be	AUX
aiua-7778	26	9	usually	usually	ADV
aiua-7778	26	10	based	base	VERB
aiua-7778	26	11	around	around	ADP
aiua-7778	26	12	composite	composite	ADJ
aiua-7778	26	13	ratios	ratio	NOUN
aiua-7778	26	14	or	or	CCONJ
aiua-7778	26	15	cumulative	cumulative	ADJ
aiua-7778	26	16	scores	score	NOUN
aiua-7778	26	17	of	of	ADP
aiua-7778	26	18	different	different	ADJ
aiua-7778	26	19	circulating	circulate	VERB
aiua-7778	26	20	white	white	ADJ
aiua-7778	26	21	blood	blood	NOUN
aiua-7778	26	22	cells	cell	NOUN
aiua-7778	26	23	representing	represent	VERB
aiua-7778	26	24	the	the	DET
aiua-7778	26	25	systemic	systemic	ADJ
aiua-7778	26	26	responses	response	NOUN
aiua-7778	26	27	of	of	ADP
aiua-7778	26	28	lymphoid	lymphoid	NOUN
aiua-7778	26	29	/	/	SYM
aiua-7778	26	30	myeloid	myeloid	ADJ
aiua-7778	26	31	tissue	tissue	NOUN
aiua-7778	26	32	.	.	PUNCT
aiua-7778	27	1	the	the	DET
aiua-7778	27	2	main	main	ADJ
aiua-7778	27	3	approach	approach	NOUN
aiua-7778	27	4	is	be	AUX
aiua-7778	27	5	to	to	PART
aiua-7778	27	6	take	take	VERB
aiua-7778	27	7	the	the	DET
aiua-7778	27	8	ratio	ratio	NOUN
aiua-7778	27	9	of	of	ADP
aiua-7778	27	10	different	different	ADJ
aiua-7778	27	11	white	white	ADJ
aiua-7778	27	12	blood	blood	NOUN
aiua-7778	27	13	cells	cell	NOUN
aiua-7778	27	14	and	and	CCONJ
aiua-7778	27	15	then	then	ADV
aiua-7778	27	16	apply	apply	VERB
aiua-7778	27	17	a	a	DET
aiua-7778	27	18	prognostic	prognostic	ADJ
aiua-7778	27	19	threshold	threshold	NOUN
aiua-7778	27	20	to	to	ADP
aiua-7778	27	21	the	the	DET
aiua-7778	27	22	ratio	ratio	NOUN
aiua-7778	27	23	such	such	ADJ
aiua-7778	27	24	that	that	DET
aiua-7778	27	25	outcome	outcome	NOUN
aiua-7778	27	26	is	be	AUX
aiua-7778	27	27	effectively	effectively	ADV
aiua-7778	27	28	stratified	stratify	VERB
aiua-7778	27	29	.	.	PUNCT
aiua-7778	28	1	the	the	DET
aiua-7778	28	2	most	most	ADV
aiua-7778	28	3	repeatedly	repeatedly	ADV
aiua-7778	28	4	validated	validate	VERB
aiua-7778	28	5	examples	example	NOUN
aiua-7778	28	6	of	of	ADP
aiua-7778	28	7	this	this	DET
aiua-7778	28	8	approach	approach	NOUN
aiua-7778	28	9	are	be	AUX
aiua-7778	28	10	the	the	DET
aiua-7778	28	11	neutrophil	neutrophil	ADJ
aiua-7778	28	12	-	-	PUNCT
aiua-7778	28	13	lymphocyte	lymphocyte	ADJ
aiua-7778	28	14	ratio	ratio	NOUN
aiua-7778	28	15	(	(	PUNCT
aiua-7778	28	16	nlr	nlr	PROPN
aiua-7778	28	17	)	)	PUNCT
aiua-7778	28	18	based	base	VERB
aiua-7778	28	19	on	on	ADP
aiua-7778	28	20	the	the	DET
aiua-7778	28	21	ratio	ratio	NOUN
aiua-7778	28	22	of	of	ADP
aiua-7778	28	23	circulating	circulate	VERB
aiua-7778	28	24	neutrophil	neutrophil	ADJ
aiua-7778	28	25	and	and	CCONJ
aiua-7778	28	26	lymphocyte	lymphocyte	ADJ
aiua-7778	28	27	counts	count	NOUN
aiua-7778	28	28	,	,	PUNCT
aiua-7778	28	29	the	the	DET
aiua-7778	28	30	platelet	platelet	ADJ
aiua-7778	28	31	-	-	PUNCT
aiua-7778	28	32	lymphocyte	lymphocyte	ADJ
aiua-7778	28	33	ratio	ratio	NOUN
aiua-7778	28	34	(	(	PUNCT
aiua-7778	28	35	plr	plr	NOUN
aiua-7778	28	36	)	)	PUNCT
aiua-7778	28	37	based	base	VERB
aiua-7778	28	38	on	on	ADP
aiua-7778	28	39	the	the	DET
aiua-7778	28	40	ratio	ratio	NOUN
aiua-7778	28	41	of	of	ADP
aiua-7778	28	42	circulating	circulate	VERB
aiua-7778	28	43	platelet	platelet	NOUN
aiua-7778	28	44	and	and	CCONJ
aiua-7778	28	45	lymphocyte	lymphocyte	ADJ
aiua-7778	28	46	counts	count	NOUN
aiua-7778	28	47	and	and	CCONJ
aiua-7778	28	48	the	the	DET
aiua-7778	28	49	lymphocyte	lymphocyte	ADJ
aiua-7778	28	50	-	-	PUNCT
aiua-7778	28	51	monocyte	monocyte	NOUN
aiua-7778	28	52	ratio	ratio	NOUN
aiua-7778	28	53	(	(	PUNCT
aiua-7778	28	54	lmr	lmr	PROPN
aiua-7778	28	55	)	)	PUNCT
aiua-7778	28	56	based	base	VERB
aiua-7778	28	57	on	on	ADP
aiua-7778	28	58	the	the	DET
aiua-7778	28	59	ratio	ratio	NOUN
aiua-7778	28	60	of	of	ADP
aiua-7778	28	61	circulating	circulate	VERB
aiua-7778	28	62	lymphocyte	lymphocyte	NOUN
aiua-7778	28	63	and	and	CCONJ
aiua-7778	28	64	monocyte	monocyte	NOUN
aiua-7778	28	65	counts	count	NOUN
aiua-7778	28	66	.	.	PUNCT
aiua-7778	29	1	in	in	ADP
aiua-7778	29	2	this	this	DET
aiua-7778	29	3	study	study	NOUN
aiua-7778	29	4	,	,	PUNCT
aiua-7778	29	5	we	we	PRON
aiua-7778	29	6	aimed	aim	VERB
aiua-7778	29	7	to	to	PART
aiua-7778	29	8	investigate	investigate	VERB
aiua-7778	29	9	the	the	DET
aiua-7778	29	10	role	role	NOUN
aiua-7778	29	11	of	of	ADP
aiua-7778	29	12	the	the	DET
aiua-7778	29	13	systemic	systemic	ADJ
aiua-7778	29	14	inflammatory	inflammatory	ADJ
aiua-7778	29	15	response	response	NOUN
aiua-7778	29	16	markers	marker	NOUN
aiua-7778	29	17	prior	prior	ADV
aiua-7778	29	18	to	to	ADP
aiua-7778	29	19	pbx	pbx	PROPN
aiua-7778	29	20	at	at	ADP
aiua-7778	29	21	predicting	predict	VERB
aiua-7778	29	22	histologic≠al	histologic≠al	ADJ
aiua-7778	29	23	outcomes	outcome	NOUN
aiua-7778	29	24	.	.	PUNCT
aiua-7778	30	1	doi	doi	NOUN
aiua-7778	30	2	:	:	PUNCT
aiua-7778	30	3	10.4081	10.4081	NUM
aiua-7778	30	4	/	/	SYM
aiua-7778	30	5	aiua.2018.4.270	aiua.2018.4.270	PROPN
aiua-7778	30	6	introduction	introduction	NOUN
aiua-7778	30	7	prostate	prostate	NOUN
aiua-7778	30	8	cancer	cancer	NOUN
aiua-7778	30	9	(	(	PUNCT
aiua-7778	30	10	pca	pca	PROPN
aiua-7778	30	11	)	)	PUNCT
aiua-7778	30	12	is	be	AUX
aiua-7778	30	13	the	the	DET
aiua-7778	30	14	second	second	ADJ
aiua-7778	30	15	most	most	ADV
aiua-7778	30	16	frequently	frequently	ADV
aiua-7778	30	17	diagnosed	diagnose	VERB
aiua-7778	30	18	cancer	cancer	NOUN
aiua-7778	30	19	and	and	CCONJ
aiua-7778	30	20	the	the	DET
aiua-7778	30	21	fifth	fifth	ADJ
aiua-7778	30	22	most	most	ADV
aiua-7778	30	23	common	common	ADJ
aiua-7778	30	24	cause	cause	NOUN
aiua-7778	30	25	of	of	ADP
aiua-7778	30	26	cancer	cancer	NOUN
aiua-7778	30	27	-	-	PUNCT
aiua-7778	30	28	associated	associate	VERB
aiua-7778	30	29	death	death	NOUN
aiua-7778	30	30	in	in	ADP
aiua-7778	30	31	men	man	NOUN
aiua-7778	30	32	worldwide	worldwide	ADV
aiua-7778	30	33	(	(	PUNCT
aiua-7778	30	34	1	1	NUM
aiua-7778	30	35	)	)	PUNCT
aiua-7778	30	36	.	.	PUNCT
aiua-7778	31	1	despite	despite	SCONJ
aiua-7778	31	2	the	the	DET
aiua-7778	31	3	recent	recent	ADJ
aiua-7778	31	4	advances	advance	NOUN
aiua-7778	31	5	in	in	ADP
aiua-7778	31	6	diagnostic	diagnostic	ADJ
aiua-7778	31	7	and	and	CCONJ
aiua-7778	31	8	therapeutic	therapeutic	ADJ
aiua-7778	31	9	approaches	approach	NOUN
aiua-7778	31	10	,	,	PUNCT
aiua-7778	31	11	it	it	PRON
aiua-7778	31	12	is	be	AUX
aiua-7778	31	13	still	still	ADV
aiua-7778	31	14	a	a	DET
aiua-7778	31	15	major	major	ADJ
aiua-7778	31	16	health	health	NOUN
aiua-7778	31	17	concern	concern	NOUN
aiua-7778	31	18	especially	especially	ADV
aiua-7778	31	19	in	in	ADP
aiua-7778	31	20	developed	develop	VERB
aiua-7778	31	21	countries	country	NOUN
aiua-7778	31	22	and	and	CCONJ
aiua-7778	31	23	especially	especially	ADV
aiua-7778	31	24	in	in	ADP
aiua-7778	31	25	elderly	elderly	ADJ
aiua-7778	31	26	men	man	NOUN
aiua-7778	31	27	(	(	PUNCT
aiua-7778	31	28	2	2	NUM
aiua-7778	31	29	)	)	PUNCT
aiua-7778	31	30	.	.	PUNCT
aiua-7778	32	1	serum	serum	NOUN
aiua-7778	32	2	prostate	prostate	NOUN
aiua-7778	32	3	-	-	PUNCT
aiua-7778	32	4	specific	specific	ADJ
aiua-7778	32	5	antigen	antigen	NOUN
aiua-7778	32	6	(	(	PUNCT
aiua-7778	32	7	psa	psa	NOUN
aiua-7778	32	8	)	)	PUNCT
aiua-7778	32	9	is	be	AUX
aiua-7778	32	10	widely	widely	ADV
aiua-7778	32	11	used	use	VERB
aiua-7778	32	12	as	as	ADP
aiua-7778	32	13	a	a	DET
aiua-7778	32	14	biomarker	biomarker	NOUN
aiua-7778	32	15	for	for	ADP
aiua-7778	32	16	this	this	DET
aiua-7778	32	17	cancer	cancer	NOUN
aiua-7778	32	18	,	,	PUNCT
aiua-7778	32	19	and	and	CCONJ
aiua-7778	32	20	its	its	PRON
aiua-7778	32	21	widespread	widespread	ADJ
aiua-7778	32	22	introduction	introduction	NOUN
aiua-7778	32	23	has	have	AUX
aiua-7778	32	24	undoubtedly	undoubtedly	ADV
aiua-7778	32	25	enhanced	enhance	VERB
aiua-7778	32	26	the	the	DET
aiua-7778	32	27	early	early	ADJ
aiua-7778	32	28	detection	detection	NOUN
aiua-7778	32	29	of	of	ADP
aiua-7778	32	30	caglayan_stesura	caglayan_stesura	ADJ
aiua-7778	32	31	seveso	seveso	NOUN
aiua-7778	32	32	10/01/19	10/01/19	PROPN
aiua-7778	32	33	16:08	16:08	NUM
aiua-7778	32	34	pagina	pagina	NOUN
aiua-7778	32	35	270	270	NUM
aiua-7778	32	36	271archivio	271archivio	PROPN
aiua-7778	32	37	italiano	italiano	NOUN
aiua-7778	32	38	di	di	X
aiua-7778	32	39	urologia	urologia	PROPN
aiua-7778	32	40	e	e	PROPN
aiua-7778	32	41	andrologia	andrologia	NOUN
aiua-7778	32	42	2018	2018	NUM
aiua-7778	32	43	;	;	PUNCT
aiua-7778	32	44	90	90	NUM
aiua-7778	32	45	,	,	PUNCT
aiua-7778	32	46	4	4	NUM
aiua-7778	32	47	lymphocyte	lymphocyte	NOUN
aiua-7778	32	48	-	-	PUNCT
aiua-7778	32	49	to	to	ADP
aiua-7778	32	50	-	-	PUNCT
aiua-7778	32	51	monocyte	monocyte	NOUN
aiua-7778	32	52	ratio	ratio	NOUN
aiua-7778	32	53	is	be	AUX
aiua-7778	32	54	a	a	DET
aiua-7778	32	55	valuable	valuable	ADJ
aiua-7778	32	56	marker	marker	NOUN
aiua-7778	32	57	to	to	PART
aiua-7778	32	58	predict	predict	VERB
aiua-7778	32	59	prostate	prostate	NOUN
aiua-7778	32	60	cancer	cancer	NOUN
aiua-7778	32	61	in	in	ADP
aiua-7778	32	62	patients	patient	NOUN
aiua-7778	32	63	with	with	ADP
aiua-7778	32	64	prostate	prostate	NOUN
aiua-7778	32	65	specific	specific	ADJ
aiua-7778	32	66	antigen	antigen	NOUN
aiua-7778	32	67	between	between	ADP
aiua-7778	32	68	4	4	NUM
aiua-7778	32	69	and	and	CCONJ
aiua-7778	32	70	10	10	NUM
aiua-7778	32	71	ng	ng	PROPN
aiua-7778	32	72	/	/	SYM
aiua-7778	32	73	dl	dl	PROPN
aiua-7778	32	74	.	.	PROPN
aiua-7778	32	75	methods	method	NOUN
aiua-7778	32	76	we	we	PRON
aiua-7778	32	77	retrospectively	retrospectively	ADV
aiua-7778	32	78	analyzed	analyze	VERB
aiua-7778	32	79	the	the	DET
aiua-7778	32	80	data	datum	NOUN
aiua-7778	32	81	of	of	ADP
aiua-7778	32	82	621	621	NUM
aiua-7778	32	83	patients	patient	NOUN
aiua-7778	32	84	who	who	PRON
aiua-7778	32	85	underwent	undergo	VERB
aiua-7778	32	86	12	12	NUM
aiua-7778	32	87	-	-	PUNCT
aiua-7778	32	88	core	core	NOUN
aiua-7778	32	89	pbx	pbx	NOUN
aiua-7778	32	90	between	between	ADP
aiua-7778	32	91	march	march	PROPN
aiua-7778	32	92	2013	2013	NUM
aiua-7778	32	93	and	and	CCONJ
aiua-7778	32	94	april	april	PROPN
aiua-7778	32	95	2018	2018	NUM
aiua-7778	32	96	.	.	PUNCT
aiua-7778	33	1	pbx	pbx	PROPN
aiua-7778	33	2	was	be	AUX
aiua-7778	33	3	performed	perform	VERB
aiua-7778	33	4	within	within	ADP
aiua-7778	33	5	4	4	NUM
aiua-7778	33	6	weeks	week	NOUN
aiua-7778	33	7	after	after	ADP
aiua-7778	33	8	blood	blood	NOUN
aiua-7778	33	9	tests	test	NOUN
aiua-7778	33	10	.	.	PUNCT
aiua-7778	34	1	age	age	NOUN
aiua-7778	34	2	,	,	PUNCT
aiua-7778	34	3	total	total	ADJ
aiua-7778	34	4	psa	psa	NOUN
aiua-7778	34	5	level	level	NOUN
aiua-7778	34	6	,	,	PUNCT
aiua-7778	34	7	free	free	ADJ
aiua-7778	34	8	psa	psa	NOUN
aiua-7778	34	9	level	level	NOUN
aiua-7778	34	10	,	,	PUNCT
aiua-7778	34	11	hemoglobin	hemoglobin	NOUN
aiua-7778	34	12	level	level	NOUN
aiua-7778	34	13	,	,	PUNCT
aiua-7778	34	14	platelet	platelet	NOUN
aiua-7778	34	15	count	count	NOUN
aiua-7778	34	16	,	,	PUNCT
aiua-7778	34	17	neutrophil	neutrophil	ADJ
aiua-7778	34	18	count	count	NOUN
aiua-7778	34	19	,	,	PUNCT
aiua-7778	34	20	lymphocyte	lymphocyte	ADJ
aiua-7778	34	21	count	count	NOUN
aiua-7778	34	22	,	,	PUNCT
aiua-7778	34	23	monocyte	monocyte	NOUN
aiua-7778	34	24	count	count	NOUN
aiua-7778	34	25	,	,	PUNCT
aiua-7778	34	26	prostate	prostate	NOUN
aiua-7778	34	27	volume	volume	NOUN
aiua-7778	34	28	and	and	CCONJ
aiua-7778	34	29	pathology	pathology	NOUN
aiua-7778	34	30	result	result	NOUN
aiua-7778	34	31	of	of	ADP
aiua-7778	34	32	the	the	DET
aiua-7778	34	33	patients	patient	NOUN
aiua-7778	34	34	were	be	AUX
aiua-7778	34	35	recorded	record	VERB
aiua-7778	34	36	.	.	PUNCT
aiua-7778	35	1	patients	patient	NOUN
aiua-7778	35	2	with	with	ADP
aiua-7778	35	3	symptomatic	symptomatic	ADJ
aiua-7778	35	4	prostatitis	prostatitis	NOUN
aiua-7778	35	5	or	or	CCONJ
aiua-7778	35	6	urinary	urinary	ADJ
aiua-7778	35	7	tract	tract	NOUN
aiua-7778	35	8	infection	infection	NOUN
aiua-7778	35	9	or	or	CCONJ
aiua-7778	35	10	systemic	systemic	ADJ
aiua-7778	35	11	inflammatory	inflammatory	ADJ
aiua-7778	35	12	disease	disease	NOUN
aiua-7778	35	13	or	or	CCONJ
aiua-7778	35	14	any	any	DET
aiua-7778	35	15	history	history	NOUN
aiua-7778	35	16	of	of	ADP
aiua-7778	35	17	anti	anti	ADJ
aiua-7778	35	18	-	-	ADJ
aiua-7778	35	19	inflammatory	inflammatory	ADJ
aiua-7778	35	20	drug	drug	NOUN
aiua-7778	35	21	use	use	NOUN
aiua-7778	35	22	within	within	ADP
aiua-7778	35	23	2	2	NUM
aiua-7778	35	24	weeks	week	NOUN
aiua-7778	35	25	before	before	SCONJ
aiua-7778	35	26	pbx	pbx	PROPN
aiua-7778	35	27	were	be	AUX
aiua-7778	35	28	excluded	exclude	VERB
aiua-7778	35	29	.	.	PUNCT
aiua-7778	36	1	also	also	ADV
aiua-7778	36	2	patients	patient	NOUN
aiua-7778	36	3	with	with	ADP
aiua-7778	36	4	high	high	ADJ
aiua-7778	36	5	grade	grade	NOUN
aiua-7778	36	6	intraepithelial	intraepithelial	ADJ
aiua-7778	36	7	neoplasia	neoplasia	NOUN
aiua-7778	36	8	(	(	PUNCT
aiua-7778	36	9	h	h	NOUN
aiua-7778	36	10	-	-	PUNCT
aiua-7778	36	11	pin	pin	NOUN
aiua-7778	36	12	)	)	PUNCT
aiua-7778	36	13	and	and	CCONJ
aiua-7778	36	14	atypical	atypical	ADJ
aiua-7778	36	15	small	small	ADJ
aiua-7778	36	16	acinar	acinar	NOUN
aiua-7778	36	17	proliferation	proliferation	NOUN
aiua-7778	36	18	(	(	PUNCT
aiua-7778	36	19	asap	asap	NOUN
aiua-7778	36	20	)	)	PUNCT
aiua-7778	36	21	were	be	AUX
aiua-7778	36	22	excluded	exclude	VERB
aiua-7778	36	23	due	due	ADP
aiua-7778	36	24	to	to	ADP
aiua-7778	36	25	the	the	DET
aiua-7778	36	26	low	low	ADJ
aiua-7778	36	27	number	number	NOUN
aiua-7778	36	28	of	of	ADP
aiua-7778	36	29	cases	case	NOUN
aiua-7778	36	30	.	.	PUNCT
aiua-7778	37	1	finally	finally	ADV
aiua-7778	37	2	the	the	DET
aiua-7778	37	3	patients	patient	NOUN
aiua-7778	37	4	whose	whose	DET
aiua-7778	37	5	psa	psa	NOUN
aiua-7778	37	6	was	be	AUX
aiua-7778	37	7	less	less	ADJ
aiua-7778	37	8	than	than	ADP
aiua-7778	37	9	100	100	NUM
aiua-7778	37	10	ng	ng	NOUN
aiua-7778	37	11	/	/	SYM
aiua-7778	37	12	ml	ml	NOUN
aiua-7778	37	13	and	and	CCONJ
aiua-7778	37	14	those	those	PRON
aiua-7778	37	15	had	have	VERB
aiua-7778	37	16	no	no	DET
aiua-7778	37	17	evidence	evidence	NOUN
aiua-7778	37	18	of	of	ADP
aiua-7778	37	19	metastasis	metastasis	NOUN
aiua-7778	37	20	in	in	ADP
aiua-7778	37	21	imaging	imaging	NOUN
aiua-7778	37	22	reports	report	NOUN
aiua-7778	37	23	were	be	AUX
aiua-7778	37	24	included	include	VERB
aiua-7778	37	25	.	.	PUNCT
aiua-7778	38	1	the	the	DET
aiua-7778	38	2	patients	patient	NOUN
aiua-7778	38	3	were	be	AUX
aiua-7778	38	4	laid	lay	VERB
aiua-7778	38	5	down	down	ADP
aiua-7778	38	6	in	in	ADP
aiua-7778	38	7	left	left	ADJ
aiua-7778	38	8	lateral	lateral	ADJ
aiua-7778	38	9	decubitus	decubitus	NOUN
aiua-7778	38	10	position	position	NOUN
aiua-7778	38	11	and	and	CCONJ
aiua-7778	38	12	in	in	ADP
aiua-7778	38	13	the	the	DET
aiua-7778	38	14	flexion	flexion	NOUN
aiua-7778	38	15	of	of	ADP
aiua-7778	38	16	knees	knee	NOUN
aiua-7778	38	17	and	and	CCONJ
aiua-7778	38	18	hips	hip	NOUN
aiua-7778	38	19	.	.	PUNCT
aiua-7778	39	1	general	general	PROPN
aiua-7778	39	2	electric	electric	PROPN
aiua-7778	39	3	logiq	logiq	PROPN
aiua-7778	39	4	100	100	NUM
aiua-7778	39	5	pro	pro	ADJ
aiua-7778	39	6	series	series	PROPN
aiua-7778	39	7	ultrasound	ultrasound	NOUN
aiua-7778	39	8	device	device	NOUN
aiua-7778	39	9	was	be	AUX
aiua-7778	39	10	used	use	VERB
aiua-7778	39	11	with	with	ADP
aiua-7778	39	12	6.5	6.5	NUM
aiua-7778	39	13	mhz	mhz	NOUN
aiua-7778	39	14	rectal	rectal	ADJ
aiua-7778	39	15	probe	probe	NOUN
aiua-7778	39	16	,	,	PUNCT
aiua-7778	39	17	the	the	DET
aiua-7778	39	18	widest	wide	ADJ
aiua-7778	39	19	diameter	diameter	NOUN
aiua-7778	39	20	of	of	ADP
aiua-7778	39	21	which	which	PRON
aiua-7778	39	22	was	be	AUX
aiua-7778	39	23	23	23	NUM
aiua-7778	39	24	mm	mm	NOUN
aiua-7778	39	25	.	.	PUNCT
aiua-7778	40	1	biopsy	biopsy	NOUN
aiua-7778	40	2	samples	sample	NOUN
aiua-7778	40	3	were	be	AUX
aiua-7778	40	4	taken	take	VERB
aiua-7778	40	5	as	as	ADP
aiua-7778	40	6	12	12	NUM
aiua-7778	40	7	cores	core	NOUN
aiua-7778	40	8	with	with	ADP
aiua-7778	40	9	the	the	DET
aiua-7778	40	10	use	use	NOUN
aiua-7778	40	11	of	of	ADP
aiua-7778	40	12	30	30	NUM
aiua-7778	40	13	cm	cm	NUM
aiua-7778	40	14	18	18	NUM
aiua-7778	40	15	gauge	gauge	NOUN
aiua-7778	40	16	full	full	ADJ
aiua-7778	40	17	automatic	automatic	ADJ
aiua-7778	40	18	biopsy	biopsy	NOUN
aiua-7778	40	19	needle	needle	NOUN
aiua-7778	40	20	.	.	PUNCT
aiua-7778	41	1	data	datum	NOUN
aiua-7778	41	2	analysis	analysis	NOUN
aiua-7778	41	3	biopsy	biopsy	NOUN
aiua-7778	41	4	results	result	NOUN
aiua-7778	41	5	,	,	PUNCT
aiua-7778	41	6	gleason	gleason	PROPN
aiua-7778	41	7	scores	score	NOUN
aiua-7778	41	8	,	,	PUNCT
aiua-7778	41	9	psa	psa	VERB
aiua-7778	41	10	,	,	PUNCT
aiua-7778	41	11	free	free	ADJ
aiua-7778	41	12	/	/	SYM
aiua-7778	41	13	total	total	ADJ
aiua-7778	41	14	psa	psa	NOUN
aiua-7778	41	15	ratio	ratio	NOUN
aiua-7778	41	16	,	,	PUNCT
aiua-7778	41	17	prostate	prostate	NOUN
aiua-7778	41	18	volume	volume	NOUN
aiua-7778	41	19	,	,	PUNCT
aiua-7778	41	20	age	age	NOUN
aiua-7778	41	21	,	,	PUNCT
aiua-7778	41	22	nlr	nlr	PROPN
aiua-7778	41	23	results	result	NOUN
aiua-7778	41	24	,	,	PUNCT
aiua-7778	41	25	plr	plr	NOUN
aiua-7778	41	26	results	result	NOUN
aiua-7778	41	27	,	,	PUNCT
aiua-7778	41	28	lmr	lmr	PROPN
aiua-7778	41	29	results	result	NOUN
aiua-7778	41	30	were	be	AUX
aiua-7778	41	31	assessed	assess	VERB
aiua-7778	41	32	using	use	VERB
aiua-7778	41	33	the	the	DET
aiua-7778	41	34	chisquare	chisquare	NOUN
aiua-7778	41	35	test	test	NOUN
aiua-7778	41	36	or	or	CCONJ
aiua-7778	41	37	mann	mann	PROPN
aiua-7778	41	38	-	-	PUNCT
aiua-7778	41	39	whitney	whitney	PROPN
aiua-7778	41	40	u	u	NOUN
aiua-7778	41	41	-	-	NOUN
aiua-7778	41	42	test	test	NOUN
aiua-7778	41	43	to	to	PART
aiua-7778	41	44	determine	determine	VERB
aiua-7778	41	45	statistically	statistically	ADV
aiua-7778	41	46	significant	significant	ADJ
aiua-7778	41	47	differences	difference	NOUN
aiua-7778	41	48	.	.	PUNCT
aiua-7778	42	1	after	after	ADP
aiua-7778	42	2	adjusting	adjust	VERB
aiua-7778	42	3	for	for	ADP
aiua-7778	42	4	confounding	confound	VERB
aiua-7778	42	5	factors	factor	NOUN
aiua-7778	42	6	,	,	PUNCT
aiua-7778	42	7	univariate	univariate	ADJ
aiua-7778	42	8	and	and	CCONJ
aiua-7778	42	9	multivariate	multivariate	VERB
aiua-7778	42	10	logistic	logistic	ADJ
aiua-7778	42	11	regression	regression	NOUN
aiua-7778	42	12	analyses	analysis	NOUN
aiua-7778	42	13	were	be	AUX
aiua-7778	42	14	performed	perform	VERB
aiua-7778	42	15	to	to	PART
aiua-7778	42	16	determine	determine	VERB
aiua-7778	42	17	the	the	DET
aiua-7778	42	18	factors	factor	NOUN
aiua-7778	42	19	effecting	effect	VERB
aiua-7778	42	20	pca	pca	NOUN
aiua-7778	42	21	diagnosis	diagnosis	NOUN
aiua-7778	42	22	.	.	PUNCT
aiua-7778	43	1	the	the	DET
aiua-7778	43	2	predictive	predictive	ADJ
aiua-7778	43	3	accuracy	accuracy	NOUN
aiua-7778	43	4	of	of	ADP
aiua-7778	43	5	the	the	DET
aiua-7778	43	6	multivariate	multivariate	NOUN
aiua-7778	43	7	model	model	NOUN
aiua-7778	43	8	was	be	AUX
aiua-7778	43	9	assessed	assess	VERB
aiua-7778	43	10	using	use	VERB
aiua-7778	43	11	receiver	receiver	NOUN
aiua-7778	43	12	operating	operate	VERB
aiua-7778	43	13	characteristic	characteristic	NOUN
aiua-7778	43	14	(	(	PUNCT
aiua-7778	43	15	roc)-derived	roc)-derived	ADJ
aiua-7778	43	16	area	area	NOUN
aiua-7778	43	17	under	under	ADP
aiua-7778	43	18	the	the	DET
aiua-7778	43	19	curve	curve	NOUN
aiua-7778	43	20	(	(	PUNCT
aiua-7778	43	21	auc	auc	NOUN
aiua-7778	43	22	)	)	PUNCT
aiua-7778	43	23	analysis	analysis	NOUN
aiua-7778	43	24	.	.	PUNCT
aiua-7778	44	1	the	the	DET
aiua-7778	44	2	ibm	ibm	PROPN
aiua-7778	44	3	spss	spss	PROPN
aiua-7778	44	4	software	software	NOUN
aiua-7778	44	5	package	package	NOUN
aiua-7778	44	6	version	version	NOUN
aiua-7778	44	7	21.0	21.0	NUM
aiua-7778	44	8	(	(	PUNCT
aiua-7778	44	9	statistical	statistical	ADJ
aiua-7778	44	10	package	package	NOUN
aiua-7778	44	11	for	for	ADP
aiua-7778	44	12	social	social	ADJ
aiua-7778	44	13	sciences	science	NOUN
aiua-7778	44	14	™	™	NOUN
aiua-7778	44	15	,	,	PUNCT
aiua-7778	44	16	chicago	chicago	PROPN
aiua-7778	44	17	,	,	PUNCT
aiua-7778	44	18	il	il	PROPN
aiua-7778	44	19	,	,	PUNCT
aiua-7778	44	20	usa	usa	PROPN
aiua-7778	44	21	)	)	PUNCT
aiua-7778	44	22	weas	wea	NOUN
aiua-7778	44	23	used	use	VERB
aiua-7778	44	24	for	for	ADP
aiua-7778	44	25	statistical	statistical	ADJ
aiua-7778	44	26	analysis	analysis	NOUN
aiua-7778	44	27	.	.	PUNCT
aiua-7778	45	1	a	a	DET
aiua-7778	45	2	two	two	NUM
aiua-7778	45	3	-	-	PUNCT
aiua-7778	45	4	tailed	tail	VERB
aiua-7778	45	5	p	p	NOUN
aiua-7778	45	6	<	<	X
aiua-7778	45	7	0.05	0.05	NUM
aiua-7778	45	8	was	be	AUX
aiua-7778	45	9	considered	consider	VERB
aiua-7778	45	10	as	as	ADP
aiua-7778	45	11	significant	significant	ADJ
aiua-7778	45	12	for	for	ADP
aiua-7778	45	13	all	all	DET
aiua-7778	45	14	analyses	analysis	NOUN
aiua-7778	45	15	.	.	PUNCT
aiua-7778	46	1	results	result	VERB
aiua-7778	46	2	a	a	DET
aiua-7778	46	3	total	total	NOUN
aiua-7778	46	4	of	of	ADP
aiua-7778	46	5	800	800	NUM
aiua-7778	46	6	patients	patient	NOUN
aiua-7778	46	7	who	who	PRON
aiua-7778	46	8	underwent	undergo	VERB
aiua-7778	46	9	transrectal	transrectal	ADJ
aiua-7778	46	10	ultrasound	ultrasound	NOUN
aiua-7778	46	11	guided	guide	VERB
aiua-7778	46	12	pbx	pbx	PROPN
aiua-7778	46	13	were	be	AUX
aiua-7778	46	14	recorded	record	VERB
aiua-7778	46	15	.	.	PUNCT
aiua-7778	47	1	of	of	ADP
aiua-7778	47	2	these	these	PRON
aiua-7778	47	3	,	,	PUNCT
aiua-7778	47	4	179	179	NUM
aiua-7778	47	5	did	do	AUX
aiua-7778	47	6	not	not	PART
aiua-7778	47	7	meet	meet	VERB
aiua-7778	47	8	inclusion	inclusion	NOUN
aiua-7778	47	9	criterias	criteria	NOUN
aiua-7778	47	10	and	and	CCONJ
aiua-7778	47	11	were	be	AUX
aiua-7778	47	12	excluded	exclude	VERB
aiua-7778	47	13	(	(	PUNCT
aiua-7778	47	14	lack	lack	NOUN
aiua-7778	47	15	of	of	ADP
aiua-7778	47	16	data	datum	NOUN
aiua-7778	47	17	regarding	regard	VERB
aiua-7778	47	18	cbc	cbc	NOUN
aiua-7778	47	19	in	in	ADP
aiua-7778	47	20	77	77	NUM
aiua-7778	47	21	patients	patient	NOUN
aiua-7778	47	22	,	,	PUNCT
aiua-7778	47	23	presence	presence	NOUN
aiua-7778	47	24	of	of	ADP
aiua-7778	47	25	hpin	hpin	NOUN
aiua-7778	47	26	or	or	CCONJ
aiua-7778	47	27	asap	asap	NOUN
aiua-7778	47	28	in	in	ADP
aiua-7778	47	29	30	30	NUM
aiua-7778	47	30	patients	patient	NOUN
aiua-7778	47	31	,	,	PUNCT
aiua-7778	47	32	presence	presence	NOUN
aiua-7778	47	33	of	of	ADP
aiua-7778	47	34	metastasis	metastasis	NOUN
aiua-7778	47	35	in	in	ADP
aiua-7778	47	36	the	the	DET
aiua-7778	47	37	imaging	imaging	NOUN
aiua-7778	47	38	reports	report	NOUN
aiua-7778	47	39	in	in	ADP
aiua-7778	47	40	47	47	NUM
aiua-7778	47	41	patients	patient	NOUN
aiua-7778	47	42	and	and	CCONJ
aiua-7778	47	43	presence	presence	NOUN
aiua-7778	47	44	of	of	ADP
aiua-7778	47	45	psa	psa	VERB
aiua-7778	47	46	higher	high	ADJ
aiua-7778	47	47	than	than	ADP
aiua-7778	47	48	100	100	NUM
aiua-7778	47	49	ng	ng	PROPN
aiua-7778	47	50	/	/	SYM
aiua-7778	47	51	dl	dl	PROPN
aiua-7778	47	52	in	in	ADP
aiua-7778	47	53	25	25	NUM
aiua-7778	47	54	patients	patient	NOUN
aiua-7778	47	55	)	)	PUNCT
aiua-7778	47	56	.	.	PUNCT
aiua-7778	48	1	finally	finally	ADV
aiua-7778	48	2	the	the	DET
aiua-7778	48	3	data	datum	NOUN
aiua-7778	48	4	of	of	ADP
aiua-7778	48	5	621	621	NUM
aiua-7778	48	6	patients	patient	NOUN
aiua-7778	48	7	were	be	AUX
aiua-7778	48	8	investigated	investigate	VERB
aiua-7778	48	9	.	.	PUNCT
aiua-7778	49	1	the	the	DET
aiua-7778	49	2	mean	mean	ADJ
aiua-7778	49	3	age	age	NOUN
aiua-7778	49	4	was	be	AUX
aiua-7778	49	5	64.97	64.97	NUM
aiua-7778	49	6	±	±	NUM
aiua-7778	49	7	6.36	6.36	NUM
aiua-7778	49	8	years	year	NOUN
aiua-7778	49	9	.	.	PUNCT
aiua-7778	50	1	the	the	DET
aiua-7778	50	2	mean	mean	ADJ
aiua-7778	50	3	prostate	prostate	NOUN
aiua-7778	50	4	volume	volume	NOUN
aiua-7778	50	5	was	be	AUX
aiua-7778	50	6	71.64	71.64	NUM
aiua-7778	50	7	±	±	NUM
aiua-7778	50	8	39.9	39.9	NUM
aiua-7778	50	9	cc	cc	NOUN
aiua-7778	50	10	.	.	PUNCT
aiua-7778	51	1	the	the	DET
aiua-7778	51	2	mean	mean	ADJ
aiua-7778	51	3	psa	psa	NOUN
aiua-7778	51	4	and	and	CCONJ
aiua-7778	51	5	free	free	ADJ
aiua-7778	51	6	/	/	SYM
aiua-7778	51	7	total	total	ADJ
aiua-7778	51	8	psa	psa	NOUN
aiua-7778	51	9	value	value	NOUN
aiua-7778	51	10	were	be	AUX
aiua-7778	51	11	9.86±7.43	9.86±7.43	PROPN
aiua-7778	51	12	ng	ng	PROPN
aiua-7778	51	13	/	/	SYM
aiua-7778	51	14	dl	dl	PROPN
aiua-7778	51	15	and	and	CCONJ
aiua-7778	51	16	0.23	0.23	NUM
aiua-7778	51	17	±	±	NUM
aiua-7778	51	18	0.10	0.10	NUM
aiua-7778	51	19	,	,	PUNCT
aiua-7778	51	20	respectively	respectively	ADV
aiua-7778	51	21	.	.	PUNCT
aiua-7778	52	1	the	the	DET
aiua-7778	52	2	mean	mean	PROPN
aiua-7778	52	3	nlr	nlr	PROPN
aiua-7778	52	4	,	,	PUNCT
aiua-7778	52	5	plr	plr	NOUN
aiua-7778	52	6	and	and	CCONJ
aiua-7778	52	7	lmr	lmr	PROPN
aiua-7778	52	8	values	value	NOUN
aiua-7778	52	9	were	be	AUX
aiua-7778	52	10	2.50	2.50	NUM
aiua-7778	52	11	±	±	NUM
aiua-7778	52	12	1.17	1.17	NUM
aiua-7778	52	13	,	,	PUNCT
aiua-7778	52	14	124.94	124.94	NUM
aiua-7778	52	15	±	±	NUM
aiua-7778	52	16	51.81	51.81	NUM
aiua-7778	52	17	and	and	CCONJ
aiua-7778	52	18	3.84	3.84	NUM
aiua-7778	52	19	±	±	NUM
aiua-7778	52	20	1.44	1.44	NUM
aiua-7778	52	21	,	,	PUNCT
aiua-7778	52	22	respectively	respectively	ADV
aiua-7778	52	23	.	.	PUNCT
aiua-7778	53	1	additionally	additionally	ADV
aiua-7778	53	2	,	,	PUNCT
aiua-7778	53	3	patients	patient	NOUN
aiua-7778	53	4	were	be	AUX
aiua-7778	53	5	grouped	group	VERB
aiua-7778	53	6	with	with	ADP
aiua-7778	53	7	regard	regard	NOUN
aiua-7778	53	8	to	to	ADP
aiua-7778	53	9	histology	histology	NOUN
aiua-7778	53	10	of	of	ADP
aiua-7778	53	11	the	the	DET
aiua-7778	53	12	biopsy	biopsy	NOUN
aiua-7778	53	13	.	.	PUNCT
aiua-7778	54	1	among	among	ADP
aiua-7778	54	2	all	all	DET
aiua-7778	54	3	table	table	NOUN
aiua-7778	54	4	1	1	NUM
aiua-7778	54	5	.	.	PUNCT
aiua-7778	54	6	comparison	comparison	NOUN
aiua-7778	54	7	of	of	ADP
aiua-7778	54	8	the	the	DET
aiua-7778	54	9	study	study	NOUN
aiua-7778	54	10	parameters	parameter	NOUN
aiua-7778	54	11	of	of	ADP
aiua-7778	54	12	3	3	NUM
aiua-7778	54	13	histology	histology	NOUN
aiua-7778	54	14	groups	group	NOUN
aiua-7778	54	15	in	in	ADP
aiua-7778	54	16	entire	entire	ADJ
aiua-7778	54	17	cohort	cohort	NOUN
aiua-7778	54	18	.	.	PUNCT
aiua-7778	55	1	bph	bph	NOUN
aiua-7778	55	2	(	(	PUNCT
aiua-7778	55	3	n	n	NOUN
aiua-7778	55	4	=	=	NUM
aiua-7778	55	5	357	357	NUM
aiua-7778	55	6	)	)	PUNCT
aiua-7778	55	7	prostatitis	prostatitis	NOUN
aiua-7778	55	8	(	(	PUNCT
aiua-7778	55	9	n	n	NOUN
aiua-7778	55	10	=	=	SYM
aiua-7778	55	11	24	24	NUM
aiua-7778	55	12	)	)	PUNCT
aiua-7778	55	13	pca	pca	NOUN
aiua-7778	55	14	(	(	PUNCT
aiua-7778	55	15	n	n	NOUN
aiua-7778	55	16	=	=	SYM
aiua-7778	55	17	240	240	NUM
aiua-7778	55	18	)	)	PUNCT
aiua-7778	55	19	p	p	NOUN
aiua-7778	55	20	value	value	NOUN
aiua-7778	55	21	age	age	NOUN
aiua-7778	55	22	,	,	PUNCT
aiua-7778	55	23	years	year	NOUN
aiua-7778	55	24	(	(	PUNCT
aiua-7778	55	25	mean	mean	PROPN
aiua-7778	55	26	±	±	NUM
aiua-7778	55	27	sd	sd	NOUN
aiua-7778	55	28	)	)	PUNCT
aiua-7778	55	29	64,45	64,45	NUM
aiua-7778	55	30	±	±	NUM
aiua-7778	55	31	6,08	6,08	NUM
aiua-7778	55	32	64	64	NUM
aiua-7778	55	33	±	±	NUM
aiua-7778	55	34	5,87	5,87	NUM
aiua-7778	55	35	65,85	65,85	NUM
aiua-7778	55	36	±	±	NUM
aiua-7778	55	37	6,74	6,74	NUM
aiua-7778	55	38	0,004	0,004	NUM
aiua-7778	55	39	total	total	ADJ
aiua-7778	55	40	psa	psa	NOUN
aiua-7778	55	41	,	,	PUNCT
aiua-7778	55	42	ng	ng	PROPN
aiua-7778	55	43	/	/	SYM
aiua-7778	55	44	dl	dl	PROPN
aiua-7778	55	45	(	(	PUNCT
aiua-7778	55	46	mean	mean	PROPN
aiua-7778	55	47	±	±	NUM
aiua-7778	55	48	sd	sd	NOUN
aiua-7778	55	49	)	)	PUNCT
aiua-7778	55	50	8,82	8,82	NUM
aiua-7778	55	51	±	±	NOUN
aiua-7778	55	52	6,61	6,61	NUM
aiua-7778	55	53	6,27	6,27	NUM
aiua-7778	55	54	±	±	NUM
aiua-7778	55	55	2,46	2,46	NUM
aiua-7778	55	56	11,79	11,79	NUM
aiua-7778	55	57	±	±	NUM
aiua-7778	55	58	8,68	8,68	NUM
aiua-7778	55	59	0,001	0,001	NUM
aiua-7778	55	60	free	free	ADJ
aiua-7778	55	61	/	/	SYM
aiua-7778	55	62	total	total	ADJ
aiua-7778	55	63	psa	psa	NOUN
aiua-7778	55	64	(	(	PUNCT
aiua-7778	55	65	mean	mean	PROPN
aiua-7778	55	66	±	±	NUM
aiua-7778	55	67	sd	sd	NOUN
aiua-7778	55	68	)	)	PUNCT
aiua-7778	55	69	0,25	0,25	NUM
aiua-7778	55	70	±	±	NUM
aiua-7778	55	71	0,10	0,10	NOUN
aiua-7778	55	72	0,29	0,29	PROPN
aiua-7778	56	1	±	±	PROPN
aiua-7778	56	2	0,06	0,06	PROPN
aiua-7778	56	3	0,18	0,18	PUNCT
aiua-7778	57	1	±	±	NUM
aiua-7778	57	2	0,10	0,10	NOUN
aiua-7778	57	3	0.000	0.000	NUM
aiua-7778	57	4	prostate	prostate	NOUN
aiua-7778	57	5	volume	volume	NOUN
aiua-7778	57	6	,	,	PUNCT
aiua-7778	57	7	cc	cc	PROPN
aiua-7778	57	8	(	(	PUNCT
aiua-7778	57	9	mean	mean	PROPN
aiua-7778	57	10	±	±	NUM
aiua-7778	57	11	sd	sd	NOUN
aiua-7778	57	12	)	)	PUNCT
aiua-7778	57	13	82,82	82,82	NUM
aiua-7778	57	14	±	±	NUM
aiua-7778	57	15	43,49	43,49	NUM
aiua-7778	57	16	72,75	72,75	NUM
aiua-7778	57	17	±	±	NUM
aiua-7778	57	18	51,14	51,14	NUM
aiua-7778	57	19	54,90	54,90	NUM
aiua-7778	57	20	±	±	NOUN
aiua-7778	57	21	24,30	24,30	NOUN
aiua-7778	57	22	0.000	0.000	NUM
aiua-7778	57	23	comparison	comparison	NOUN
aiua-7778	57	24	of	of	ADP
aiua-7778	57	25	the	the	DET
aiua-7778	57	26	study	study	NOUN
aiua-7778	57	27	parameters	parameter	NOUN
aiua-7778	57	28	of	of	ADP
aiua-7778	57	29	3	3	NUM
aiua-7778	57	30	histology	histology	NOUN
aiua-7778	57	31	groups	group	NOUN
aiua-7778	57	32	in	in	ADP
aiua-7778	57	33	psa	psa	VERB
aiua-7778	57	34	4	4	NUM
aiua-7778	57	35	-	-	SYM
aiua-7778	57	36	10	10	NUM
aiua-7778	57	37	range	range	NOUN
aiua-7778	57	38	bph	bph	NOUN
aiua-7778	57	39	(	(	PUNCT
aiua-7778	57	40	n	n	NOUN
aiua-7778	57	41	=	=	NUM
aiua-7778	57	42	252	252	NUM
aiua-7778	57	43	)	)	PUNCT
aiua-7778	57	44	prostatitis	prostatitis	NOUN
aiua-7778	57	45	(	(	PUNCT
aiua-7778	57	46	n	n	NOUN
aiua-7778	57	47	=	=	SYM
aiua-7778	57	48	18	18	NUM
aiua-7778	57	49	)	)	PUNCT
aiua-7778	57	50	pca	pca	NOUN
aiua-7778	57	51	(	(	PUNCT
aiua-7778	57	52	n	n	NOUN
aiua-7778	57	53	=	=	SYM
aiua-7778	57	54	150	150	NUM
aiua-7778	57	55	)	)	PUNCT
aiua-7778	57	56	age	age	NOUN
aiua-7778	57	57	,	,	PUNCT
aiua-7778	57	58	years	year	NOUN
aiua-7778	57	59	(	(	PUNCT
aiua-7778	57	60	mean	mean	PROPN
aiua-7778	57	61	±	±	NUM
aiua-7778	57	62	sd	sd	NOUN
aiua-7778	57	63	)	)	PUNCT
aiua-7778	57	64	64.58	64.58	NUM
aiua-7778	57	65	±	±	NUM
aiua-7778	57	66	5.89	5.89	NUM
aiua-7778	57	67	63.17	63.17	NUM
aiua-7778	57	68	±	±	NUM
aiua-7778	57	69	6.5	6.5	NUM
aiua-7778	57	70	66.64	66.64	NUM
aiua-7778	57	71	±	±	NUM
aiua-7778	57	72	6.04	6.04	NUM
aiua-7778	57	73	0.000	0.000	NUM
aiua-7778	57	74	total	total	NOUN
aiua-7778	57	75	psa	psa	NOUN
aiua-7778	57	76	,	,	PUNCT
aiua-7778	57	77	ng	ng	PROPN
aiua-7778	57	78	/	/	SYM
aiua-7778	57	79	dl	dl	PROPN
aiua-7778	57	80	(	(	PUNCT
aiua-7778	57	81	mean	mean	PROPN
aiua-7778	57	82	±	±	NUM
aiua-7778	57	83	sd	sd	NOUN
aiua-7778	57	84	)	)	PUNCT
aiua-7778	57	85	6.6	6.6	NUM
aiua-7778	57	86	±	±	NUM
aiua-7778	57	87	1.63	1.63	NUM
aiua-7778	57	88	6.13	6.13	NUM
aiua-7778	57	89	±	±	NUM
aiua-7778	57	90	1.72	1.72	NUM
aiua-7778	57	91	6.86	6.86	NUM
aiua-7778	57	92	±	±	NUM
aiua-7778	57	93	1.72	1.72	NUM
aiua-7778	57	94	0.106	0.106	NUM
aiua-7778	57	95	free	free	ADJ
aiua-7778	57	96	/	/	SYM
aiua-7778	57	97	total	total	ADJ
aiua-7778	57	98	psa	psa	NOUN
aiua-7778	57	99	(	(	PUNCT
aiua-7778	57	100	mean	mean	PROPN
aiua-7778	57	101	±	±	NUM
aiua-7778	57	102	sd	sd	NOUN
aiua-7778	57	103	)	)	PUNCT
aiua-7778	57	104	0.25	0.25	NUM
aiua-7778	57	105	±	±	NUM
aiua-7778	57	106	0.09	0.09	NUM
aiua-7778	57	107	0.30	0.30	NUM
aiua-7778	57	108	±	±	NUM
aiua-7778	57	109	0.06	0.06	NUM
aiua-7778	57	110	0.19	0.19	NUM
aiua-7778	57	111	±	±	NUM
aiua-7778	57	112	0.11	0.11	NUM
aiua-7778	57	113	0.000	0.000	NUM
aiua-7778	57	114	prostate	prostate	NOUN
aiua-7778	57	115	volume	volume	NOUN
aiua-7778	57	116	,	,	PUNCT
aiua-7778	57	117	cc	cc	PROPN
aiua-7778	57	118	(	(	PUNCT
aiua-7778	57	119	mean	mean	PROPN
aiua-7778	57	120	±	±	NUM
aiua-7778	57	121	sd	sd	NOUN
aiua-7778	57	122	)	)	PUNCT
aiua-7778	57	123	80.3	80.3	NUM
aiua-7778	57	124	±	±	NUM
aiua-7778	57	125	39.6	39.6	NUM
aiua-7778	57	126	80.17	80.17	NUM
aiua-7778	57	127	±	±	NUM
aiua-7778	57	128	54.75	54.75	NUM
aiua-7778	57	129	50.78	50.78	NUM
aiua-7778	57	130	±	±	NUM
aiua-7778	57	131	19.08	19.08	NUM
aiua-7778	57	132	0.000	0.000	NUM
aiua-7778	57	133	pca	pca	NOUN
aiua-7778	57	134	:	:	PUNCT
aiua-7778	57	135	prostate	prostate	NOUN
aiua-7778	57	136	cancer	cancer	NOUN
aiua-7778	57	137	;	;	PUNCT
aiua-7778	57	138	bph	bph	NOUN
aiua-7778	57	139	:	:	PUNCT
aiua-7778	57	140	benign	benign	ADJ
aiua-7778	57	141	prostate	prostate	NOUN
aiua-7778	57	142	hyperplasia	hyperplasia	NOUN
aiua-7778	57	143	;	;	PUNCT
aiua-7778	57	144	sd	sd	X
aiua-7778	57	145	:	:	PUNCT
aiua-7778	57	146	standart	standart	NOUN
aiua-7778	57	147	deviation	deviation	NOUN
aiua-7778	57	148	;	;	PUNCT
aiua-7778	57	149	psa	psa	VERB
aiua-7778	57	150	:	:	PUNCT
aiua-7778	57	151	prostate	prostate	NOUN
aiua-7778	57	152	spesific	spesific	NOUN
aiua-7778	57	153	antigen	antigen	PROPN
aiua-7778	57	154	.	.	PUNCT
aiua-7778	58	1	table	table	NOUN
aiua-7778	58	2	2	2	NUM
aiua-7778	58	3	.	.	PUNCT
aiua-7778	59	1	mean	mean	NOUN
aiua-7778	59	2	±	±	NUM
aiua-7778	59	3	sd	sd	ADP
aiua-7778	59	4	values	value	NOUN
aiua-7778	59	5	of	of	ADP
aiua-7778	59	6	the	the	DET
aiua-7778	59	7	inflammation	inflammation	NOUN
aiua-7778	59	8	markers	marker	NOUN
aiua-7778	59	9	and	and	CCONJ
aiua-7778	59	10	p	p	NOUN
aiua-7778	59	11	values	value	NOUN
aiua-7778	59	12	for	for	ADP
aiua-7778	59	13	comparison	comparison	NOUN
aiua-7778	59	14	of	of	ADP
aiua-7778	59	15	the	the	DET
aiua-7778	59	16	histological	histological	ADJ
aiua-7778	59	17	groups	group	NOUN
aiua-7778	59	18	in	in	ADP
aiua-7778	59	19	the	the	DET
aiua-7778	59	20	entire	entire	ADJ
aiua-7778	59	21	cohort	cohort	NOUN
aiua-7778	59	22	.	.	PUNCT
aiua-7778	60	1	bph	bph	NOUN
aiua-7778	60	2	(	(	PUNCT
aiua-7778	60	3	n	n	NOUN
aiua-7778	60	4	=	=	NUM
aiua-7778	60	5	357	357	NUM
aiua-7778	60	6	)	)	PUNCT
aiua-7778	60	7	prostatitis	prostatitis	NOUN
aiua-7778	60	8	(	(	PUNCT
aiua-7778	60	9	n	n	NOUN
aiua-7778	60	10	=	=	SYM
aiua-7778	60	11	24	24	NUM
aiua-7778	60	12	)	)	PUNCT
aiua-7778	60	13	pca	pca	NOUN
aiua-7778	60	14	(	(	PUNCT
aiua-7778	60	15	n	n	NOUN
aiua-7778	60	16	=	=	SYM
aiua-7778	60	17	240	240	NUM
aiua-7778	60	18	)	)	PUNCT
aiua-7778	60	19	nlr	nlr	PROPN
aiua-7778	60	20	value	value	NOUN
aiua-7778	60	21	bph	bph	NOUN
aiua-7778	60	22	=	=	NOUN
aiua-7778	60	23	2,50	2,50	NUM
aiua-7778	60	24	±	±	NUM
aiua-7778	60	25	1,22	1,22	NUM
aiua-7778	60	26	1	1	NUM
aiua-7778	60	27	0,529	0,529	NUM
aiua-7778	60	28	0,543	0,543	NUM
aiua-7778	60	29	(	(	PUNCT
aiua-7778	60	30	mean	mean	PROPN
aiua-7778	60	31	±	±	NUM
aiua-7778	60	32	sd	sd	NOUN
aiua-7778	60	33	)	)	PUNCT
aiua-7778	60	34	prostatitis	prostatitis	NOUN
aiua-7778	60	35	=	=	SYM
aiua-7778	60	36	2,34	2,34	NUM
aiua-7778	60	37	±	±	NUM
aiua-7778	60	38	0,96	0,96	NOUN
aiua-7778	60	39	0,529	0,529	NUM
aiua-7778	60	40	1	1	NUM
aiua-7778	60	41	0,207	0,207	NUM
aiua-7778	60	42	pca	pca	NOUN
aiua-7778	60	43	=	=	SYM
aiua-7778	60	44	2,51	2,51	PROPN
aiua-7778	60	45	±	±	NUM
aiua-7778	60	46	1,10	1,10	NUM
aiua-7778	60	47	0,543	0,543	NUM
aiua-7778	60	48	0,207	0,207	NUM
aiua-7778	60	49	1	1	NUM
aiua-7778	60	50	plr	plr	NOUN
aiua-7778	60	51	value	value	NOUN
aiua-7778	60	52	bph	bph	NOUN
aiua-7778	60	53	=	=	SYM
aiua-7778	60	54	124,02	124,02	PROPN
aiua-7778	60	55	±	±	NUM
aiua-7778	60	56	49,25	49,25	PROPN
aiua-7778	60	57	1	1	NUM
aiua-7778	60	58	0,480	0,480	NUM
aiua-7778	60	59	0,669	0,669	NUM
aiua-7778	60	60	(	(	PUNCT
aiua-7778	60	61	mean	mean	PROPN
aiua-7778	60	62	±	±	NUM
aiua-7778	60	63	sd	sd	NOUN
aiua-7778	60	64	)	)	PUNCT
aiua-7778	60	65	prostatitis	prostatitis	NOUN
aiua-7778	60	66	=	=	PUNCT
aiua-7778	60	67	108,93	108,93	NUM
aiua-7778	60	68	±	±	NUM
aiua-7778	60	69	39,05	39,05	NUM
aiua-7778	60	70	0,480	0,480	NUM
aiua-7778	60	71	1	1	NUM
aiua-7778	60	72	0,512	0,512	NUM
aiua-7778	60	73	pca	pca	NOUN
aiua-7778	60	74	=	=	PROPN
aiua-7778	60	75	127,89	127,89	ADJ
aiua-7778	60	76	±	±	NUM
aiua-7778	61	1	56,30	56,30	NUM
aiua-7778	61	2	0,669	0,669	NUM
aiua-7778	61	3	0,512	0,512	NUM
aiua-7778	61	4	1	1	NUM
aiua-7778	61	5	lmr	lmr	PROPN
aiua-7778	61	6	value	value	NOUN
aiua-7778	61	7	bph	bph	NOUN
aiua-7778	61	8	=	=	NOUN
aiua-7778	61	9	3,92	3,92	NUM
aiua-7778	61	10	±	±	NUM
aiua-7778	61	11	1,45	1,45	NUM
aiua-7778	61	12	1	1	NUM
aiua-7778	61	13	0,485	0,485	NUM
aiua-7778	61	14	0,047	0,047	NUM
aiua-7778	61	15	(	(	PUNCT
aiua-7778	61	16	mean	mean	PROPN
aiua-7778	61	17	±	±	NUM
aiua-7778	61	18	sd	sd	NOUN
aiua-7778	61	19	)	)	PUNCT
aiua-7778	61	20	prostatitis	prostatitis	NOUN
aiua-7778	61	21	=	=	SYM
aiua-7778	61	22	4,11	4,11	SYM
aiua-7778	62	1	±	±	NOUN
aiua-7778	62	2	1,19	1,19	NUM
aiua-7778	62	3	0,485	0,485	NUM
aiua-7778	62	4	1	1	NUM
aiua-7778	62	5	0,098	0,098	NUM
aiua-7778	62	6	pca	pca	NOUN
aiua-7778	62	7	=	=	PUNCT
aiua-7778	62	8	3,67	3,67	NUM
aiua-7778	62	9	±	±	NUM
aiua-7778	62	10	1,44	1,44	NUM
aiua-7778	62	11	0,047	0,047	NUM
aiua-7778	62	12	0,098	0,098	NUM
aiua-7778	62	13	1	1	NUM
aiua-7778	62	14	pca	pca	NOUN
aiua-7778	62	15	:	:	PUNCT
aiua-7778	62	16	prostate	prostate	NOUN
aiua-7778	62	17	cancer	cancer	NOUN
aiua-7778	62	18	;	;	PUNCT
aiua-7778	62	19	bph	bph	NOUN
aiua-7778	62	20	:	:	PUNCT
aiua-7778	62	21	benign	benign	ADJ
aiua-7778	62	22	prostate	prostate	NOUN
aiua-7778	62	23	hyperplasia	hyperplasia	NOUN
aiua-7778	62	24	;	;	PUNCT
aiua-7778	62	25	sd	sd	X
aiua-7778	62	26	:	:	PUNCT
aiua-7778	62	27	standart	standart	NOUN
aiua-7778	62	28	deviation	deviation	NOUN
aiua-7778	62	29	;	;	PUNCT
aiua-7778	62	30	psa	psa	VERB
aiua-7778	62	31	:	:	PUNCT
aiua-7778	62	32	prostate	prostate	NOUN
aiua-7778	62	33	spesific	spesific	NOUN
aiua-7778	62	34	antigen	antigen	PROPN
aiua-7778	62	35	;	;	PUNCT
aiua-7778	62	36	nlr	nlr	PROPN
aiua-7778	62	37	:	:	PUNCT
aiua-7778	62	38	neutrophile	neutrophile	ADV
aiua-7778	62	39	to	to	ADP
aiua-7778	62	40	lymphocyte	lymphocyte	ADJ
aiua-7778	62	41	ratio	ratio	NOUN
aiua-7778	62	42	;	;	PUNCT
aiua-7778	62	43	plr	plr	NOUN
aiua-7778	62	44	:	:	PUNCT
aiua-7778	62	45	platelet	platelet	NOUN
aiua-7778	62	46	to	to	ADP
aiua-7778	62	47	lymphocyte	lymphocyte	ADJ
aiua-7778	62	48	ratio	ratio	NOUN
aiua-7778	62	49	;	;	PUNCT
aiua-7778	62	50	lmr	lmr	NOUN
aiua-7778	62	51	:	:	PUNCT
aiua-7778	62	52	lymphocyte	lymphocyte	ADJ
aiua-7778	62	53	to	to	ADP
aiua-7778	62	54	monocyte	monocyte	NOUN
aiua-7778	62	55	ratio	ratio	NOUN
aiua-7778	62	56	.	.	PUNCT
aiua-7778	63	1	bph	bph	NOUN
aiua-7778	63	2	(	(	PUNCT
aiua-7778	63	3	n	n	NOUN
aiua-7778	63	4	=	=	NUM
aiua-7778	63	5	252	252	NUM
aiua-7778	63	6	)	)	PUNCT
aiua-7778	63	7	prostatitis	prostatitis	NOUN
aiua-7778	63	8	(	(	PUNCT
aiua-7778	63	9	n	n	NOUN
aiua-7778	63	10	=	=	SYM
aiua-7778	63	11	18	18	NUM
aiua-7778	63	12	)	)	PUNCT
aiua-7778	63	13	pca	pca	NOUN
aiua-7778	63	14	(	(	PUNCT
aiua-7778	63	15	n	n	NOUN
aiua-7778	63	16	=	=	SYM
aiua-7778	63	17	150	150	NUM
aiua-7778	63	18	)	)	PUNCT
aiua-7778	63	19	nlr	nlr	PROPN
aiua-7778	63	20	value	value	NOUN
aiua-7778	63	21	bph	bph	NOUN
aiua-7778	63	22	=	=	NOUN
aiua-7778	63	23	2.52	2.52	NUM
aiua-7778	63	24	±	±	NUM
aiua-7778	63	25	1.31	1.31	NUM
aiua-7778	63	26	1	1	NUM
aiua-7778	63	27	0.439	0.439	NUM
aiua-7778	63	28	0.295	0.295	NUM
aiua-7778	63	29	(	(	PUNCT
aiua-7778	63	30	mean	mean	PROPN
aiua-7778	63	31	±	±	NUM
aiua-7778	63	32	sd	sd	NOUN
aiua-7778	63	33	)	)	PUNCT
aiua-7778	63	34	prostatitis	prostatitis	NOUN
aiua-7778	63	35	=	=	PUNCT
aiua-7778	63	36	2.64	2.64	NUM
aiua-7778	63	37	±	±	NUM
aiua-7778	63	38	0.94	0.94	NUM
aiua-7778	63	39	0.439	0.439	NUM
aiua-7778	63	40	1	1	NUM
aiua-7778	63	41	0.982	0.982	NUM
aiua-7778	63	42	pca	pca	NOUN
aiua-7778	63	43	=	=	PUNCT
aiua-7778	63	44	2.55	2.55	NUM
aiua-7778	63	45	±	±	NUM
aiua-7778	63	46	1.10	1.10	NUM
aiua-7778	63	47	0.295	0.295	NUM
aiua-7778	63	48	0.982	0.982	NUM
aiua-7778	63	49	1	1	NUM
aiua-7778	63	50	plr	plr	NOUN
aiua-7778	63	51	value	value	NOUN
aiua-7778	63	52	bph	bph	NOUN
aiua-7778	63	53	=	=	NOUN
aiua-7778	63	54	123.64	123.64	NUM
aiua-7778	63	55	±	±	NUM
aiua-7778	63	56	49.58	49.58	NUM
aiua-7778	63	57	1	1	NUM
aiua-7778	63	58	0.910	0.910	NUM
aiua-7778	63	59	0.743	0.743	NUM
aiua-7778	63	60	(	(	PUNCT
aiua-7778	63	61	mean	mean	PROPN
aiua-7778	63	62	±	±	NUM
aiua-7778	63	63	sd	sd	NOUN
aiua-7778	63	64	)	)	PUNCT
aiua-7778	63	65	prostatitis	prostatitis	NOUN
aiua-7778	63	66	=	=	SYM
aiua-7778	63	67	114.06	114.06	NUM
aiua-7778	63	68	±	±	NUM
aiua-7778	63	69	28.13	28.13	NUM
aiua-7778	63	70	0.910	0.910	NUM
aiua-7778	63	71	1	1	NUM
aiua-7778	63	72	0.782	0.782	NUM
aiua-7778	63	73	pca	pca	NOUN
aiua-7778	63	74	=	=	PROPN
aiua-7778	63	75	124.13	124.13	NUM
aiua-7778	63	76	±	±	NUM
aiua-7778	63	77	48.79	48.79	NUM
aiua-7778	63	78	0.743	0.743	NUM
aiua-7778	63	79	0.782	0.782	NUM
aiua-7778	63	80	1	1	NUM
aiua-7778	63	81	lmr	lmr	PROPN
aiua-7778	63	82	value	value	NOUN
aiua-7778	63	83	bph	bph	NOUN
aiua-7778	63	84	=	=	NOUN
aiua-7778	63	85	3.95	3.95	NUM
aiua-7778	63	86	±	±	NUM
aiua-7778	63	87	1.54	1.54	NUM
aiua-7778	63	88	1	1	NUM
aiua-7778	63	89	0.536	0.536	NUM
aiua-7778	63	90	0.012	0.012	NUM
aiua-7778	63	91	(	(	PUNCT
aiua-7778	63	92	mean	mean	PROPN
aiua-7778	63	93	±	±	NUM
aiua-7778	63	94	sd	sd	NOUN
aiua-7778	63	95	)	)	PUNCT
aiua-7778	63	96	prostatitis	prostatitis	NOUN
aiua-7778	63	97	=	=	PUNCT
aiua-7778	63	98	3.80	3.80	NUM
aiua-7778	63	99	±	±	NUM
aiua-7778	63	100	1.19	1.19	NUM
aiua-7778	63	101	0.536	0.536	NUM
aiua-7778	63	102	1	1	NUM
aiua-7778	63	103	0.533	0.533	NUM
aiua-7778	63	104	pca	pca	NOUN
aiua-7778	63	105	=	=	PUNCT
aiua-7778	63	106	3.56	3.56	NUM
aiua-7778	63	107	±	±	NUM
aiua-7778	63	108	1.33	1.33	NUM
aiua-7778	63	109	0.012	0.012	NUM
aiua-7778	63	110	0.533	0.533	NUM
aiua-7778	63	111	1	1	NUM
aiua-7778	63	112	pca	pca	NOUN
aiua-7778	63	113	:	:	PUNCT
aiua-7778	63	114	prostate	prostate	NOUN
aiua-7778	63	115	cancer	cancer	NOUN
aiua-7778	63	116	;	;	PUNCT
aiua-7778	63	117	bph	bph	NOUN
aiua-7778	63	118	:	:	PUNCT
aiua-7778	63	119	benign	benign	ADJ
aiua-7778	63	120	prostate	prostate	NOUN
aiua-7778	63	121	hyperplasia	hyperplasia	NOUN
aiua-7778	63	122	;	;	PUNCT
aiua-7778	63	123	sd	sd	X
aiua-7778	63	124	:	:	PUNCT
aiua-7778	63	125	standart	standart	NOUN
aiua-7778	63	126	deviation	deviation	NOUN
aiua-7778	63	127	;	;	PUNCT
aiua-7778	63	128	psa	psa	VERB
aiua-7778	63	129	:	:	PUNCT
aiua-7778	63	130	prostate	prostate	NOUN
aiua-7778	63	131	spesific	spesific	NOUN
aiua-7778	63	132	antigen	antigen	PROPN
aiua-7778	63	133	;	;	PUNCT
aiua-7778	63	134	nlr	nlr	PROPN
aiua-7778	63	135	:	:	PUNCT
aiua-7778	63	136	neutrophile	neutrophile	ADV
aiua-7778	63	137	to	to	ADP
aiua-7778	63	138	lymphocyte	lymphocyte	ADJ
aiua-7778	63	139	ratio	ratio	NOUN
aiua-7778	63	140	;	;	PUNCT
aiua-7778	63	141	plr	plr	NOUN
aiua-7778	63	142	:	:	PUNCT
aiua-7778	63	143	platelet	platelet	NOUN
aiua-7778	63	144	to	to	ADP
aiua-7778	63	145	lymphocyte	lymphocyte	ADJ
aiua-7778	63	146	ratio	ratio	NOUN
aiua-7778	63	147	;	;	PUNCT
aiua-7778	63	148	lmr	lmr	NOUN
aiua-7778	63	149	:	:	PUNCT
aiua-7778	63	150	lymphocyte	lymphocyte	ADJ
aiua-7778	63	151	to	to	ADP
aiua-7778	63	152	monocyte	monocyte	NOUN
aiua-7778	63	153	ratio	ratio	NOUN
aiua-7778	63	154	.	.	PUNCT
aiua-7778	64	1	table	table	NOUN
aiua-7778	64	2	3	3	NUM
aiua-7778	64	3	.	.	PUNCT
aiua-7778	65	1	mean	mean	NOUN
aiua-7778	65	2	±	±	NUM
aiua-7778	65	3	sd	sd	ADP
aiua-7778	65	4	values	value	NOUN
aiua-7778	65	5	of	of	ADP
aiua-7778	65	6	the	the	DET
aiua-7778	65	7	inflammation	inflammation	NOUN
aiua-7778	65	8	markers	marker	NOUN
aiua-7778	65	9	and	and	CCONJ
aiua-7778	65	10	p	p	NOUN
aiua-7778	65	11	values	value	NOUN
aiua-7778	65	12	for	for	ADP
aiua-7778	65	13	comparison	comparison	NOUN
aiua-7778	65	14	of	of	ADP
aiua-7778	65	15	the	the	DET
aiua-7778	65	16	histological	histological	ADJ
aiua-7778	65	17	groups	group	NOUN
aiua-7778	65	18	in	in	ADP
aiua-7778	65	19	the	the	DET
aiua-7778	65	20	cohort	cohort	NOUN
aiua-7778	65	21	psa	psa	VERB
aiua-7778	65	22	4	4	NUM
aiua-7778	65	23	-	-	SYM
aiua-7778	65	24	10	10	NUM
aiua-7778	65	25	ng	ng	PROPN
aiua-7778	65	26	/	/	SYM
aiua-7778	65	27	dl	dl	PROPN
aiua-7778	65	28	range	range	NOUN
aiua-7778	65	29	.	.	PUNCT
aiua-7778	66	1	caglayan_stesura	caglayan_stesura	NOUN
aiua-7778	66	2	seveso	seveso	VERB
aiua-7778	66	3	10/01/19	10/01/19	PROPN
aiua-7778	66	4	16:08	16:08	NUM
aiua-7778	66	5	pagina	pagina	NOUN
aiua-7778	66	6	271	271	NUM
aiua-7778	66	7	archivio	archivio	NOUN
aiua-7778	66	8	italiano	italiano	X
aiua-7778	66	9	di	di	X
aiua-7778	66	10	urologia	urologia	PROPN
aiua-7778	66	11	e	e	PROPN
aiua-7778	66	12	andrologia	andrologia	NOUN
aiua-7778	66	13	2018	2018	NUM
aiua-7778	66	14	;	;	PUNCT
aiua-7778	66	15	90	90	NUM
aiua-7778	66	16	,	,	PUNCT
aiua-7778	66	17	4	4	NUM
aiua-7778	66	18	v.	v.	ADP
aiua-7778	66	19	caglayan	caglayan	NOUN
aiua-7778	66	20	,	,	PUNCT
aiua-7778	66	21	e.	e.	PROPN
aiua-7778	66	22	onen	onen	PROPN
aiua-7778	66	23	,	,	PUNCT
aiua-7778	66	24	s.	s.	PROPN
aiua-7778	66	25	avci	avci	PROPN
aiua-7778	66	26	,	,	PUNCT
aiua-7778	66	27	m.	m.	NOUN
aiua-7778	66	28	sambel	sambel	NOUN
aiua-7778	66	29	,	,	PUNCT
aiua-7778	66	30	m.	m.	NOUN
aiua-7778	66	31	kilic	kilic	PROPN
aiua-7778	66	32	,	,	PUNCT
aiua-7778	66	33	s.	s.	PROPN
aiua-7778	66	34	oner	oner	PROPN
aiua-7778	66	35	,	,	PUNCT
aiua-7778	66	36	m.	m.	NOUN
aiua-7778	66	37	murat	murat	PROPN
aiua-7778	66	38	aydos	aydos	PROPN
aiua-7778	66	39	,	,	PUNCT
aiua-7778	66	40	h.	h.	PROPN
aiua-7778	66	41	emre	emre	PROPN
aiua-7778	66	42	yıldız	yıldız	PROPN
aiua-7778	66	43	272	272	NUM
aiua-7778	66	44	the	the	DET
aiua-7778	66	45	individuals	individual	NOUN
aiua-7778	66	46	,	,	PUNCT
aiua-7778	66	47	bph	bph	NOUN
aiua-7778	66	48	was	be	AUX
aiua-7778	66	49	detected	detect	VERB
aiua-7778	66	50	in	in	ADP
aiua-7778	66	51	357	357	NUM
aiua-7778	66	52	patients	patient	NOUN
aiua-7778	66	53	,	,	PUNCT
aiua-7778	66	54	prostatitis	prostatitis	NOUN
aiua-7778	66	55	was	be	AUX
aiua-7778	66	56	detected	detect	VERB
aiua-7778	66	57	in	in	ADP
aiua-7778	66	58	24	24	NUM
aiua-7778	66	59	and	and	CCONJ
aiua-7778	66	60	pca	pca	PROPN
aiua-7778	66	61	was	be	AUX
aiua-7778	66	62	detected	detect	VERB
aiua-7778	66	63	in	in	ADP
aiua-7778	66	64	240	240	NUM
aiua-7778	66	65	.	.	PUNCT
aiua-7778	67	1	the	the	DET
aiua-7778	67	2	mean	mean	ADJ
aiua-7778	67	3	age	age	NOUN
aiua-7778	67	4	and	and	CCONJ
aiua-7778	67	5	the	the	DET
aiua-7778	67	6	mean	mean	ADJ
aiua-7778	67	7	psa	psa	NOUN
aiua-7778	67	8	value	value	NOUN
aiua-7778	67	9	of	of	ADP
aiua-7778	67	10	the	the	DET
aiua-7778	67	11	pca	pca	PROPN
aiua-7778	67	12	group	group	NOUN
aiua-7778	67	13	were	be	AUX
aiua-7778	67	14	significantly	significantly	ADV
aiua-7778	67	15	higher	high	ADJ
aiua-7778	67	16	when	when	SCONJ
aiua-7778	67	17	compared	compare	VERB
aiua-7778	67	18	to	to	ADP
aiua-7778	67	19	the	the	DET
aiua-7778	67	20	other	other	ADJ
aiua-7778	67	21	groups	group	NOUN
aiua-7778	67	22	.	.	PUNCT
aiua-7778	68	1	also	also	ADV
aiua-7778	68	2	the	the	DET
aiua-7778	68	3	mean	mean	ADJ
aiua-7778	68	4	prostate	prostate	NOUN
aiua-7778	68	5	volume	volume	NOUN
aiua-7778	68	6	and	and	CCONJ
aiua-7778	68	7	free	free	ADJ
aiua-7778	68	8	/	/	SYM
aiua-7778	68	9	total	total	ADJ
aiua-7778	68	10	psa	psa	NOUN
aiua-7778	68	11	ratio	ratio	NOUN
aiua-7778	68	12	were	be	AUX
aiua-7778	68	13	significantly	significantly	ADV
aiua-7778	68	14	lower	low	ADJ
aiua-7778	68	15	(	(	PUNCT
aiua-7778	68	16	table	table	NOUN
aiua-7778	68	17	1	1	NUM
aiua-7778	68	18	)	)	PUNCT
aiua-7778	68	19	.	.	PUNCT
aiua-7778	69	1	nlr	nlr	PROPN
aiua-7778	69	2	,	,	PUNCT
aiua-7778	69	3	plr	plr	NOUN
aiua-7778	69	4	and	and	CCONJ
aiua-7778	69	5	lmr	lmr	PROPN
aiua-7778	69	6	values	value	NOUN
aiua-7778	69	7	of	of	ADP
aiua-7778	69	8	the	the	DET
aiua-7778	69	9	histological	histological	ADJ
aiua-7778	69	10	groups	group	NOUN
aiua-7778	69	11	were	be	AUX
aiua-7778	69	12	compared	compare	VERB
aiua-7778	69	13	.	.	PUNCT
aiua-7778	70	1	any	any	DET
aiua-7778	70	2	statistically	statistically	ADV
aiua-7778	70	3	significant	significant	ADJ
aiua-7778	70	4	difference	difference	NOUN
aiua-7778	70	5	was	be	AUX
aiua-7778	70	6	not	not	PART
aiua-7778	70	7	observed	observe	VERB
aiua-7778	70	8	for	for	ADP
aiua-7778	70	9	nlr	nlr	PROPN
aiua-7778	70	10	and	and	CCONJ
aiua-7778	70	11	plr	plr	NOUN
aiua-7778	70	12	values	value	NOUN
aiua-7778	70	13	.	.	PUNCT
aiua-7778	71	1	mean	mean	VERB
aiua-7778	71	2	lmr	lmr	PROPN
aiua-7778	71	3	value	value	NOUN
aiua-7778	71	4	of	of	ADP
aiua-7778	71	5	the	the	DET
aiua-7778	71	6	patients	patient	NOUN
aiua-7778	71	7	with	with	ADP
aiua-7778	71	8	pca	pca	PROPN
aiua-7778	71	9	was	be	AUX
aiua-7778	71	10	significantly	significantly	ADV
aiua-7778	71	11	lower	low	ADJ
aiua-7778	71	12	than	than	ADP
aiua-7778	71	13	patients	patient	NOUN
aiua-7778	71	14	with	with	ADP
aiua-7778	71	15	bph	bph	NOUN
aiua-7778	71	16	and	and	CCONJ
aiua-7778	71	17	prostatitis	prostatitis	NOUN
aiua-7778	71	18	(	(	PUNCT
aiua-7778	71	19	p	p	X
aiua-7778	71	20	=	=	NOUN
aiua-7778	71	21	0.047	0.047	NUM
aiua-7778	71	22	)	)	PUNCT
aiua-7778	71	23	(	(	PUNCT
aiua-7778	71	24	table	table	NOUN
aiua-7778	71	25	2	2	NUM
aiua-7778	71	26	)	)	PUNCT
aiua-7778	71	27	.	.	PUNCT
aiua-7778	72	1	the	the	DET
aiua-7778	72	2	patients	patient	NOUN
aiua-7778	72	3	were	be	AUX
aiua-7778	72	4	divided	divide	VERB
aiua-7778	72	5	into	into	ADP
aiua-7778	72	6	3	3	NUM
aiua-7778	72	7	groups	group	NOUN
aiua-7778	72	8	as	as	ADP
aiua-7778	72	9	;	;	PUNCT
aiua-7778	72	10	with	with	ADP
aiua-7778	72	11	psa	psa	VERB
aiua-7778	72	12	lower	low	ADJ
aiua-7778	72	13	than	than	ADP
aiua-7778	72	14	4	4	NUM
aiua-7778	72	15	ng	ng	PROPN
aiua-7778	72	16	/	/	SYM
aiua-7778	72	17	dl	dl	PROPN
aiua-7778	72	18	,	,	PUNCT
aiua-7778	72	19	with	with	ADP
aiua-7778	72	20	psa	psa	NOUN
aiua-7778	72	21	between	between	ADP
aiua-7778	72	22	4	4	NUM
aiua-7778	72	23	and	and	CCONJ
aiua-7778	72	24	10	10	NUM
aiua-7778	72	25	ng	ng	PROPN
aiua-7778	72	26	/	/	SYM
aiua-7778	72	27	dl	dl	PROPN
aiua-7778	72	28	and	and	CCONJ
aiua-7778	72	29	with	with	ADP
aiua-7778	72	30	psa	psa	NOUN
aiua-7778	72	31	higher	high	ADJ
aiua-7778	72	32	than	than	ADP
aiua-7778	72	33	10	10	NUM
aiua-7778	72	34	ng	ng	PROPN
aiua-7778	72	35	/	/	SYM
aiua-7778	72	36	dl	dl	PROPN
aiua-7778	72	37	.	.	PROPN
aiua-7778	72	38	in	in	ADP
aiua-7778	72	39	the	the	DET
aiua-7778	72	40	patients	patient	NOUN
aiua-7778	72	41	with	with	ADP
aiua-7778	72	42	psa	psa	VERB
aiua-7778	72	43	between	between	ADP
aiua-7778	72	44	4	4	NUM
aiua-7778	72	45	and	and	CCONJ
aiua-7778	72	46	10	10	NUM
aiua-7778	72	47	ng	ng	PROPN
aiua-7778	72	48	/	/	SYM
aiua-7778	72	49	dl	dl	PROPN
aiua-7778	72	50	,	,	PUNCT
aiua-7778	72	51	lmr	lmr	PROPN
aiua-7778	72	52	value	value	NOUN
aiua-7778	72	53	was	be	AUX
aiua-7778	72	54	significantly	significantly	ADV
aiua-7778	72	55	lower	low	ADJ
aiua-7778	72	56	in	in	ADP
aiua-7778	72	57	patients	patient	NOUN
aiua-7778	72	58	with	with	ADP
aiua-7778	72	59	pca	pca	PROPN
aiua-7778	72	60	than	than	ADP
aiua-7778	72	61	those	those	PRON
aiua-7778	72	62	with	with	ADP
aiua-7778	72	63	bph	bph	NOUN
aiua-7778	72	64	or	or	CCONJ
aiua-7778	72	65	prostatitis	prostatitis	NOUN
aiua-7778	72	66	(	(	PUNCT
aiua-7778	72	67	p	p	NOUN
aiua-7778	72	68	=	=	NOUN
aiua-7778	72	69	0.012	0.012	NUM
aiua-7778	72	70	)	)	PUNCT
aiua-7778	72	71	(	(	PUNCT
aiua-7778	72	72	table	table	NOUN
aiua-7778	72	73	3	3	NUM
aiua-7778	72	74	)	)	PUNCT
aiua-7778	72	75	.	.	PUNCT
aiua-7778	73	1	any	any	DET
aiua-7778	73	2	statistically	statistically	ADV
aiua-7778	73	3	significant	significant	ADJ
aiua-7778	73	4	difference	difference	NOUN
aiua-7778	73	5	between	between	ADP
aiua-7778	73	6	the	the	DET
aiua-7778	73	7	groups	group	NOUN
aiua-7778	73	8	was	be	AUX
aiua-7778	73	9	not	not	PART
aiua-7778	73	10	observed	observe	VERB
aiua-7778	73	11	in	in	ADP
aiua-7778	73	12	nlr	nlr	PROPN
aiua-7778	73	13	and	and	CCONJ
aiua-7778	73	14	plr	plr	NOUN
aiua-7778	73	15	in	in	ADP
aiua-7778	73	16	the	the	DET
aiua-7778	73	17	psa	psa	NOUN
aiua-7778	73	18	410	410	NUM
aiua-7778	73	19	ng	ng	PROPN
aiua-7778	73	20	/	/	SYM
aiua-7778	73	21	dl	dl	PROPN
aiua-7778	73	22	range	range	NOUN
aiua-7778	73	23	.	.	PUNCT
aiua-7778	74	1	in	in	ADP
aiua-7778	74	2	the	the	DET
aiua-7778	74	3	group	group	NOUN
aiua-7778	74	4	of	of	ADP
aiua-7778	74	5	the	the	DET
aiua-7778	74	6	patients	patient	NOUN
aiua-7778	74	7	with	with	ADP
aiua-7778	74	8	psa	psa	VERB
aiua-7778	74	9	higher	high	ADJ
aiua-7778	74	10	than	than	ADP
aiua-7778	74	11	10	10	NUM
aiua-7778	74	12	ng	ng	PROPN
aiua-7778	74	13	/	/	SYM
aiua-7778	74	14	dl	dl	PROPN
aiua-7778	74	15	,	,	PUNCT
aiua-7778	74	16	there	there	PRON
aiua-7778	74	17	was	be	VERB
aiua-7778	74	18	not	not	PART
aiua-7778	74	19	any	any	DET
aiua-7778	74	20	statistically	statistically	ADV
aiua-7778	74	21	significant	significant	ADJ
aiua-7778	74	22	variation	variation	NOUN
aiua-7778	74	23	for	for	ADP
aiua-7778	74	24	nlr	nlr	PROPN
aiua-7778	74	25	,	,	PUNCT
aiua-7778	74	26	plr	plr	NOUN
aiua-7778	74	27	and	and	CCONJ
aiua-7778	74	28	lmr	lmr	PROPN
aiua-7778	74	29	(	(	PUNCT
aiua-7778	74	30	table	table	NOUN
aiua-7778	74	31	4	4	NUM
aiua-7778	74	32	)	)	PUNCT
aiua-7778	74	33	.	.	PUNCT
aiua-7778	75	1	in	in	ADP
aiua-7778	75	2	this	this	DET
aiua-7778	75	3	group	group	NOUN
aiua-7778	75	4	,	,	PUNCT
aiua-7778	75	5	the	the	DET
aiua-7778	75	6	presence	presence	NOUN
aiua-7778	75	7	of	of	ADP
aiua-7778	75	8	prostatitis	prostatitis	NOUN
aiua-7778	75	9	could	could	AUX
aiua-7778	75	10	not	not	PART
aiua-7778	75	11	be	be	AUX
aiua-7778	75	12	compared	compare	VERB
aiua-7778	75	13	due	due	ADP
aiua-7778	75	14	to	to	ADP
aiua-7778	75	15	the	the	DET
aiua-7778	75	16	low	low	ADJ
aiua-7778	75	17	number	number	NOUN
aiua-7778	75	18	of	of	ADP
aiua-7778	75	19	patients	patient	NOUN
aiua-7778	75	20	.	.	PUNCT
aiua-7778	76	1	the	the	DET
aiua-7778	76	2	patients	patient	NOUN
aiua-7778	76	3	with	with	ADP
aiua-7778	76	4	pca	pca	PROPN
aiua-7778	76	5	were	be	AUX
aiua-7778	76	6	seperated	seperate	VERB
aiua-7778	76	7	into	into	ADP
aiua-7778	76	8	2	2	NUM
aiua-7778	76	9	groups	group	NOUN
aiua-7778	76	10	as	as	SCONJ
aiua-7778	76	11	patients	patient	NOUN
aiua-7778	76	12	with	with	ADP
aiua-7778	76	13	gleason	gleason	PROPN
aiua-7778	76	14	score	score	VERB
aiua-7778	76	15	6	6	NUM
aiua-7778	76	16	and	and	CCONJ
aiua-7778	76	17	patients	patient	NOUN
aiua-7778	76	18	with	with	ADP
aiua-7778	76	19	gleason	gleason	PROPN
aiua-7778	76	20	score	score	VERB
aiua-7778	76	21	7	7	NUM
aiua-7778	76	22	and	and	CCONJ
aiua-7778	76	23	above	above	ADV
aiua-7778	76	24	.	.	PUNCT
aiua-7778	77	1	there	there	PRON
aiua-7778	77	2	was	be	VERB
aiua-7778	77	3	no	no	DET
aiua-7778	77	4	statistically	statistically	ADV
aiua-7778	77	5	significant	significant	ADJ
aiua-7778	77	6	difference	difference	NOUN
aiua-7778	77	7	between	between	ADP
aiua-7778	77	8	the	the	DET
aiua-7778	77	9	groups	group	NOUN
aiua-7778	77	10	in	in	ADP
aiua-7778	77	11	nlr	nlr	PROPN
aiua-7778	77	12	,	,	PUNCT
aiua-7778	77	13	plr	plr	NOUN
aiua-7778	77	14	and	and	CCONJ
aiua-7778	77	15	lmr	lmr	PROPN
aiua-7778	77	16	value	value	NOUN
aiua-7778	77	17	(	(	PUNCT
aiua-7778	77	18	table	table	NOUN
aiua-7778	77	19	5	5	NUM
aiua-7778	77	20	)	)	PUNCT
aiua-7778	77	21	.	.	PUNCT
aiua-7778	78	1	in	in	ADP
aiua-7778	78	2	the	the	DET
aiua-7778	78	3	patients	patient	NOUN
aiua-7778	78	4	with	with	ADP
aiua-7778	78	5	psa	psa	VERB
aiua-7778	78	6	between	between	ADP
aiua-7778	78	7	4	4	NUM
aiua-7778	78	8	and	and	CCONJ
aiua-7778	78	9	10	10	NUM
aiua-7778	78	10	ng	ng	PROPN
aiua-7778	78	11	/	/	SYM
aiua-7778	78	12	dl	dl	PROPN
aiua-7778	78	13	,	,	PUNCT
aiua-7778	78	14	age	age	NOUN
aiua-7778	78	15	,	,	PUNCT
aiua-7778	78	16	free	free	ADJ
aiua-7778	78	17	/	/	SYM
aiua-7778	78	18	total	total	ADJ
aiua-7778	78	19	psa	psa	NOUN
aiua-7778	78	20	ratio	ratio	NOUN
aiua-7778	78	21	and	and	CCONJ
aiua-7778	78	22	lmr	lmr	PROPN
aiua-7778	78	23	were	be	AUX
aiua-7778	78	24	significant	significant	ADJ
aiua-7778	78	25	factors	factor	NOUN
aiua-7778	78	26	to	to	PART
aiua-7778	78	27	predict	predict	VERB
aiua-7778	78	28	pca	pca	PROPN
aiua-7778	78	29	.	.	PROPN
aiua-7778	79	1	based	base	VERB
aiua-7778	79	2	on	on	ADP
aiua-7778	79	3	the	the	DET
aiua-7778	79	4	auroc	auroc	NOUN
aiua-7778	79	5	curve	curve	NOUN
aiua-7778	79	6	,	,	PUNCT
aiua-7778	79	7	the	the	DET
aiua-7778	79	8	cut	cut	VERB
aiua-7778	79	9	-	-	PUNCT
aiua-7778	79	10	off	off	ADP
aiua-7778	79	11	points	point	NOUN
aiua-7778	79	12	of	of	ADP
aiua-7778	79	13	lmr	lmr	PROPN
aiua-7778	79	14	,	,	PUNCT
aiua-7778	79	15	free	free	ADJ
aiua-7778	79	16	/	/	SYM
aiua-7778	79	17	total	total	ADJ
aiua-7778	79	18	psa	psa	NOUN
aiua-7778	79	19	and	and	CCONJ
aiua-7778	79	20	age	age	NOUN
aiua-7778	79	21	were	be	AUX
aiua-7778	79	22	3.05	3.05	NUM
aiua-7778	79	23	,	,	PUNCT
aiua-7778	79	24	0.15	0.15	NUM
aiua-7778	79	25	and	and	CCONJ
aiua-7778	79	26	65.5	65.5	NUM
aiua-7778	79	27	respectively	respectively	ADV
aiua-7778	79	28	(	(	PUNCT
aiua-7778	79	29	figure	figure	NOUN
aiua-7778	79	30	1	1	NUM
aiua-7778	79	31	)	)	PUNCT
aiua-7778	79	32	.	.	PUNCT
aiua-7778	80	1	multivariate	multivariate	NOUN
aiua-7778	80	2	analysis	analysis	NOUN
aiua-7778	80	3	showed	show	VERB
aiua-7778	80	4	that	that	SCONJ
aiua-7778	80	5	lmr	lmr	PROPN
aiua-7778	80	6	(	(	PUNCT
aiua-7778	80	7	hr	hr	NOUN
aiua-7778	80	8	=	=	PROPN
aiua-7778	80	9	1.65	1.65	NUM
aiua-7778	80	10	)	)	PUNCT
aiua-7778	80	11	,	,	PUNCT
aiua-7778	80	12	age	age	NOUN
aiua-7778	80	13	(	(	PUNCT
aiua-7778	80	14	hr	hr	NOUN
aiua-7778	80	15	=	=	NOUN
aiua-7778	80	16	2.77	2.77	NUM
aiua-7778	80	17	)	)	PUNCT
aiua-7778	80	18	and	and	CCONJ
aiua-7778	80	19	free	free	ADJ
aiua-7778	80	20	/	/	SYM
aiua-7778	80	21	total	total	ADJ
aiua-7778	80	22	psa	psa	NOUN
aiua-7778	80	23	ratio	ratio	NOUN
aiua-7778	80	24	(	(	PUNCT
aiua-7778	80	25	hr	hr	NOUN
aiua-7778	80	26	=	=	NOUN
aiua-7778	80	27	12.3	12.3	NUM
aiua-7778	80	28	)	)	PUNCT
aiua-7778	80	29	were	be	AUX
aiua-7778	80	30	independent	independent	ADJ
aiua-7778	80	31	risk	risk	NOUN
aiua-7778	80	32	factors	factor	NOUN
aiua-7778	80	33	to	to	PART
aiua-7778	80	34	predict	predict	VERB
aiua-7778	80	35	pca	pca	PROPN
aiua-7778	80	36	(	(	PUNCT
aiua-7778	80	37	table	table	NOUN
aiua-7778	80	38	6	6	NUM
aiua-7778	80	39	)	)	PUNCT
aiua-7778	80	40	.	.	PUNCT
aiua-7778	81	1	the	the	DET
aiua-7778	81	2	sensitivities	sensitivity	NOUN
aiua-7778	81	3	,	,	PUNCT
aiua-7778	81	4	spesificities	spesificitie	NOUN
aiua-7778	81	5	,	,	PUNCT
aiua-7778	81	6	positive	positive	ADJ
aiua-7778	81	7	predictive	predictive	ADJ
aiua-7778	81	8	values	value	NOUN
aiua-7778	81	9	and	and	CCONJ
aiua-7778	81	10	negative	negative	ADJ
aiua-7778	81	11	predictive	predictive	ADJ
aiua-7778	81	12	values	value	NOUN
aiua-7778	81	13	using	use	VERB
aiua-7778	81	14	lmr	lmr	PROPN
aiua-7778	81	15	cut	cut	PROPN
aiua-7778	81	16	-	-	PUNCT
aiua-7778	81	17	off	off	NOUN
aiua-7778	81	18	,	,	PUNCT
aiua-7778	81	19	free	free	ADJ
aiua-7778	81	20	/	/	SYM
aiua-7778	81	21	total	total	ADJ
aiua-7778	81	22	psa	psa	NOUN
aiua-7778	81	23	cut	cut	NOUN
aiua-7778	81	24	-	-	PUNCT
aiua-7778	81	25	off	off	NOUN
aiua-7778	81	26	and	and	CCONJ
aiua-7778	81	27	their	their	PRON
aiua-7778	81	28	combination	combination	NOUN
aiua-7778	81	29	were	be	AUX
aiua-7778	81	30	showed	show	VERB
aiua-7778	81	31	in	in	ADP
aiua-7778	81	32	table	table	NOUN
aiua-7778	81	33	7	7	NUM
aiua-7778	81	34	.	.	PUNCT
aiua-7778	81	35	specificity	specificity	NOUN
aiua-7778	81	36	and	and	CCONJ
aiua-7778	81	37	positive	positive	ADJ
aiua-7778	81	38	predictive	predictive	ADJ
aiua-7778	81	39	value	value	NOUN
aiua-7778	81	40	of	of	ADP
aiua-7778	81	41	the	the	DET
aiua-7778	81	42	combination	combination	NOUN
aiua-7778	81	43	group	group	NOUN
aiua-7778	81	44	were	be	AUX
aiua-7778	81	45	higher	high	ADJ
aiua-7778	81	46	(	(	PUNCT
aiua-7778	81	47	97.2	97.2	NUM
aiua-7778	81	48	%	%	NOUN
aiua-7778	81	49	,	,	PUNCT
aiua-7778	81	50	83.3	83.3	NUM
aiua-7778	81	51	%	%	NOUN
aiua-7778	81	52	respectively	respectively	ADV
aiua-7778	81	53	)	)	PUNCT
aiua-7778	81	54	compared	compare	VERB
aiua-7778	81	55	to	to	ADP
aiua-7778	81	56	the	the	DET
aiua-7778	81	57	free	free	ADJ
aiua-7778	81	58	/	/	SYM
aiua-7778	81	59	total	total	ADJ
aiua-7778	81	60	psa	psa	NOUN
aiua-7778	81	61	cut	cut	VERB
aiua-7778	81	62	-	-	PUNCT
aiua-7778	81	63	off	off	ADP
aiua-7778	81	64	group	group	NOUN
aiua-7778	81	65	(	(	PUNCT
aiua-7778	81	66	91.6	91.6	NUM
aiua-7778	81	67	%	%	NOUN
aiua-7778	81	68	,	,	PUNCT
aiua-7778	81	69	76.6	76.6	NUM
aiua-7778	81	70	%	%	NOUN
aiua-7778	81	71	respectively	respectively	ADV
aiua-7778	81	72	)	)	PUNCT
aiua-7778	81	73	and	and	CCONJ
aiua-7778	81	74	lmr	lmr	PROPN
aiua-7778	81	75	cut	cut	PROPN
aiua-7778	81	76	-	-	PUNCT
aiua-7778	81	77	off	off	ADP
aiua-7778	81	78	group	group	NOUN
aiua-7778	81	79	(	(	PUNCT
aiua-7778	81	80	67.8	67.8	NUM
aiua-7778	81	81	%	%	NOUN
aiua-7778	81	82	,	,	PUNCT
aiua-7778	81	83	43.7	43.7	NUM
aiua-7778	81	84	%	%	NOUN
aiua-7778	81	85	respectively	respectively	ADV
aiua-7778	81	86	)	)	PUNCT
aiua-7778	81	87	(	(	PUNCT
aiua-7778	81	88	table	table	NOUN
aiua-7778	81	89	7	7	NUM
aiua-7778	81	90	)	)	PUNCT
aiua-7778	81	91	.	.	PUNCT
aiua-7778	82	1	table	table	NOUN
aiua-7778	82	2	4	4	NUM
aiua-7778	82	3	.	.	PUNCT
aiua-7778	83	1	mean	mean	NOUN
aiua-7778	83	2	±	±	NUM
aiua-7778	83	3	sd	sd	ADP
aiua-7778	83	4	values	value	NOUN
aiua-7778	83	5	of	of	ADP
aiua-7778	83	6	the	the	DET
aiua-7778	83	7	inflammation	inflammation	NOUN
aiua-7778	83	8	markers	marker	NOUN
aiua-7778	83	9	and	and	CCONJ
aiua-7778	83	10	p	p	NOUN
aiua-7778	83	11	values	value	NOUN
aiua-7778	83	12	for	for	ADP
aiua-7778	83	13	comparsion	comparsion	NOUN
aiua-7778	83	14	of	of	ADP
aiua-7778	83	15	the	the	DET
aiua-7778	83	16	histological	histological	ADJ
aiua-7778	83	17	groups	group	NOUN
aiua-7778	83	18	in	in	ADP
aiua-7778	83	19	the	the	DET
aiua-7778	83	20	patients	patient	NOUN
aiua-7778	83	21	with	with	ADP
aiua-7778	83	22	psa	psa	VERB
aiua-7778	83	23	higher	high	ADJ
aiua-7778	83	24	than	than	ADP
aiua-7778	83	25	10	10	NUM
aiua-7778	83	26	ng	ng	PROPN
aiua-7778	83	27	/	/	SYM
aiua-7778	83	28	dl	dl	PROPN
aiua-7778	83	29	.	.	PROPN
aiua-7778	83	30	bph	bph	PROPN
aiua-7778	83	31	(	(	PUNCT
aiua-7778	83	32	n	n	NOUN
aiua-7778	83	33	=	=	SYM
aiua-7778	83	34	78	78	NUM
aiua-7778	83	35	)	)	PUNCT
aiua-7778	83	36	pca	pca	NOUN
aiua-7778	83	37	(	(	PUNCT
aiua-7778	83	38	n	n	NOUN
aiua-7778	83	39	=	=	SYM
aiua-7778	83	40	72	72	NUM
aiua-7778	83	41	)	)	PUNCT
aiua-7778	83	42	nlr	nlr	PROPN
aiua-7778	83	43	(	(	PUNCT
aiua-7778	83	44	mean	mean	PROPN
aiua-7778	83	45	±	±	NUM
aiua-7778	83	46	sd	sd	NOUN
aiua-7778	83	47	)	)	PUNCT
aiua-7778	83	48	bph	bph	NOUN
aiua-7778	83	49	=	=	NOUN
aiua-7778	83	50	2.63	2.63	NUM
aiua-7778	83	51	±	±	NUM
aiua-7778	83	52	1.0	1.0	NUM
aiua-7778	83	53	1	1	NUM
aiua-7778	83	54	0.839	0.839	NUM
aiua-7778	83	55	pca	pca	NOUN
aiua-7778	83	56	=	=	PUNCT
aiua-7778	83	57	2.66	2.66	NUM
aiua-7778	83	58	±	±	NUM
aiua-7778	83	59	1.1	1.1	NUM
aiua-7778	83	60	0.839	0.839	NUM
aiua-7778	83	61	1	1	NUM
aiua-7778	83	62	plr	plr	NOUN
aiua-7778	83	63	(	(	PUNCT
aiua-7778	83	64	mean	mean	NOUN
aiua-7778	83	65	±	±	NUM
aiua-7778	83	66	sd	sd	NOUN
aiua-7778	83	67	)	)	PUNCT
aiua-7778	83	68	bph	bph	NOUN
aiua-7778	83	69	=	=	NOUN
aiua-7778	83	70	133.3	133.3	NUM
aiua-7778	83	71	±	±	NUM
aiua-7778	83	72	51.1	51.1	NUM
aiua-7778	83	73	1	1	NUM
aiua-7778	83	74	0.965	0.965	NUM
aiua-7778	83	75	pca	pca	NOUN
aiua-7778	83	76	=	=	PUNCT
aiua-7778	83	77	143±71	143±71	NUM
aiua-7778	83	78	0.965	0.965	NUM
aiua-7778	83	79	1	1	NUM
aiua-7778	83	80	lmr	lmr	PROPN
aiua-7778	83	81	(	(	PUNCT
aiua-7778	83	82	mean	mean	PROPN
aiua-7778	83	83	±	±	NUM
aiua-7778	83	84	sd	sd	NOUN
aiua-7778	83	85	)	)	PUNCT
aiua-7778	83	86	bph	bph	NOUN
aiua-7778	83	87	=	=	NOUN
aiua-7778	83	88	3.76	3.76	NUM
aiua-7778	83	89	±	±	NUM
aiua-7778	83	90	1.1	1.1	NUM
aiua-7778	83	91	1	1	NUM
aiua-7778	83	92	0.892	0.892	NUM
aiua-7778	83	93	pca	pca	NOUN
aiua-7778	83	94	=	=	PUNCT
aiua-7778	83	95	3.69	3.69	NUM
aiua-7778	83	96	±	±	NUM
aiua-7778	83	97	1.3	1.3	NUM
aiua-7778	83	98	0.892	0.892	NUM
aiua-7778	83	99	1	1	NUM
aiua-7778	83	100	pca	pca	NOUN
aiua-7778	83	101	:	:	PUNCT
aiua-7778	83	102	prostate	prostate	NOUN
aiua-7778	83	103	cancer	cancer	NOUN
aiua-7778	83	104	;	;	PUNCT
aiua-7778	83	105	bph	bph	NOUN
aiua-7778	83	106	:	:	PUNCT
aiua-7778	83	107	benign	benign	ADJ
aiua-7778	83	108	prostate	prostate	NOUN
aiua-7778	83	109	hyperplasia	hyperplasia	NOUN
aiua-7778	83	110	;	;	PUNCT
aiua-7778	83	111	sd	sd	X
aiua-7778	83	112	:	:	PUNCT
aiua-7778	83	113	standart	standart	NOUN
aiua-7778	83	114	deviation	deviation	NOUN
aiua-7778	83	115	;	;	PUNCT
aiua-7778	83	116	psa	psa	VERB
aiua-7778	83	117	:	:	PUNCT
aiua-7778	83	118	prostate	prostate	NOUN
aiua-7778	83	119	spesific	spesific	NOUN
aiua-7778	83	120	antigen	antigen	PROPN
aiua-7778	83	121	;	;	PUNCT
aiua-7778	83	122	nlr	nlr	PROPN
aiua-7778	83	123	:	:	PUNCT
aiua-7778	83	124	neutrophile	neutrophile	ADV
aiua-7778	83	125	to	to	ADP
aiua-7778	83	126	lymphocyte	lymphocyte	ADJ
aiua-7778	83	127	ratio	ratio	NOUN
aiua-7778	83	128	;	;	PUNCT
aiua-7778	83	129	plr	plr	NOUN
aiua-7778	83	130	:	:	PUNCT
aiua-7778	83	131	platelet	platelet	NOUN
aiua-7778	83	132	to	to	ADP
aiua-7778	83	133	lymphocyte	lymphocyte	ADJ
aiua-7778	83	134	ratio	ratio	NOUN
aiua-7778	83	135	;	;	PUNCT
aiua-7778	83	136	lmr	lmr	NOUN
aiua-7778	83	137	:	:	PUNCT
aiua-7778	83	138	lymphocyte	lymphocyte	ADJ
aiua-7778	83	139	to	to	ADP
aiua-7778	83	140	monocyte	monocyte	NOUN
aiua-7778	83	141	ratio	ratio	NOUN
aiua-7778	83	142	.	.	PUNCT
aiua-7778	84	1	table	table	NOUN
aiua-7778	84	2	5	5	NUM
aiua-7778	84	3	.	.	PUNCT
aiua-7778	85	1	mean	mean	NOUN
aiua-7778	85	2	±	±	NUM
aiua-7778	85	3	sd	sd	ADP
aiua-7778	85	4	values	value	NOUN
aiua-7778	85	5	of	of	ADP
aiua-7778	85	6	the	the	DET
aiua-7778	85	7	inflammation	inflammation	NOUN
aiua-7778	85	8	markers	marker	NOUN
aiua-7778	85	9	and	and	CCONJ
aiua-7778	85	10	p	p	NOUN
aiua-7778	85	11	values	value	NOUN
aiua-7778	85	12	for	for	ADP
aiua-7778	85	13	comparsion	comparsion	NOUN
aiua-7778	85	14	of	of	ADP
aiua-7778	85	15	the	the	DET
aiua-7778	85	16	gleason	gleason	PROPN
aiua-7778	85	17	score	score	NOUN
aiua-7778	85	18	groups	group	NOUN
aiua-7778	85	19	in	in	ADP
aiua-7778	85	20	the	the	DET
aiua-7778	85	21	entire	entire	ADJ
aiua-7778	85	22	cohort	cohort	NOUN
aiua-7778	85	23	.	.	PUNCT
aiua-7778	86	1	gleason	gleason	PROPN
aiua-7778	86	2	6	6	NUM
aiua-7778	86	3	(	(	PUNCT
aiua-7778	86	4	n	n	NOUN
aiua-7778	86	5	=	=	SYM
aiua-7778	86	6	173	173	NUM
aiua-7778	86	7	)	)	PUNCT
aiua-7778	86	8	gleason	gleason	PROPN
aiua-7778	86	9	>	>	X
aiua-7778	86	10	7	7	NUM
aiua-7778	86	11	(	(	PUNCT
aiua-7778	86	12	n	n	NOUN
aiua-7778	86	13	=	=	SYM
aiua-7778	86	14	67	67	NUM
aiua-7778	86	15	)	)	PUNCT
aiua-7778	86	16	nlr	nlr	PROPN
aiua-7778	86	17	(	(	PUNCT
aiua-7778	86	18	mean	mean	PROPN
aiua-7778	86	19	±	±	NUM
aiua-7778	86	20	sd	sd	NOUN
aiua-7778	86	21	)	)	PUNCT
aiua-7778	86	22	gs	gs	NOUN
aiua-7778	86	23	6	6	NUM
aiua-7778	86	24	=	=	SYM
aiua-7778	86	25	2.5	2.5	NUM
aiua-7778	86	26	±	±	NUM
aiua-7778	86	27	1.05	1.05	NUM
aiua-7778	86	28	1	1	NUM
aiua-7778	86	29	0.454	0.454	NUM
aiua-7778	86	30	gs	gs	NOUN
aiua-7778	86	31	>	>	X
aiua-7778	86	32	7	7	NUM
aiua-7778	86	33	=	=	SYM
aiua-7778	86	34	2.57	2.57	NUM
aiua-7778	86	35	±	±	NUM
aiua-7778	86	36	1.23	1.23	NUM
aiua-7778	86	37	0,454	0,454	NUM
aiua-7778	86	38	1	1	NUM
aiua-7778	86	39	plr	plr	NOUN
aiua-7778	86	40	(	(	PUNCT
aiua-7778	86	41	mean	mean	NOUN
aiua-7778	86	42	±	±	NUM
aiua-7778	86	43	sd	sd	NOUN
aiua-7778	86	44	)	)	PUNCT
aiua-7778	86	45	gs	gs	NOUN
aiua-7778	86	46	6	6	NUM
aiua-7778	86	47	=	=	SYM
aiua-7778	86	48	122.1	122.1	NUM
aiua-7778	86	49	±	±	NUM
aiua-7778	86	50	46.8	46.8	NUM
aiua-7778	86	51	1	1	NUM
aiua-7778	86	52	0.082	0.082	NUM
aiua-7778	86	53	gs	gs	X
aiua-7778	86	54	>	>	X
aiua-7778	86	55	7	7	NUM
aiua-7778	86	56	=	=	SYM
aiua-7778	86	57	142.8	142.8	NUM
aiua-7778	86	58	±	±	NUM
aiua-7778	86	59	73.8	73.8	NUM
aiua-7778	86	60	0,082	0,082	NUM
aiua-7778	86	61	1	1	NUM
aiua-7778	86	62	lmr	lmr	PROPN
aiua-7778	86	63	(	(	PUNCT
aiua-7778	86	64	mean	mean	PROPN
aiua-7778	86	65	±	±	NUM
aiua-7778	86	66	sd	sd	NOUN
aiua-7778	86	67	)	)	PUNCT
aiua-7778	86	68	gs	gs	ADP
aiua-7778	86	69	6	6	NUM
aiua-7778	86	70	=	=	SYM
aiua-7778	86	71	3.7	3.7	NUM
aiua-7778	86	72	±	±	NUM
aiua-7778	86	73	1.15	1.15	NUM
aiua-7778	86	74	1	1	NUM
aiua-7778	86	75	0.177	0.177	NUM
aiua-7778	86	76	gs	gs	NOUN
aiua-7778	86	77	>	>	X
aiua-7778	86	78	7	7	NUM
aiua-7778	86	79	=	=	SYM
aiua-7778	86	80	3.6	3.6	NUM
aiua-7778	86	81	±	±	NUM
aiua-7778	86	82	2.02	2.02	NUM
aiua-7778	86	83	0,177	0,177	NUM
aiua-7778	86	84	1	1	NUM
aiua-7778	86	85	sd	sd	NUM
aiua-7778	86	86	:	:	PUNCT
aiua-7778	86	87	standart	standart	NOUN
aiua-7778	86	88	deviation	deviation	NOUN
aiua-7778	86	89	;	;	PUNCT
aiua-7778	86	90	nlr	nlr	PROPN
aiua-7778	86	91	:	:	PUNCT
aiua-7778	86	92	neutrophile	neutrophile	ADV
aiua-7778	86	93	to	to	ADP
aiua-7778	86	94	lymphocyte	lymphocyte	ADJ
aiua-7778	86	95	ratio	ratio	NOUN
aiua-7778	86	96	;	;	PUNCT
aiua-7778	86	97	plr	plr	NOUN
aiua-7778	86	98	:	:	PUNCT
aiua-7778	86	99	platelet	platelet	NOUN
aiua-7778	86	100	to	to	ADP
aiua-7778	86	101	lymphocyte	lymphocyte	ADJ
aiua-7778	86	102	ratio	ratio	NOUN
aiua-7778	86	103	;	;	PUNCT
aiua-7778	86	104	lmr	lmr	NOUN
aiua-7778	86	105	:	:	PUNCT
aiua-7778	86	106	lymphocyte	lymphocyte	ADJ
aiua-7778	86	107	to	to	ADP
aiua-7778	86	108	monocyte	monocyte	NOUN
aiua-7778	86	109	ratio	ratio	NOUN
aiua-7778	86	110	;	;	PUNCT
aiua-7778	86	111	gs	gs	PRON
aiua-7778	86	112	:	:	PUNCT
aiua-7778	86	113	gleason	gleason	PROPN
aiua-7778	86	114	score	score	PROPN
aiua-7778	86	115	.	.	PUNCT
aiua-7778	87	1	table	table	NOUN
aiua-7778	87	2	6	6	NUM
aiua-7778	87	3	.	.	PUNCT
aiua-7778	87	4	univariate	univariate	ADJ
aiua-7778	87	5	and	and	CCONJ
aiua-7778	87	6	multivariate	multivariate	VERB
aiua-7778	87	7	analyses	analysis	NOUN
aiua-7778	87	8	for	for	ADP
aiua-7778	87	9	predicting	predict	VERB
aiua-7778	87	10	prostate	prostate	NOUN
aiua-7778	87	11	cancer	cancer	NOUN
aiua-7778	87	12	.	.	PUNCT
aiua-7778	88	1	n	n	PRON
aiua-7778	88	2	univariate	univariate	VERB
aiua-7778	88	3	analysis	analysis	NOUN
aiua-7778	88	4	multivariate	multivariate	NOUN
aiua-7778	88	5	analysis	analysis	NOUN
aiua-7778	88	6	hr	hr	NOUN
aiua-7778	88	7	95	95	NUM
aiua-7778	88	8	%	%	NOUN
aiua-7778	88	9	ci	ci	NOUN
aiua-7778	89	1	p	p	NOUN
aiua-7778	90	1	hr	hr	NOUN
aiua-7778	91	1	%	%	INTJ
aiua-7778	91	2	95	95	NUM
aiua-7778	91	3	ci	ci	NOUN
aiua-7778	91	4	p	p	NOUN
aiua-7778	91	5	age	age	NOUN
aiua-7778	91	6	(	(	PUNCT
aiua-7778	91	7	year	year	NOUN
aiua-7778	91	8	)	)	PUNCT
aiua-7778	91	9	<	<	X
aiua-7778	91	10	65.5	65.5	NUM
aiua-7778	91	11	186	186	NUM
aiua-7778	91	12	1	1	NUM
aiua-7778	91	13	1.14	1.14	NUM
aiua-7778	91	14	-	-	SYM
aiua-7778	91	15	1.86	1.86	NUM
aiua-7778	91	16	0.01	0.01	NUM
aiua-7778	91	17	1	1	NUM
aiua-7778	91	18	1.68	1.68	NUM
aiua-7778	91	19	-	-	SYM
aiua-7778	91	20	4.56	4.56	NUM
aiua-7778	91	21	<	<	X
aiua-7778	91	22	0.001	0.001	NUM
aiua-7778	91	23	>	>	SYM
aiua-7778	91	24	65.5	65.5	NUM
aiua-7778	91	25	216	216	NUM
aiua-7778	91	26	1.45	1.45	NUM
aiua-7778	91	27	2.77	2.77	NUM
aiua-7778	91	28	lmr	lmr	PROPN
aiua-7778	91	29	value	value	NOUN
aiua-7778	91	30	>	>	X
aiua-7778	91	31	3.05	3.05	NUM
aiua-7778	91	32	258	258	NUM
aiua-7778	91	33	1	1	NUM
aiua-7778	91	34	0.99	0.99	NUM
aiua-7778	91	35	-	-	SYM
aiua-7778	91	36	1.37	1.37	NUM
aiua-7778	91	37	0.04	0.04	NUM
aiua-7778	91	38	1	1	NUM
aiua-7778	91	39	1.02	1.02	NUM
aiua-7778	91	40	-	-	SYM
aiua-7778	91	41	2.6	2.6	NUM
aiua-7778	91	42	0.037	0.037	NUM
aiua-7778	91	43	<	<	X
aiua-7778	91	44	3.05	3.05	NUM
aiua-7778	91	45	144	144	NUM
aiua-7778	91	46	1.17	1.17	NUM
aiua-7778	91	47	1.65	1.65	NUM
aiua-7778	91	48	free	free	ADJ
aiua-7778	91	49	/	/	SYM
aiua-7778	91	50	total	total	ADJ
aiua-7778	91	51	psa	psa	NOUN
aiua-7778	91	52	value	value	NOUN
aiua-7778	91	53	>	>	X
aiua-7778	91	54	0.15	0.15	NUM
aiua-7778	91	55	1	1	NUM
aiua-7778	91	56	1.45	1.45	NUM
aiua-7778	91	57	-	-	SYM
aiua-7778	91	58	1.97	1.97	NUM
aiua-7778	91	59	<	<	NOUN
aiua-7778	91	60	0.001	0.001	NUM
aiua-7778	91	61	1	1	NUM
aiua-7778	91	62	6.80	6.80	NUM
aiua-7778	91	63	-	-	SYM
aiua-7778	91	64	22.22	22.22	NUM
aiua-7778	91	65	<	<	X
aiua-7778	91	66	0.001	0.001	NUM
aiua-7778	91	67	<	<	X
aiua-7778	91	68	0.15	0.15	NUM
aiua-7778	91	69	1.69	1.69	NUM
aiua-7778	91	70	12.3	12.3	NUM
aiua-7778	91	71	psa	psa	NOUN
aiua-7778	91	72	:	:	PUNCT
aiua-7778	91	73	prostate	prostate	NOUN
aiua-7778	91	74	spesific	spesific	NOUN
aiua-7778	91	75	antigen	antigen	ADV
aiua-7778	91	76	;	;	PUNCT
aiua-7778	91	77	lmr	lmr	NOUN
aiua-7778	91	78	:	:	PUNCT
aiua-7778	91	79	lymphocyte	lymphocyte	ADJ
aiua-7778	91	80	to	to	ADP
aiua-7778	91	81	monocyte	monocyte	NOUN
aiua-7778	91	82	ratio	ratio	NOUN
aiua-7778	91	83	;	;	PUNCT
aiua-7778	91	84	hr	hr	NOUN
aiua-7778	91	85	:	:	PUNCT
aiua-7778	91	86	hazard	hazard	NOUN
aiua-7778	91	87	ratio	ratio	NOUN
aiua-7778	91	88	;	;	PUNCT
aiua-7778	91	89	ci	ci	NOUN
aiua-7778	91	90	:	:	PUNCT
aiua-7778	91	91	confidence	confidence	NOUN
aiua-7778	91	92	interval	interval	NOUN
aiua-7778	91	93	.	.	PUNCT
aiua-7778	92	1	sensitivity	sensitivity	NOUN
aiua-7778	92	2	specificity	specificity	NOUN
aiua-7778	92	3	ppv	ppv	NOUN
aiua-7778	92	4	npv	npv	NOUN
aiua-7778	92	5	free	free	ADJ
aiua-7778	92	6	/	/	SYM
aiua-7778	92	7	total	total	ADJ
aiua-7778	92	8	psa	psa	NOUN
aiua-7778	92	9	<	<	X
aiua-7778	92	10	0.15	0.15	NUM
aiua-7778	92	11	46	46	NUM
aiua-7778	92	12	%	%	NOUN
aiua-7778	92	13	(	(	PUNCT
aiua-7778	92	14	69	69	NUM
aiua-7778	92	15	of	of	ADP
aiua-7778	92	16	150	150	NUM
aiua-7778	92	17	)	)	PUNCT
aiua-7778	92	18	%	%	NOUN
aiua-7778	92	19	91.6	91.6	NUM
aiua-7778	92	20	(	(	PUNCT
aiua-7778	92	21	231of	231of	NOUN
aiua-7778	92	22	252	252	NUM
aiua-7778	92	23	)	)	PUNCT
aiua-7778	92	24	%	%	NOUN
aiua-7778	92	25	76.6	76.6	NUM
aiua-7778	92	26	(	(	PUNCT
aiua-7778	92	27	69	69	NUM
aiua-7778	92	28	of	of	ADP
aiua-7778	92	29	90	90	NUM
aiua-7778	92	30	)	)	PUNCT
aiua-7778	92	31	%	%	NOUN
aiua-7778	92	32	71.7	71.7	NUM
aiua-7778	92	33	(	(	PUNCT
aiua-7778	92	34	231	231	NUM
aiua-7778	92	35	of	of	ADP
aiua-7778	92	36	322	322	NUM
aiua-7778	92	37	)	)	PUNCT
aiua-7778	92	38	lmr	lmr	NOUN
aiua-7778	92	39	<	<	X
aiua-7778	92	40	3.050	3.050	NUM
aiua-7778	92	41	%	%	NOUN
aiua-7778	92	42	42	42	NUM
aiua-7778	92	43	(	(	PUNCT
aiua-7778	92	44	63	63	NUM
aiua-7778	92	45	of	of	ADP
aiua-7778	92	46	150	150	NUM
aiua-7778	92	47	)	)	PUNCT
aiua-7778	92	48	%	%	NOUN
aiua-7778	92	49	67.8	67.8	NUM
aiua-7778	92	50	(	(	PUNCT
aiua-7778	92	51	171	171	NUM
aiua-7778	92	52	of	of	ADP
aiua-7778	92	53	252	252	NUM
aiua-7778	92	54	)	)	PUNCT
aiua-7778	92	55	%	%	NOUN
aiua-7778	92	56	43.7	43.7	NUM
aiua-7778	92	57	(	(	PUNCT
aiua-7778	92	58	63	63	NUM
aiua-7778	92	59	of	of	ADP
aiua-7778	92	60	144	144	NUM
aiua-7778	92	61	)	)	PUNCT
aiua-7778	92	62	%	%	NOUN
aiua-7778	92	63	73	73	NUM
aiua-7778	92	64	(	(	PUNCT
aiua-7778	92	65	171	171	NUM
aiua-7778	92	66	of	of	ADP
aiua-7778	92	67	234	234	NUM
aiua-7778	92	68	)	)	PUNCT
aiua-7778	92	69	free	free	ADJ
aiua-7778	92	70	/	/	SYM
aiua-7778	92	71	total	total	ADJ
aiua-7778	92	72	psa	psa	NOUN
aiua-7778	92	73	<	<	X
aiua-7778	92	74	0.15	0.15	NUM
aiua-7778	92	75	&	&	CCONJ
aiua-7778	92	76	lmr	lmr	PROPN
aiua-7778	92	77	<	<	X
aiua-7778	92	78	3.050	3.050	NUM
aiua-7778	92	79	%	%	NOUN
aiua-7778	92	80	16.6	16.6	NUM
aiua-7778	92	81	(	(	PUNCT
aiua-7778	92	82	25	25	NUM
aiua-7778	92	83	of	of	ADP
aiua-7778	92	84	150	150	NUM
aiua-7778	92	85	)	)	PUNCT
aiua-7778	92	86	%	%	NOUN
aiua-7778	92	87	97.2	97.2	NUM
aiua-7778	92	88	(	(	PUNCT
aiua-7778	92	89	247	247	NUM
aiua-7778	92	90	of	of	ADP
aiua-7778	92	91	252	252	NUM
aiua-7778	92	92	)	)	PUNCT
aiua-7778	92	93	%	%	NOUN
aiua-7778	92	94	83.3	83.3	NUM
aiua-7778	92	95	(	(	PUNCT
aiua-7778	92	96	25	25	NUM
aiua-7778	92	97	of	of	ADP
aiua-7778	92	98	30	30	NUM
aiua-7778	92	99	)	)	PUNCT
aiua-7778	92	100	%	%	NOUN
aiua-7778	92	101	66.4	66.4	NUM
aiua-7778	92	102	(	(	PUNCT
aiua-7778	92	103	247	247	NUM
aiua-7778	92	104	of	of	ADP
aiua-7778	92	105	372	372	NUM
aiua-7778	92	106	)	)	PUNCT
aiua-7778	92	107	ppv	ppv	NOUN
aiua-7778	92	108	:	:	PUNCT
aiua-7778	92	109	positive	positive	ADJ
aiua-7778	92	110	predictive	predictive	ADJ
aiua-7778	92	111	value	value	NOUN
aiua-7778	92	112	;	;	PUNCT
aiua-7778	92	113	npv	npv	NOUN
aiua-7778	92	114	:	:	PUNCT
aiua-7778	92	115	negative	negative	ADJ
aiua-7778	92	116	predictive	predictive	ADJ
aiua-7778	92	117	value	value	NOUN
aiua-7778	92	118	;	;	PUNCT
aiua-7778	92	119	psa	psa	VERB
aiua-7778	92	120	:	:	PUNCT
aiua-7778	92	121	prostate	prostate	NOUN
aiua-7778	92	122	spesific	spesific	NOUN
aiua-7778	92	123	antigen	antigen	ADV
aiua-7778	92	124	;	;	PUNCT
aiua-7778	92	125	lmr	lmr	NOUN
aiua-7778	92	126	:	:	PUNCT
aiua-7778	92	127	lymphocyte	lymphocyte	ADJ
aiua-7778	92	128	to	to	ADP
aiua-7778	92	129	monocyte	monocyte	NOUN
aiua-7778	92	130	ratio	ratio	NOUN
aiua-7778	92	131	.	.	PUNCT
aiua-7778	93	1	table	table	NOUN
aiua-7778	93	2	7	7	NUM
aiua-7778	93	3	.	.	PUNCT
aiua-7778	94	1	mean	mean	NOUN
aiua-7778	94	2	±	±	NUM
aiua-7778	94	3	sd	sd	ADP
aiua-7778	94	4	values	value	NOUN
aiua-7778	94	5	of	of	ADP
aiua-7778	94	6	the	the	DET
aiua-7778	94	7	inflammation	inflammation	NOUN
aiua-7778	94	8	markers	marker	NOUN
aiua-7778	94	9	and	and	CCONJ
aiua-7778	94	10	p	p	NOUN
aiua-7778	94	11	values	value	NOUN
aiua-7778	94	12	for	for	ADP
aiua-7778	94	13	comparison	comparison	NOUN
aiua-7778	94	14	of	of	ADP
aiua-7778	94	15	the	the	DET
aiua-7778	94	16	histological	histological	ADJ
aiua-7778	94	17	groups	group	NOUN
aiua-7778	94	18	in	in	ADP
aiua-7778	94	19	the	the	DET
aiua-7778	94	20	cohort	cohort	NOUN
aiua-7778	94	21	psa	psa	VERB
aiua-7778	94	22	4	4	NUM
aiua-7778	94	23	-	-	SYM
aiua-7778	94	24	10	10	NUM
aiua-7778	94	25	ng	ng	PROPN
aiua-7778	94	26	/	/	SYM
aiua-7778	94	27	dl	dl	PROPN
aiua-7778	94	28	range	range	NOUN
aiua-7778	94	29	.	.	PUNCT
aiua-7778	95	1	caglayan_stesura	caglayan_stesura	NOUN
aiua-7778	95	2	seveso	seveso	VERB
aiua-7778	95	3	10/01/19	10/01/19	PROPN
aiua-7778	95	4	16:08	16:08	NUM
aiua-7778	95	5	pagina	pagina	NOUN
aiua-7778	95	6	272	272	NUM
aiua-7778	95	7	273archivio	273archivio	PROPN
aiua-7778	95	8	italiano	italiano	NOUN
aiua-7778	95	9	di	di	X
aiua-7778	95	10	urologia	urologia	PROPN
aiua-7778	95	11	e	e	PROPN
aiua-7778	95	12	andrologia	andrologia	NOUN
aiua-7778	95	13	2018	2018	NUM
aiua-7778	95	14	;	;	PUNCT
aiua-7778	95	15	90	90	NUM
aiua-7778	95	16	,	,	PUNCT
aiua-7778	95	17	4	4	NUM
aiua-7778	95	18	lymphocyte	lymphocyte	NOUN
aiua-7778	95	19	-	-	PUNCT
aiua-7778	95	20	to	to	ADP
aiua-7778	95	21	-	-	PUNCT
aiua-7778	95	22	monocyte	monocyte	NOUN
aiua-7778	95	23	ratio	ratio	NOUN
aiua-7778	95	24	is	be	AUX
aiua-7778	95	25	a	a	DET
aiua-7778	95	26	valuable	valuable	ADJ
aiua-7778	95	27	marker	marker	NOUN
aiua-7778	95	28	to	to	PART
aiua-7778	95	29	predict	predict	VERB
aiua-7778	95	30	prostate	prostate	NOUN
aiua-7778	95	31	cancer	cancer	NOUN
aiua-7778	95	32	in	in	ADP
aiua-7778	95	33	patients	patient	NOUN
aiua-7778	95	34	with	with	ADP
aiua-7778	95	35	prostate	prostate	NOUN
aiua-7778	95	36	specific	specific	ADJ
aiua-7778	95	37	antigen	antigen	NOUN
aiua-7778	95	38	between	between	ADP
aiua-7778	95	39	4	4	NUM
aiua-7778	95	40	and	and	CCONJ
aiua-7778	95	41	10	10	NUM
aiua-7778	95	42	ng	ng	PROPN
aiua-7778	95	43	/	/	SYM
aiua-7778	95	44	dl	dl	PROPN
aiua-7778	95	45	.	.	PROPN
aiua-7778	95	46	discussion	discussion	NOUN
aiua-7778	95	47	the	the	DET
aiua-7778	95	48	immune	immune	ADJ
aiua-7778	95	49	system	system	NOUN
aiua-7778	95	50	plays	play	VERB
aiua-7778	95	51	an	an	DET
aiua-7778	95	52	important	important	ADJ
aiua-7778	95	53	role	role	NOUN
aiua-7778	95	54	in	in	ADP
aiua-7778	95	55	cancer	cancer	NOUN
aiua-7778	95	56	pathogenesis	pathogenesis	NOUN
aiua-7778	95	57	.	.	PUNCT
aiua-7778	96	1	serum	serum	NOUN
aiua-7778	96	2	biomarkers	biomarker	NOUN
aiua-7778	96	3	which	which	PRON
aiua-7778	96	4	can	can	AUX
aiua-7778	96	5	be	be	AUX
aiua-7778	96	6	easily	easily	ADV
aiua-7778	96	7	derived	derive	VERB
aiua-7778	96	8	from	from	ADP
aiua-7778	96	9	complete	complete	ADJ
aiua-7778	96	10	blood	blood	NOUN
aiua-7778	96	11	count	count	NOUN
aiua-7778	96	12	(	(	PUNCT
aiua-7778	96	13	cbc	cbc	NOUN
aiua-7778	96	14	)	)	PUNCT
aiua-7778	96	15	are	be	AUX
aiua-7778	96	16	useful	useful	ADJ
aiua-7778	96	17	tools	tool	NOUN
aiua-7778	96	18	to	to	PART
aiua-7778	96	19	estimate	estimate	VERB
aiua-7778	96	20	the	the	DET
aiua-7778	96	21	prognosis	prognosis	NOUN
aiua-7778	96	22	and	and	CCONJ
aiua-7778	96	23	survival	survival	NOUN
aiua-7778	96	24	in	in	ADP
aiua-7778	96	25	many	many	ADJ
aiua-7778	96	26	solid	solid	ADJ
aiua-7778	96	27	cancers	cancer	NOUN
aiua-7778	96	28	.	.	PUNCT
aiua-7778	97	1	the	the	DET
aiua-7778	97	2	presence	presence	NOUN
aiua-7778	97	3	of	of	ADP
aiua-7778	97	4	low	low	PROPN
aiua-7778	97	5	lmr	lmr	PROPN
aiua-7778	97	6	,	,	PUNCT
aiua-7778	97	7	high	high	ADJ
aiua-7778	97	8	plr	plr	NOUN
aiua-7778	97	9	and	and	CCONJ
aiua-7778	97	10	high	high	ADJ
aiua-7778	97	11	nlr	nlr	PROPN
aiua-7778	97	12	values	value	NOUN
aiua-7778	97	13	were	be	AUX
aiua-7778	97	14	associated	associate	VERB
aiua-7778	97	15	with	with	ADP
aiua-7778	97	16	poor	poor	ADJ
aiua-7778	97	17	overall	overall	ADJ
aiua-7778	97	18	survival	survival	NOUN
aiua-7778	97	19	(	(	PUNCT
aiua-7778	97	20	os	os	NOUN
aiua-7778	97	21	)	)	PUNCT
aiua-7778	97	22	in	in	ADP
aiua-7778	97	23	the	the	DET
aiua-7778	97	24	published	publish	VERB
aiua-7778	97	25	systemic	systemic	ADJ
aiua-7778	97	26	reviews	review	NOUN
aiua-7778	97	27	(	(	PUNCT
aiua-7778	97	28	6	6	NUM
aiua-7778	97	29	-	-	SYM
aiua-7778	97	30	8)	8)	NUM
aiua-7778	97	31	.	.	PUNCT
aiua-7778	98	1	in	in	ADP
aiua-7778	98	2	the	the	DET
aiua-7778	98	3	study	study	NOUN
aiua-7778	98	4	performed	perform	VERB
aiua-7778	98	5	by	by	ADP
aiua-7778	98	6	gu	gu	PROPN
aiua-7778	98	7	et	et	PROPN
aiua-7778	98	8	al	al	PROPN
aiua-7778	98	9	.	.	PROPN
aiua-7778	98	10	,	,	PUNCT
aiua-7778	98	11	elevated	elevate	VERB
aiua-7778	98	12	nlr	nlr	PROPN
aiua-7778	98	13	was	be	AUX
aiua-7778	98	14	closely	closely	ADV
aiua-7778	98	15	associated	associate	VERB
aiua-7778	98	16	with	with	ADP
aiua-7778	98	17	poor	poor	ADJ
aiua-7778	98	18	os	os	NOUN
aiua-7778	98	19	in	in	ADP
aiua-7778	98	20	pca	pca	PROPN
aiua-7778	98	21	(	(	PUNCT
aiua-7778	98	22	9	9	NUM
aiua-7778	98	23	)	)	PUNCT
aiua-7778	98	24	.	.	PUNCT
aiua-7778	99	1	also	also	ADV
aiua-7778	99	2	a	a	DET
aiua-7778	99	3	similar	similar	ADJ
aiua-7778	99	4	study	study	NOUN
aiua-7778	99	5	in	in	ADP
aiua-7778	99	6	japan	japan	PROPN
aiua-7778	99	7	,	,	PUNCT
aiua-7778	99	8	revealed	reveal	VERB
aiua-7778	99	9	that	that	SCONJ
aiua-7778	99	10	elevated	elevated	ADJ
aiua-7778	99	11	nlr	nlr	PROPN
aiua-7778	99	12	was	be	AUX
aiua-7778	99	13	correlated	correlate	VERB
aiua-7778	99	14	with	with	ADP
aiua-7778	99	15	both	both	CCONJ
aiua-7778	99	16	poor	poor	ADJ
aiua-7778	99	17	cancer	cancer	NOUN
aiua-7778	99	18	-	-	PUNCT
aiua-7778	99	19	spesific	spesific	NOUN
aiua-7778	99	20	survival	survival	NOUN
aiua-7778	99	21	(	(	PUNCT
aiua-7778	99	22	p	p	NOUN
aiua-7778	99	23	=	=	NOUN
aiua-7778	99	24	0.018	0.018	NUM
aiua-7778	99	25	)	)	PUNCT
aiua-7778	99	26	and	and	CCONJ
aiua-7778	99	27	os	os	INTJ
aiua-7778	99	28	(	(	PUNCT
aiua-7778	99	29	p	p	X
aiua-7778	99	30	=	=	NOUN
aiua-7778	99	31	0.008	0.008	NUM
aiua-7778	99	32	)	)	PUNCT
aiua-7778	99	33	in	in	ADP
aiua-7778	99	34	patients	patient	NOUN
aiua-7778	99	35	with	with	ADP
aiua-7778	99	36	metastatic	metastatic	ADJ
aiua-7778	99	37	pca.10	pca.10	NOUN
aiua-7778	99	38	besides	besides	ADV
aiua-7778	99	39	,	,	PUNCT
aiua-7778	99	40	nonsteroidal	nonsteroidal	NOUN
aiua-7778	99	41	anti	anti	ADJ
aiua-7778	99	42	-	-	ADJ
aiua-7778	99	43	inflammatory	inflammatory	ADJ
aiua-7778	99	44	drug	drug	NOUN
aiua-7778	99	45	medications	medication	NOUN
aiua-7778	99	46	have	have	AUX
aiua-7778	99	47	been	be	AUX
aiua-7778	99	48	suggested	suggest	VERB
aiua-7778	99	49	to	to	PART
aiua-7778	99	50	reduce	reduce	VERB
aiua-7778	99	51	the	the	DET
aiua-7778	99	52	development	development	NOUN
aiua-7778	99	53	risk	risk	NOUN
aiua-7778	99	54	of	of	ADP
aiua-7778	99	55	pca	pca	PROPN
aiua-7778	99	56	(	(	PUNCT
aiua-7778	99	57	11	11	NUM
aiua-7778	99	58	,	,	PUNCT
aiua-7778	99	59	12	12	NUM
aiua-7778	99	60	)	)	PUNCT
aiua-7778	99	61	.	.	PUNCT
aiua-7778	100	1	additionally	additionally	ADV
aiua-7778	100	2	to	to	ADP
aiua-7778	100	3	the	the	DET
aiua-7778	100	4	prognostic	prognostic	ADJ
aiua-7778	100	5	value	value	NOUN
aiua-7778	100	6	of	of	ADP
aiua-7778	100	7	serum	serum	NOUN
aiua-7778	100	8	inflammation	inflammation	NOUN
aiua-7778	100	9	markers	marker	NOUN
aiua-7778	100	10	,	,	PUNCT
aiua-7778	100	11	there	there	PRON
aiua-7778	100	12	are	be	VERB
aiua-7778	100	13	also	also	ADV
aiua-7778	100	14	many	many	ADJ
aiua-7778	100	15	studies	study	NOUN
aiua-7778	100	16	assessing	assess	VERB
aiua-7778	100	17	the	the	DET
aiua-7778	100	18	diagnostic	diagnostic	ADJ
aiua-7778	100	19	value	value	NOUN
aiua-7778	100	20	of	of	ADP
aiua-7778	100	21	those	those	PRON
aiua-7778	100	22	prior	prior	ADV
aiua-7778	100	23	to	to	ADP
aiua-7778	100	24	the	the	DET
aiua-7778	100	25	pbx	pbx	NOUN
aiua-7778	100	26	with	with	ADP
aiua-7778	100	27	controversial	controversial	ADJ
aiua-7778	100	28	results	result	NOUN
aiua-7778	100	29	in	in	ADP
aiua-7778	100	30	the	the	DET
aiua-7778	100	31	literature	literature	NOUN
aiua-7778	100	32	.	.	PUNCT
aiua-7778	101	1	in	in	ADP
aiua-7778	101	2	the	the	DET
aiua-7778	101	3	study	study	NOUN
aiua-7778	101	4	performed	perform	VERB
aiua-7778	101	5	by	by	ADP
aiua-7778	101	6	kamali	kamali	PROPN
aiua-7778	101	7	et	et	PROPN
aiua-7778	101	8	al	al	PROPN
aiua-7778	101	9	.	.	PROPN
aiua-7778	101	10	,	,	PUNCT
aiua-7778	101	11	500	500	NUM
aiua-7778	101	12	patients	patient	NOUN
aiua-7778	101	13	who	who	PRON
aiua-7778	101	14	underwent	undergo	VERB
aiua-7778	101	15	pbx	pbx	PROPN
aiua-7778	101	16	were	be	AUX
aiua-7778	101	17	evaluated	evaluate	VERB
aiua-7778	101	18	but	but	CCONJ
aiua-7778	101	19	statistically	statistically	ADV
aiua-7778	101	20	significant	significant	ADJ
aiua-7778	101	21	difference	difference	NOUN
aiua-7778	101	22	was	be	AUX
aiua-7778	101	23	obtained	obtain	VERB
aiua-7778	101	24	between	between	ADP
aiua-7778	101	25	the	the	DET
aiua-7778	101	26	nlr	nlr	PROPN
aiua-7778	101	27	of	of	ADP
aiua-7778	101	28	the	the	DET
aiua-7778	101	29	patients	patient	NOUN
aiua-7778	101	30	with	with	ADP
aiua-7778	101	31	positive	positive	ADJ
aiua-7778	101	32	biopsy	biopsy	NOUN
aiua-7778	101	33	and	and	CCONJ
aiua-7778	101	34	those	those	PRON
aiua-7778	101	35	with	with	ADP
aiua-7778	101	36	negative	negative	ADJ
aiua-7778	101	37	biopsy	biopsy	NOUN
aiua-7778	101	38	p	p	NOUN
aiua-7778	101	39	=	=	PROPN
aiua-7778	101	40	0.112	0.112	NUM
aiua-7778	101	41	):	):	PUNCT
aiua-7778	101	42	nlr	nlr	PROPN
aiua-7778	101	43	was	be	AUX
aiua-7778	101	44	not	not	PART
aiua-7778	101	45	described	describe	VERB
aiua-7778	101	46	as	as	ADP
aiua-7778	101	47	a	a	DET
aiua-7778	101	48	predictive	predictive	ADJ
aiua-7778	101	49	factor	factor	NOUN
aiua-7778	101	50	for	for	ADP
aiua-7778	101	51	positive	positive	ADJ
aiua-7778	101	52	pca	pca	NOUN
aiua-7778	101	53	biopsy	biopsy	NOUN
aiua-7778	101	54	(	(	PUNCT
aiua-7778	101	55	13	13	NUM
aiua-7778	101	56	)	)	PUNCT
aiua-7778	101	57	.	.	PUNCT
aiua-7778	102	1	in	in	ADP
aiua-7778	102	2	another	another	DET
aiua-7778	102	3	study	study	NOUN
aiua-7778	102	4	,	,	PUNCT
aiua-7778	102	5	3913	3913	NUM
aiua-7778	102	6	men	man	NOUN
aiua-7778	102	7	who	who	PRON
aiua-7778	102	8	underwent	undergo	VERB
aiua-7778	102	9	pbx	pbx	PROPN
aiua-7778	102	10	were	be	AUX
aiua-7778	102	11	analyzed	analyze	VERB
aiua-7778	102	12	retrospectively	retrospectively	ADV
aiua-7778	102	13	.	.	PUNCT
aiua-7778	103	1	the	the	DET
aiua-7778	103	2	nlr	nlr	PROPN
aiua-7778	103	3	value	value	NOUN
aiua-7778	103	4	was	be	AUX
aiua-7778	103	5	higher	high	ADJ
aiua-7778	103	6	in	in	ADP
aiua-7778	103	7	the	the	DET
aiua-7778	103	8	biopsy	biopsy	NOUN
aiua-7778	103	9	-	-	PUNCT
aiua-7778	103	10	positive	positive	ADJ
aiua-7778	103	11	group	group	NOUN
aiua-7778	103	12	than	than	ADP
aiua-7778	103	13	in	in	ADP
aiua-7778	103	14	the	the	DET
aiua-7778	103	15	biopsy	biopsy	NOUN
aiua-7778	103	16	-	-	PUNCT
aiua-7778	103	17	negative	negative	ADJ
aiua-7778	103	18	group	group	NOUN
aiua-7778	103	19	(	(	PUNCT
aiua-7778	103	20	p	p	X
aiua-7778	103	21	<	<	X
aiua-7778	103	22	0.001	0.001	NUM
aiua-7778	103	23	)	)	PUNCT
aiua-7778	103	24	.	.	PUNCT
aiua-7778	104	1	also	also	ADV
aiua-7778	104	2	the	the	DET
aiua-7778	104	3	nlr	nlr	PROPN
aiua-7778	104	4	value	value	NOUN
aiua-7778	104	5	was	be	AUX
aiua-7778	104	6	significantly	significantly	ADV
aiua-7778	104	7	higher	high	ADJ
aiua-7778	104	8	in	in	ADP
aiua-7778	104	9	high	high	ADJ
aiua-7778	104	10	-	-	PUNCT
aiua-7778	104	11	grade	grade	NOUN
aiua-7778	104	12	gleason	gleason	PROPN
aiua-7778	104	13	pca	pca	PROPN
aiua-7778	104	14	group	group	NOUN
aiua-7778	104	15	than	than	ADP
aiua-7778	104	16	the	the	DET
aiua-7778	104	17	biopsy	biopsy	NOUN
aiua-7778	104	18	-	-	PUNCT
aiua-7778	104	19	negative	negative	ADJ
aiua-7778	104	20	group	group	NOUN
aiua-7778	104	21	and	and	CCONJ
aiua-7778	104	22	low	low	ADJ
aiua-7778	104	23	-	-	PUNCT
aiua-7778	104	24	grade	grade	NOUN
aiua-7778	104	25	pca	pca	NOUN
aiua-7778	104	26	group	group	NOUN
aiua-7778	104	27	(	(	PUNCT
aiua-7778	104	28	p	p	X
aiua-7778	104	29	<	<	X
aiua-7778	104	30	0.001	0.001	NUM
aiua-7778	104	31	)	)	PUNCT
aiua-7778	104	32	.	.	PUNCT
aiua-7778	105	1	on	on	ADP
aiua-7778	105	2	multivariate	multivariate	NOUN
aiua-7778	105	3	analyses	analysis	NOUN
aiua-7778	105	4	,	,	PUNCT
aiua-7778	105	5	a	a	DET
aiua-7778	105	6	higher	high	ADJ
aiua-7778	105	7	nlr	nlr	PROPN
aiua-7778	105	8	was	be	AUX
aiua-7778	105	9	associated	associate	VERB
aiua-7778	105	10	with	with	ADP
aiua-7778	105	11	pca	pca	NOUN
aiua-7778	105	12	detection	detection	NOUN
aiua-7778	105	13	(	(	PUNCT
aiua-7778	105	14	or	or	CCONJ
aiua-7778	105	15	=	=	SYM
aiua-7778	105	16	1.37	1.37	NUM
aiua-7778	105	17	,	,	PUNCT
aiua-7778	105	18	95	95	NUM
aiua-7778	105	19	%	%	NOUN
aiua-7778	105	20	ci	ci	NOUN
aiua-7778	105	21	:	:	PUNCT
aiua-7778	105	22	1.017	1.017	NUM
aiua-7778	105	23	-	-	SYM
aiua-7778	105	24	1.850	1.850	NUM
aiua-7778	105	25	,	,	PUNCT
aiua-7778	105	26	p	p	NOUN
aiua-7778	105	27	=	=	NOUN
aiua-7778	105	28	0.038	0.038	NUM
aiua-7778	105	29	)	)	PUNCT
aiua-7778	105	30	(	(	PUNCT
aiua-7778	105	31	14	14	NUM
aiua-7778	105	32	)	)	PUNCT
aiua-7778	105	33	.	.	PUNCT
aiua-7778	106	1	kawahara	kawahara	PROPN
aiua-7778	106	2	et	et	PROPN
aiua-7778	107	1	al	al	PROPN
aiua-7778	107	2	.	.	PROPN
aiua-7778	107	3	investigated	investigate	VERB
aiua-7778	107	4	the	the	DET
aiua-7778	107	5	data	datum	NOUN
aiua-7778	107	6	of	of	ADP
aiua-7778	107	7	810	810	NUM
aiua-7778	107	8	men	man	NOUN
aiua-7778	107	9	with	with	ADP
aiua-7778	107	10	psa	psa	NOUN
aiua-7778	107	11	value	value	NOUN
aiua-7778	107	12	between	between	ADP
aiua-7778	107	13	4	4	NUM
aiua-7778	107	14	and	and	CCONJ
aiua-7778	107	15	10	10	NUM
aiua-7778	107	16	ng	ng	PROPN
aiua-7778	107	17	/	/	SYM
aiua-7778	107	18	ml	ml	PROPN
aiua-7778	107	19	who	who	PRON
aiua-7778	107	20	underwent	undergo	VERB
aiua-7778	107	21	pbx	pbx	PROPN
aiua-7778	107	22	.	.	PUNCT
aiua-7778	108	1	nlr	nlr	PROPN
aiua-7778	108	2	value	value	NOUN
aiua-7778	108	3	was	be	AUX
aiua-7778	108	4	significantly	significantly	ADV
aiua-7778	108	5	higher	high	ADJ
aiua-7778	108	6	in	in	ADP
aiua-7778	108	7	men	man	NOUN
aiua-7778	108	8	with	with	ADP
aiua-7778	108	9	positive	positive	ADJ
aiua-7778	108	10	biopsy	biopsy	NOUN
aiua-7778	108	11	than	than	ADP
aiua-7778	108	12	in	in	ADP
aiua-7778	108	13	those	those	PRON
aiua-7778	108	14	with	with	ADP
aiua-7778	108	15	negative	negative	ADJ
aiua-7778	108	16	biopsy	biopsy	NOUN
aiua-7778	108	17	(	(	PUNCT
aiua-7778	108	18	p	p	X
aiua-7778	108	19	<	<	X
aiua-7778	108	20	0.001	0.001	NUM
aiua-7778	108	21	)	)	PUNCT
aiua-7778	108	22	.	.	PUNCT
aiua-7778	109	1	using	use	VERB
aiua-7778	109	2	nlr	nlr	PROPN
aiua-7778	109	3	cut	cut	VERB
aiua-7778	109	4	-	-	PUNCT
aiua-7778	109	5	off	off	ADP
aiua-7778	109	6	point	point	NOUN
aiua-7778	109	7	of	of	ADP
aiua-7778	109	8	2.40	2.40	NUM
aiua-7778	109	9	determined	determine	VERB
aiua-7778	109	10	by	by	ADP
aiua-7778	109	11	the	the	DET
aiua-7778	109	12	auroc	auroc	NOUN
aiua-7778	109	13	curve	curve	NOUN
aiua-7778	109	14	,	,	PUNCT
aiua-7778	109	15	positive	positive	ADJ
aiua-7778	109	16	/	/	SYM
aiua-7778	109	17	negative	negative	ADJ
aiua-7778	109	18	predictive	predictive	ADJ
aiua-7778	109	19	values	value	NOUN
aiua-7778	109	20	of	of	ADP
aiua-7778	109	21	nlr	nlr	PROPN
aiua-7778	109	22	alone	alone	ADJ
aiua-7778	109	23	and	and	CCONJ
aiua-7778	109	24	nlr	nlr	PROPN
aiua-7778	109	25	combined	combine	VERB
aiua-7778	109	26	with	with	ADP
aiua-7778	109	27	free	free	ADJ
aiua-7778	109	28	/	/	SYM
aiua-7778	109	29	total	total	ADJ
aiua-7778	109	30	psa	psa	NOUN
aiua-7778	109	31	ratio	ratio	NOUN
aiua-7778	109	32	(	(	PUNCT
aiua-7778	109	33	cut	cut	NOUN
aiua-7778	109	34	-	-	PUNCT
aiua-7778	109	35	off	off	NOUN
aiua-7778	109	36	:	:	PUNCT
aiua-7778	109	37	0.15	0.15	NUM
aiua-7778	109	38	)	)	PUNCT
aiua-7778	109	39	were	be	AUX
aiua-7778	109	40	56.6%/60.8	56.6%/60.8	NUM
aiua-7778	109	41	%	%	NOUN
aiua-7778	109	42	and	and	CCONJ
aiua-7778	109	43	80.7%/60.1	80.7%/60.1	NUM
aiua-7778	109	44	%	%	NOUN
aiua-7778	109	45	,	,	PUNCT
aiua-7778	109	46	respectively	respectively	ADV
aiua-7778	109	47	(	(	PUNCT
aiua-7778	109	48	15	15	NUM
aiua-7778	109	49	)	)	PUNCT
aiua-7778	109	50	.	.	PUNCT
aiua-7778	110	1	huang	huang	PROPN
aiua-7778	110	2	et	et	PROPN
aiua-7778	110	3	al	al	PROPN
aiua-7778	110	4	.	.	PROPN
aiua-7778	110	5	analyzed	analyze	VERB
aiua-7778	110	6	a	a	DET
aiua-7778	110	7	total	total	NOUN
aiua-7778	110	8	of	of	ADP
aiua-7778	110	9	662	662	NUM
aiua-7778	110	10	patients	patient	NOUN
aiua-7778	110	11	who	who	PRON
aiua-7778	110	12	underwent	undergo	VERB
aiua-7778	110	13	transperineal	transperineal	NOUN
aiua-7778	110	14	template	template	NOUN
aiua-7778	110	15	guided	guide	VERB
aiua-7778	110	16	pbx	pbx	NOUN
aiua-7778	110	17	.	.	PUNCT
aiua-7778	111	1	in	in	ADP
aiua-7778	111	2	the	the	DET
aiua-7778	111	3	entire	entire	ADJ
aiua-7778	111	4	cohort	cohort	NOUN
aiua-7778	111	5	,	,	PUNCT
aiua-7778	111	6	any	any	DET
aiua-7778	111	7	significant	significant	ADJ
aiua-7778	111	8	difference	difference	NOUN
aiua-7778	111	9	was	be	AUX
aiua-7778	111	10	not	not	PART
aiua-7778	111	11	found	find	VERB
aiua-7778	111	12	in	in	ADP
aiua-7778	111	13	nlr	nlr	PROPN
aiua-7778	111	14	when	when	SCONJ
aiua-7778	111	15	patients	patient	NOUN
aiua-7778	111	16	were	be	AUX
aiua-7778	111	17	grouped	group	VERB
aiua-7778	111	18	with	with	ADP
aiua-7778	111	19	regard	regard	NOUN
aiua-7778	111	20	to	to	ADP
aiua-7778	111	21	histology	histology	NOUN
aiua-7778	111	22	of	of	ADP
aiua-7778	111	23	the	the	DET
aiua-7778	111	24	biopsy	biopsy	NOUN
aiua-7778	111	25	(	(	PUNCT
aiua-7778	111	26	cancer	cancer	NOUN
aiua-7778	111	27	and	and	CCONJ
aiua-7778	111	28	no	no	DET
aiua-7778	111	29	cancer	cancer	NOUN
aiua-7778	111	30	)	)	PUNCT
aiua-7778	112	1	(	(	PUNCT
aiua-7778	112	2	p	p	X
aiua-7778	112	3	=	=	NOUN
aiua-7778	112	4	0.424	0.424	NUM
aiua-7778	112	5	)	)	PUNCT
aiua-7778	112	6	.	.	PUNCT
aiua-7778	113	1	however	however	ADV
aiua-7778	113	2	,	,	PUNCT
aiua-7778	113	3	they	they	PRON
aiua-7778	113	4	observed	observe	VERB
aiua-7778	113	5	additional	additional	ADJ
aiua-7778	113	6	significant	significant	ADJ
aiua-7778	113	7	difference	difference	NOUN
aiua-7778	113	8	in	in	ADP
aiua-7778	113	9	nlr	nlr	PROPN
aiua-7778	113	10	figure	figure	NOUN
aiua-7778	113	11	1	1	NUM
aiua-7778	113	12	.	.	PUNCT
aiua-7778	114	1	auroc	auroc	NOUN
aiua-7778	114	2	for	for	ADP
aiua-7778	114	3	variables	variable	NOUN
aiua-7778	114	4	to	to	PART
aiua-7778	114	5	predict	predict	VERB
aiua-7778	114	6	prostate	prostate	NOUN
aiua-7778	114	7	cancer	cancer	NOUN
aiua-7778	114	8	.	.	PUNCT
aiua-7778	115	1	caglayan_stesura	caglayan_stesura	NOUN
aiua-7778	115	2	seveso	seveso	NOUN
aiua-7778	115	3	10/01/19	10/01/19	PROPN
aiua-7778	115	4	16:08	16:08	NUM
aiua-7778	115	5	pagina	pagina	NOUN
aiua-7778	115	6	273	273	NUM
aiua-7778	115	7	archivio	archivio	NOUN
aiua-7778	115	8	italiano	italiano	X
aiua-7778	115	9	di	di	X
aiua-7778	115	10	urologia	urologia	PROPN
aiua-7778	115	11	e	e	PROPN
aiua-7778	115	12	andrologia	andrologia	NOUN
aiua-7778	115	13	2018	2018	NUM
aiua-7778	115	14	;	;	PUNCT
aiua-7778	115	15	90	90	NUM
aiua-7778	115	16	,	,	PUNCT
aiua-7778	115	17	4	4	NUM
aiua-7778	115	18	v.	v.	ADP
aiua-7778	115	19	caglayan	caglayan	NOUN
aiua-7778	115	20	,	,	PUNCT
aiua-7778	115	21	e.	e.	PROPN
aiua-7778	115	22	onen	onen	PROPN
aiua-7778	115	23	,	,	PUNCT
aiua-7778	115	24	s.	s.	PROPN
aiua-7778	115	25	avci	avci	PROPN
aiua-7778	115	26	,	,	PUNCT
aiua-7778	115	27	m.	m.	NOUN
aiua-7778	115	28	sambel	sambel	NOUN
aiua-7778	115	29	,	,	PUNCT
aiua-7778	115	30	m.	m.	NOUN
aiua-7778	115	31	kilic	kilic	PROPN
aiua-7778	115	32	,	,	PUNCT
aiua-7778	115	33	s.	s.	PROPN
aiua-7778	115	34	oner	oner	PROPN
aiua-7778	115	35	,	,	PUNCT
aiua-7778	115	36	m.	m.	NOUN
aiua-7778	115	37	murat	murat	PROPN
aiua-7778	115	38	aydos	aydos	PROPN
aiua-7778	115	39	,	,	PUNCT
aiua-7778	115	40	h.	h.	PROPN
aiua-7778	115	41	emre	emre	PROPN
aiua-7778	115	42	yıldız	yıldız	PROPN
aiua-7778	115	43	274	274	NUM
aiua-7778	115	44	value	value	NOUN
aiua-7778	115	45	(	(	PUNCT
aiua-7778	115	46	p	p	NOUN
aiua-7778	115	47	=	=	NOUN
aiua-7778	115	48	0.002	0.002	NUM
aiua-7778	115	49	)	)	PUNCT
aiua-7778	115	50	when	when	SCONJ
aiua-7778	115	51	analyses	analysis	NOUN
aiua-7778	115	52	were	be	AUX
aiua-7778	115	53	restricted	restrict	VERB
aiua-7778	115	54	to	to	ADP
aiua-7778	115	55	patients	patient	NOUN
aiua-7778	115	56	with	with	ADP
aiua-7778	115	57	psa	psa	NOUN
aiua-7778	115	58	ranged	range	VERB
aiua-7778	115	59	from	from	ADP
aiua-7778	115	60	4	4	NUM
aiua-7778	115	61	to	to	PART
aiua-7778	115	62	10	10	NUM
aiua-7778	115	63	ng	ng	PROPN
aiua-7778	115	64	/	/	SYM
aiua-7778	115	65	ml	ml	PROPN
aiua-7778	115	66	(	(	PUNCT
aiua-7778	115	67	cut	cut	VERB
aiua-7778	115	68	-	-	PUNCT
aiua-7778	115	69	off	off	ADP
aiua-7778	115	70	value	value	NOUN
aiua-7778	115	71	was	be	AUX
aiua-7778	115	72	set	set	VERB
aiua-7778	115	73	at	at	ADP
aiua-7778	115	74	2.44	2.44	NUM
aiua-7778	115	75	)	)	PUNCT
aiua-7778	115	76	.	.	PUNCT
aiua-7778	116	1	accordingly	accordingly	ADV
aiua-7778	116	2	the	the	DET
aiua-7778	116	3	patients	patient	NOUN
aiua-7778	116	4	were	be	AUX
aiua-7778	116	5	classified	classify	VERB
aiua-7778	116	6	into	into	ADP
aiua-7778	116	7	high	high	ADJ
aiua-7778	116	8	-	-	PUNCT
aiua-7778	116	9	nlr	nlr	NOUN
aiua-7778	116	10	and	and	CCONJ
aiua-7778	116	11	low	low	ADJ
aiua-7778	116	12	-	-	PUNCT
aiua-7778	116	13	nlr	nlr	PROPN
aiua-7778	116	14	group	group	NOUN
aiua-7778	116	15	.	.	PUNCT
aiua-7778	117	1	the	the	DET
aiua-7778	117	2	highnlr	highnlr	PROPN
aiua-7778	117	3	showed	show	VERB
aiua-7778	117	4	significantly	significantly	ADV
aiua-7778	117	5	high	high	ADJ
aiua-7778	117	6	pca	pca	NOUN
aiua-7778	117	7	detection	detection	NOUN
aiua-7778	117	8	rate	rate	NOUN
aiua-7778	117	9	in	in	ADP
aiua-7778	117	10	the	the	DET
aiua-7778	117	11	entire	entire	ADJ
aiua-7778	117	12	cohort	cohort	NOUN
aiua-7778	117	13	and	and	CCONJ
aiua-7778	117	14	in	in	ADP
aiua-7778	117	15	the	the	DET
aiua-7778	117	16	cohort	cohort	NOUN
aiua-7778	117	17	with	with	ADP
aiua-7778	117	18	psa	psa	NOUN
aiua-7778	117	19	ranged	range	VERB
aiua-7778	117	20	from	from	ADP
aiua-7778	117	21	4	4	NUM
aiua-7778	117	22	to	to	PART
aiua-7778	117	23	10	10	NUM
aiua-7778	117	24	ng	ng	PROPN
aiua-7778	117	25	/	/	SYM
aiua-7778	117	26	ml	ml	PROPN
aiua-7778	117	27	(	(	PUNCT
aiua-7778	117	28	175/338	175/338	NUM
aiua-7778	117	29	,	,	PUNCT
aiua-7778	117	30	142/324	142/324	NUM
aiua-7778	117	31	,	,	PUNCT
aiua-7778	117	32	p	p	NOUN
aiua-7778	117	33	=	=	NOUN
aiua-7778	117	34	0.041	0.041	NUM
aiua-7778	117	35	and	and	CCONJ
aiua-7778	117	36	36/77	36/77	NUM
aiua-7778	117	37	,	,	PUNCT
aiua-7778	117	38	14/87	14/87	NUM
aiua-7778	117	39	,	,	PUNCT
aiua-7778	117	40	p	p	X
aiua-7778	117	41	<	<	X
aiua-7778	117	42	0.001	0.001	NUM
aiua-7778	117	43	respectively	respectively	ADV
aiua-7778	117	44	)	)	PUNCT
aiua-7778	117	45	(	(	PUNCT
aiua-7778	117	46	16	16	NUM
aiua-7778	117	47	)	)	PUNCT
aiua-7778	117	48	.	.	PUNCT
aiua-7778	118	1	gokce	gokce	PROPN
aiua-7778	118	2	et	et	PROPN
aiua-7778	118	3	al	al	PROPN
aiua-7778	118	4	.	.	PROPN
aiua-7778	118	5	investigated	investigate	VERB
aiua-7778	118	6	the	the	DET
aiua-7778	118	7	data	datum	NOUN
aiua-7778	118	8	of	of	ADP
aiua-7778	118	9	1836	1836	NUM
aiua-7778	118	10	patients	patient	NOUN
aiua-7778	118	11	.	.	PUNCT
aiua-7778	119	1	patients	patient	NOUN
aiua-7778	119	2	were	be	AUX
aiua-7778	119	3	divided	divide	VERB
aiua-7778	119	4	as	as	SCONJ
aiua-7778	119	5	follows	follow	VERB
aiua-7778	119	6	:	:	PUNCT
aiua-7778	119	7	the	the	DET
aiua-7778	119	8	group	group	NOUN
aiua-7778	119	9	with	with	ADP
aiua-7778	119	10	bph	bph	NOUN
aiua-7778	119	11	,	,	PUNCT
aiua-7778	119	12	the	the	DET
aiua-7778	119	13	group	group	NOUN
aiua-7778	119	14	with	with	ADP
aiua-7778	119	15	prostatitis	prostatitis	NOUN
aiua-7778	119	16	and	and	CCONJ
aiua-7778	119	17	the	the	DET
aiua-7778	119	18	group	group	NOUN
aiua-7778	119	19	with	with	ADP
aiua-7778	119	20	pca	pca	PROPN
aiua-7778	119	21	.	.	PUNCT
aiua-7778	120	1	pre	pre	ADJ
aiua-7778	120	2	-	-	ADJ
aiua-7778	120	3	biopsy	biopsy	ADJ
aiua-7778	120	4	mean	mean	PROPN
aiua-7778	120	5	nlr	nlr	PROPN
aiua-7778	120	6	value	value	NOUN
aiua-7778	120	7	of	of	ADP
aiua-7778	120	8	the	the	DET
aiua-7778	120	9	prostatitis	prostatitis	NOUN
aiua-7778	120	10	group	group	NOUN
aiua-7778	120	11	was	be	AUX
aiua-7778	120	12	significantly	significantly	ADV
aiua-7778	120	13	higher	high	ADJ
aiua-7778	120	14	compared	compare	VERB
aiua-7778	120	15	to	to	ADP
aiua-7778	120	16	the	the	DET
aiua-7778	120	17	pca	pca	PROPN
aiua-7778	120	18	and	and	CCONJ
aiua-7778	120	19	bph	bph	NOUN
aiua-7778	120	20	groups	group	NOUN
aiua-7778	120	21	(	(	PUNCT
aiua-7778	120	22	p	p	X
aiua-7778	120	23	=	=	NOUN
aiua-7778	120	24	0.0001	0.0001	NUM
aiua-7778	120	25	)	)	PUNCT
aiua-7778	120	26	.	.	PUNCT
aiua-7778	121	1	the	the	DET
aiua-7778	121	2	mean	mean	ADJ
aiua-7778	121	3	nlr	nlr	PROPN
aiua-7778	121	4	of	of	ADP
aiua-7778	121	5	pca	pca	PROPN
aiua-7778	121	6	group	group	NOUN
aiua-7778	121	7	was	be	AUX
aiua-7778	121	8	significantly	significantly	ADV
aiua-7778	121	9	higher	high	ADJ
aiua-7778	121	10	compared	compare	VERB
aiua-7778	121	11	to	to	ADP
aiua-7778	121	12	the	the	DET
aiua-7778	121	13	bph	bph	NOUN
aiua-7778	121	14	group	group	NOUN
aiua-7778	121	15	(	(	PUNCT
aiua-7778	121	16	p	p	X
aiua-7778	121	17	=	=	NOUN
aiua-7778	121	18	0.002	0.002	NUM
aiua-7778	121	19	)	)	PUNCT
aiua-7778	121	20	.	.	PUNCT
aiua-7778	122	1	also	also	ADV
aiua-7778	122	2	,	,	PUNCT
aiua-7778	122	3	the	the	DET
aiua-7778	122	4	pca	pca	NOUN
aiua-7778	122	5	patients	patient	NOUN
aiua-7778	122	6	with	with	ADP
aiua-7778	122	7	high	high	ADJ
aiua-7778	122	8	gleason	gleason	PROPN
aiua-7778	122	9	score	score	NOUN
aiua-7778	122	10	(	(	PUNCT
aiua-7778	122	11	gs	gs	NOUN
aiua-7778	122	12	)	)	PUNCT
aiua-7778	122	13	(	(	PUNCT
aiua-7778	122	14	gs	gs	INTJ
aiua-7778	122	15	8	8	NUM
aiua-7778	122	16	and	and	CCONJ
aiua-7778	122	17	above	above	ADV
aiua-7778	122	18	)	)	PUNCT
aiua-7778	122	19	had	have	VERB
aiua-7778	122	20	a	a	DET
aiua-7778	122	21	significantly	significantly	ADV
aiua-7778	122	22	higher	high	ADJ
aiua-7778	122	23	mean	mean	PROPN
aiua-7778	122	24	nlr	nlr	PROPN
aiua-7778	122	25	compared	compare	VERB
aiua-7778	122	26	to	to	ADP
aiua-7778	122	27	the	the	DET
aiua-7778	122	28	pca	pca	NOUN
aiua-7778	122	29	patients	patient	NOUN
aiua-7778	122	30	with	with	ADP
aiua-7778	122	31	gs	gs	PROPN
aiua-7778	122	32	5	5	NUM
aiua-7778	122	33	-	-	SYM
aiua-7778	122	34	6	6	NUM
aiua-7778	122	35	and	and	CCONJ
aiua-7778	122	36	gs	gs	INTJ
aiua-7778	122	37	7	7	NUM
aiua-7778	122	38	(	(	PUNCT
aiua-7778	122	39	p	p	NOUN
aiua-7778	122	40	=	=	NOUN
aiua-7778	122	41	0.0001	0.0001	NUM
aiua-7778	122	42	)	)	PUNCT
aiua-7778	122	43	(	(	PUNCT
aiua-7778	122	44	17	17	NUM
aiua-7778	122	45	)	)	PUNCT
aiua-7778	122	46	.	.	PUNCT
aiua-7778	123	1	in	in	ADP
aiua-7778	123	2	the	the	DET
aiua-7778	123	3	present	present	ADJ
aiua-7778	123	4	study	study	NOUN
aiua-7778	123	5	;	;	PUNCT
aiua-7778	123	6	when	when	SCONJ
aiua-7778	123	7	evaluating	evaluate	VERB
aiua-7778	123	8	the	the	DET
aiua-7778	123	9	nlr	nlr	PROPN
aiua-7778	123	10	,	,	PUNCT
aiua-7778	123	11	any	any	DET
aiua-7778	123	12	statistically	statistically	ADV
aiua-7778	123	13	significant	significant	ADJ
aiua-7778	123	14	difference	difference	NOUN
aiua-7778	123	15	was	be	AUX
aiua-7778	123	16	not	not	PART
aiua-7778	123	17	observed	observe	VERB
aiua-7778	123	18	based	base	VERB
aiua-7778	123	19	on	on	ADP
aiua-7778	123	20	the	the	DET
aiua-7778	123	21	biopsy	biopsy	NOUN
aiua-7778	123	22	results	result	NOUN
aiua-7778	123	23	.	.	PUNCT
aiua-7778	124	1	also	also	ADV
aiua-7778	124	2	,	,	PUNCT
aiua-7778	124	3	cohort	cohort	PROPN
aiua-7778	124	4	were	be	AUX
aiua-7778	124	5	seperated	seperate	VERB
aiua-7778	124	6	into	into	ADP
aiua-7778	124	7	3	3	NUM
aiua-7778	124	8	groups	group	NOUN
aiua-7778	124	9	as	as	ADP
aiua-7778	124	10	men	man	NOUN
aiua-7778	124	11	with	with	ADP
aiua-7778	124	12	psa	psa	NOUN
aiua-7778	124	13	value	value	NOUN
aiua-7778	124	14	of	of	ADP
aiua-7778	124	15	<	<	X
aiua-7778	124	16	4	4	NUM
aiua-7778	124	17	,	,	PUNCT
aiua-7778	124	18	psa	psa	VERB
aiua-7778	124	19	between	between	ADP
aiua-7778	124	20	4	4	NUM
aiua-7778	124	21	and	and	CCONJ
aiua-7778	124	22	10	10	NUM
aiua-7778	124	23	and	and	CCONJ
aiua-7778	124	24	psa	psa	VERB
aiua-7778	124	25	of	of	ADP
aiua-7778	124	26	>	>	X
aiua-7778	124	27	10	10	NUM
aiua-7778	124	28	ng	ng	PROPN
aiua-7778	124	29	/	/	SYM
aiua-7778	124	30	dl	dl	PROPN
aiua-7778	124	31	.	.	PUNCT
aiua-7778	125	1	no	no	DET
aiua-7778	125	2	statistically	statistically	ADV
aiua-7778	125	3	significant	significant	ADJ
aiua-7778	125	4	nlr	nlr	PROPN
aiua-7778	125	5	difference	difference	NOUN
aiua-7778	125	6	was	be	AUX
aiua-7778	125	7	observed	observe	VERB
aiua-7778	125	8	based	base	VERB
aiua-7778	125	9	on	on	ADP
aiua-7778	125	10	the	the	DET
aiua-7778	125	11	biopsy	biopsy	NOUN
aiua-7778	125	12	results	result	NOUN
aiua-7778	125	13	in	in	ADP
aiua-7778	125	14	any	any	DET
aiua-7778	125	15	psa	psa	NOUN
aiua-7778	125	16	range	range	NOUN
aiua-7778	125	17	.	.	PUNCT
aiua-7778	126	1	we	we	PRON
aiua-7778	126	2	divided	divide	VERB
aiua-7778	126	3	the	the	DET
aiua-7778	126	4	pca	pca	NOUN
aiua-7778	126	5	patients	patient	NOUN
aiua-7778	126	6	into	into	ADP
aiua-7778	126	7	2	2	NUM
aiua-7778	126	8	groups	group	NOUN
aiua-7778	126	9	as	as	ADP
aiua-7778	126	10	the	the	DET
aiua-7778	126	11	group	group	NOUN
aiua-7778	126	12	with	with	ADP
aiua-7778	126	13	gs	gs	PROPN
aiua-7778	126	14	6	6	NUM
aiua-7778	126	15	and	and	CCONJ
aiua-7778	126	16	gs	gs	INTJ
aiua-7778	126	17	7	7	NUM
aiua-7778	126	18	and	and	CCONJ
aiua-7778	126	19	above	above	ADV
aiua-7778	126	20	.	.	PUNCT
aiua-7778	127	1	there	there	PRON
aiua-7778	127	2	was	be	VERB
aiua-7778	127	3	not	not	PART
aiua-7778	127	4	a	a	DET
aiua-7778	127	5	statistically	statistically	ADV
aiua-7778	127	6	significant	significant	ADJ
aiua-7778	127	7	difference	difference	NOUN
aiua-7778	127	8	between	between	ADP
aiua-7778	127	9	the	the	DET
aiua-7778	127	10	gs	gs	PROPN
aiua-7778	127	11	groups	group	NOUN
aiua-7778	127	12	.	.	PUNCT
aiua-7778	128	1	additionally	additionally	ADV
aiua-7778	128	2	,	,	PUNCT
aiua-7778	128	3	controversial	controversial	ADJ
aiua-7778	128	4	to	to	ADP
aiua-7778	128	5	the	the	DET
aiua-7778	128	6	study	study	NOUN
aiua-7778	128	7	performed	perform	VERB
aiua-7778	128	8	by	by	ADP
aiua-7778	128	9	gokce	gokce	PROPN
aiua-7778	128	10	et	et	PROPN
aiua-7778	128	11	al	al	PROPN
aiua-7778	128	12	.	.	PROPN
aiua-7778	128	13	,	,	PUNCT
aiua-7778	128	14	we	we	PRON
aiua-7778	128	15	did	do	AUX
aiua-7778	128	16	not	not	PART
aiua-7778	128	17	observe	observe	VERB
aiua-7778	128	18	a	a	DET
aiua-7778	128	19	significant	significant	ADJ
aiua-7778	128	20	highness	highness	NOUN
aiua-7778	128	21	in	in	ADP
aiua-7778	128	22	the	the	DET
aiua-7778	128	23	prostatitis	prostatitis	NOUN
aiua-7778	128	24	group	group	NOUN
aiua-7778	128	25	compared	compare	VERB
aiua-7778	128	26	to	to	ADP
aiua-7778	128	27	the	the	DET
aiua-7778	128	28	pca	pca	PROPN
aiua-7778	128	29	and	and	CCONJ
aiua-7778	128	30	bph	bph	NOUN
aiua-7778	128	31	group	group	NOUN
aiua-7778	128	32	.	.	PUNCT
aiua-7778	129	1	our	our	PRON
aiua-7778	129	2	data	datum	NOUN
aiua-7778	129	3	showed	show	VERB
aiua-7778	129	4	that	that	SCONJ
aiua-7778	129	5	chronic	chronic	ADJ
aiua-7778	129	6	prostatitis	prostatitis	NOUN
aiua-7778	129	7	does	do	AUX
aiua-7778	129	8	not	not	PART
aiua-7778	129	9	effect	effect	VERB
aiua-7778	129	10	the	the	DET
aiua-7778	129	11	inflammation	inflammation	NOUN
aiua-7778	129	12	markers	marker	NOUN
aiua-7778	129	13	derived	derive	VERB
aiua-7778	129	14	from	from	ADP
aiua-7778	129	15	cbc	cbc	NOUN
aiua-7778	129	16	considerably	considerably	ADV
aiua-7778	129	17	.	.	PUNCT
aiua-7778	130	1	kaynar	kaynar	PROPN
aiua-7778	130	2	et	et	PROPN
aiua-7778	130	3	al	al	PROPN
aiua-7778	130	4	.	.	PROPN
aiua-7778	130	5	retrospectively	retrospectively	ADV
aiua-7778	130	6	reviewed	review	VERB
aiua-7778	130	7	the	the	DET
aiua-7778	130	8	data	datum	NOUN
aiua-7778	130	9	of	of	ADP
aiua-7778	130	10	201	201	NUM
aiua-7778	130	11	patients	patient	NOUN
aiua-7778	130	12	.	.	PUNCT
aiua-7778	131	1	pathological	pathological	ADJ
aiua-7778	131	2	sample	sample	NOUN
aiua-7778	131	3	results	result	NOUN
aiua-7778	131	4	were	be	AUX
aiua-7778	131	5	categorized	categorize	VERB
aiua-7778	131	6	as	as	ADP
aiua-7778	131	7	chronic	chronic	ADJ
aiua-7778	131	8	prostatitis	prostatitis	NOUN
aiua-7778	131	9	,	,	PUNCT
aiua-7778	131	10	bph	bph	NOUN
aiua-7778	131	11	and	and	CCONJ
aiua-7778	131	12	pca	pca	PROPN
aiua-7778	131	13	.	.	PUNCT
aiua-7778	132	1	psa	psa	PROPN
aiua-7778	132	2	levels	level	NOUN
aiua-7778	132	3	were	be	AUX
aiua-7778	132	4	also	also	ADV
aiua-7778	132	5	categorized	categorize	VERB
aiua-7778	132	6	as	as	ADP
aiua-7778	132	7	0	0	NUM
aiua-7778	132	8	-	-	SYM
aiua-7778	132	9	4	4	NUM
aiua-7778	132	10	ng	ng	PROPN
aiua-7778	132	11	/	/	SYM
aiua-7778	132	12	ml	ml	NOUN
aiua-7778	132	13	,	,	PUNCT
aiua-7778	132	14	4	4	NUM
aiua-7778	132	15	-	-	SYM
aiua-7778	132	16	10	10	NUM
aiua-7778	132	17	ng	ng	PROPN
aiua-7778	132	18	/	/	SYM
aiua-7778	132	19	ml	ml	PROPN
aiua-7778	132	20	,	,	PUNCT
aiua-7778	132	21	and	and	CCONJ
aiua-7778	132	22	10	10	NUM
aiua-7778	132	23	ng	ng	NOUN
aiua-7778	132	24	/	/	SYM
aiua-7778	132	25	ml	ml	PROPN
aiua-7778	132	26	and	and	CCONJ
aiua-7778	132	27	above.any	above.any	NUM
aiua-7778	132	28	statistically	statistically	ADV
aiua-7778	132	29	significant	significant	ADJ
aiua-7778	132	30	difference	difference	NOUN
aiua-7778	132	31	was	be	AUX
aiua-7778	132	32	not	not	PART
aiua-7778	132	33	observed	observe	VERB
aiua-7778	132	34	between	between	ADP
aiua-7778	132	35	benign	benign	ADJ
aiua-7778	132	36	or	or	CCONJ
aiua-7778	132	37	malign	malign	ADJ
aiua-7778	132	38	groups	group	NOUN
aiua-7778	132	39	in	in	ADP
aiua-7778	132	40	terms	term	NOUN
aiua-7778	132	41	of	of	ADP
aiua-7778	132	42	age	age	NOUN
aiua-7778	132	43	,	,	PUNCT
aiua-7778	132	44	nlr	nlr	PROPN
aiua-7778	132	45	and	and	CCONJ
aiua-7778	132	46	mean	mean	VERB
aiua-7778	132	47	prostate	prostate	NOUN
aiua-7778	132	48	volume	volume	NOUN
aiua-7778	132	49	.	.	PUNCT
aiua-7778	133	1	statistically	statistically	ADV
aiua-7778	133	2	significant	significant	ADJ
aiua-7778	133	3	differences	difference	NOUN
aiua-7778	133	4	were	be	AUX
aiua-7778	133	5	present	present	ADJ
aiua-7778	133	6	only	only	ADV
aiua-7778	133	7	in	in	ADP
aiua-7778	133	8	the	the	DET
aiua-7778	133	9	psa	psa	PROPN
aiua-7778	133	10	10	10	NUM
aiua-7778	133	11	ng	ng	PROPN
aiua-7778	133	12	/	/	SYM
aiua-7778	133	13	ml	ml	NOUN
aiua-7778	133	14	and	and	CCONJ
aiua-7778	133	15	above	above	ADP
aiua-7778	133	16	group	group	NOUN
aiua-7778	133	17	related	relate	VERB
aiua-7778	133	18	to	to	PART
aiua-7778	133	19	mean	mean	VERB
aiua-7778	133	20	plr	plr	NOUN
aiua-7778	133	21	values	value	NOUN
aiua-7778	133	22	(	(	PUNCT
aiua-7778	133	23	p	p	X
aiua-7778	133	24	:	:	PUNCT
aiua-7778	133	25	0.044	0.044	NUM
aiua-7778	133	26	)	)	PUNCT
aiua-7778	133	27	(	(	PUNCT
aiua-7778	133	28	18	18	NUM
aiua-7778	133	29	)	)	PUNCT
aiua-7778	133	30	.	.	PUNCT
aiua-7778	134	1	in	in	ADP
aiua-7778	134	2	another	another	DET
aiua-7778	134	3	study	study	NOUN
aiua-7778	134	4	,	,	PUNCT
aiua-7778	134	5	plr	plr	NOUN
aiua-7778	134	6	value	value	NOUN
aiua-7778	134	7	was	be	AUX
aiua-7778	134	8	statistically	statistically	ADV
aiua-7778	134	9	higher	high	ADJ
aiua-7778	134	10	in	in	ADP
aiua-7778	134	11	pca	pca	PROPN
aiua-7778	134	12	group	group	NOUN
aiua-7778	134	13	than	than	ADP
aiua-7778	134	14	in	in	ADP
aiua-7778	134	15	bph	bph	NOUN
aiua-7778	134	16	group	group	NOUN
aiua-7778	134	17	while	while	SCONJ
aiua-7778	134	18	nlr	nlr	PROPN
aiua-7778	134	19	value	value	NOUN
aiua-7778	134	20	was	be	AUX
aiua-7778	134	21	not	not	PART
aiua-7778	134	22	(	(	PUNCT
aiua-7778	134	23	19	19	NUM
aiua-7778	134	24	)	)	PUNCT
aiua-7778	134	25	.	.	PUNCT
aiua-7778	135	1	in	in	ADP
aiua-7778	135	2	our	our	PRON
aiua-7778	135	3	study	study	NOUN
aiua-7778	135	4	,	,	PUNCT
aiua-7778	135	5	pre	pre	ADJ
aiua-7778	135	6	-	-	ADJ
aiua-7778	135	7	biopsy	biopsy	ADJ
aiua-7778	135	8	plr	plr	NOUN
aiua-7778	135	9	value	value	NOUN
aiua-7778	135	10	was	be	AUX
aiua-7778	135	11	not	not	PART
aiua-7778	135	12	associated	associate	VERB
aiua-7778	135	13	with	with	ADP
aiua-7778	135	14	higher	high	ADJ
aiua-7778	135	15	pca	pca	NOUN
aiua-7778	135	16	detection	detection	NOUN
aiua-7778	135	17	rate	rate	NOUN
aiua-7778	135	18	in	in	ADP
aiua-7778	135	19	any	any	DET
aiua-7778	135	20	psa	psa	NOUN
aiua-7778	135	21	range	range	NOUN
aiua-7778	135	22	or	or	CCONJ
aiua-7778	135	23	in	in	ADP
aiua-7778	135	24	any	any	DET
aiua-7778	135	25	gleason	gleason	PROPN
aiua-7778	135	26	score	score	NOUN
aiua-7778	135	27	range	range	NOUN
aiua-7778	135	28	.	.	PUNCT
aiua-7778	136	1	to	to	ADP
aiua-7778	136	2	our	our	PRON
aiua-7778	136	3	knowledge	knowledge	NOUN
aiua-7778	136	4	,	,	PUNCT
aiua-7778	136	5	there	there	PRON
aiua-7778	136	6	is	be	VERB
aiua-7778	136	7	not	not	PART
aiua-7778	136	8	any	any	DET
aiua-7778	136	9	study	study	NOUN
aiua-7778	136	10	assessing	assess	VERB
aiua-7778	136	11	the	the	DET
aiua-7778	136	12	predictive	predictive	ADJ
aiua-7778	136	13	value	value	NOUN
aiua-7778	136	14	of	of	ADP
aiua-7778	136	15	lmr	lmr	PROPN
aiua-7778	136	16	for	for	ADP
aiua-7778	136	17	pca	pca	PROPN
aiua-7778	136	18	risk	risk	NOUN
aiua-7778	136	19	.	.	PUNCT
aiua-7778	137	1	in	in	ADP
aiua-7778	137	2	the	the	DET
aiua-7778	137	3	present	present	ADJ
aiua-7778	137	4	study	study	NOUN
aiua-7778	137	5	,	,	PUNCT
aiua-7778	137	6	lmr	lmr	PROPN
aiua-7778	137	7	was	be	AUX
aiua-7778	137	8	the	the	DET
aiua-7778	137	9	only	only	ADJ
aiua-7778	137	10	inflammation	inflammation	ADJ
aiua-7778	137	11	marker	marker	NOUN
aiua-7778	137	12	associated	associate	VERB
aiua-7778	137	13	with	with	ADP
aiua-7778	137	14	pca	pca	NOUN
aiua-7778	137	15	diagnosis	diagnosis	NOUN
aiua-7778	137	16	(	(	PUNCT
aiua-7778	137	17	p	p	X
aiua-7778	137	18	=	=	NOUN
aiua-7778	137	19	0.047	0.047	NUM
aiua-7778	137	20	)	)	PUNCT
aiua-7778	137	21	.	.	PUNCT
aiua-7778	138	1	interestingly	interestingly	ADV
aiua-7778	138	2	,	,	PUNCT
aiua-7778	138	3	in	in	ADP
aiua-7778	138	4	the	the	DET
aiua-7778	138	5	4	4	NUM
aiua-7778	138	6	-	-	SYM
aiua-7778	138	7	10	10	NUM
aiua-7778	138	8	ng	ng	PROPN
aiua-7778	138	9	/	/	SYM
aiua-7778	138	10	dl	dl	PROPN
aiua-7778	138	11	psa	psa	PROPN
aiua-7778	138	12	range	range	PROPN
aiua-7778	138	13	lmr	lmr	PROPN
aiua-7778	138	14	value	value	NOUN
aiua-7778	138	15	was	be	AUX
aiua-7778	138	16	extremely	extremely	ADV
aiua-7778	138	17	lower	low	ADJ
aiua-7778	138	18	in	in	ADP
aiua-7778	138	19	patients	patient	NOUN
aiua-7778	138	20	with	with	ADP
aiua-7778	138	21	positive	positive	ADJ
aiua-7778	138	22	biopsy	biopsy	NOUN
aiua-7778	138	23	than	than	ADP
aiua-7778	138	24	those	those	PRON
aiua-7778	138	25	with	with	ADP
aiua-7778	138	26	negative	negative	ADJ
aiua-7778	138	27	biopsy	biopsy	NOUN
aiua-7778	138	28	(	(	PUNCT
aiua-7778	138	29	p	p	NOUN
aiua-7778	138	30	=	=	NOUN
aiua-7778	138	31	0,012	0,012	NUM
aiua-7778	138	32	)	)	PUNCT
aiua-7778	138	33	.	.	PUNCT
aiua-7778	139	1	in	in	ADP
aiua-7778	139	2	this	this	DET
aiua-7778	139	3	group	group	NOUN
aiua-7778	139	4	free	free	ADJ
aiua-7778	139	5	/	/	SYM
aiua-7778	139	6	total	total	ADJ
aiua-7778	139	7	psa	psa	NOUN
aiua-7778	139	8	ratio	ratio	NOUN
aiua-7778	139	9	lower	low	ADJ
aiua-7778	139	10	0.15	0.15	NUM
aiua-7778	139	11	and	and	CCONJ
aiua-7778	139	12	age	age	NOUN
aiua-7778	139	13	higher	high	ADJ
aiua-7778	139	14	than	than	ADP
aiua-7778	139	15	65.5	65.5	NUM
aiua-7778	139	16	were	be	AUX
aiua-7778	139	17	also	also	ADV
aiua-7778	139	18	risk	risk	NOUN
aiua-7778	139	19	factors	factor	NOUN
aiua-7778	139	20	to	to	PART
aiua-7778	139	21	predict	predict	VERB
aiua-7778	139	22	pca	pca	PROPN
aiua-7778	139	23	.	.	PUNCT
aiua-7778	140	1	additionally	additionally	ADV
aiua-7778	140	2	our	our	PRON
aiua-7778	140	3	data	datum	NOUN
aiua-7778	140	4	showed	show	VERB
aiua-7778	140	5	that	that	SCONJ
aiua-7778	140	6	,	,	PUNCT
aiua-7778	140	7	when	when	SCONJ
aiua-7778	140	8	lmr	lmr	PROPN
aiua-7778	140	9	and	and	CCONJ
aiua-7778	140	10	free	free	ADJ
aiua-7778	140	11	/	/	SYM
aiua-7778	140	12	total	total	ADJ
aiua-7778	140	13	psa	psa	NOUN
aiua-7778	140	14	cut	cut	VERB
aiua-7778	140	15	-	-	PUNCT
aiua-7778	140	16	off	off	ADP
aiua-7778	140	17	values	value	NOUN
aiua-7778	140	18	were	be	AUX
aiua-7778	140	19	combined	combine	VERB
aiua-7778	140	20	,	,	PUNCT
aiua-7778	140	21	the	the	DET
aiua-7778	140	22	specificity	specificity	NOUN
aiua-7778	140	23	and	and	CCONJ
aiua-7778	140	24	positive	positive	ADJ
aiua-7778	140	25	predictive	predictive	ADJ
aiua-7778	140	26	value	value	NOUN
aiua-7778	140	27	were	be	AUX
aiua-7778	140	28	higher	high	ADJ
aiua-7778	140	29	compared	compare	VERB
aiua-7778	140	30	to	to	ADP
aiua-7778	140	31	the	the	DET
aiua-7778	140	32	use	use	NOUN
aiua-7778	140	33	of	of	ADP
aiua-7778	140	34	lmr	lmr	NOUN
aiua-7778	140	35	or	or	CCONJ
aiua-7778	140	36	free	free	ADJ
aiua-7778	140	37	/	/	SYM
aiua-7778	140	38	total	total	ADJ
aiua-7778	140	39	psa	psa	NOUN
aiua-7778	140	40	ratio	ratio	NOUN
aiua-7778	140	41	alone	alone	ADV
aiua-7778	140	42	.	.	PUNCT
aiua-7778	141	1	there	there	PRON
aiua-7778	141	2	are	be	VERB
aiua-7778	141	3	many	many	ADJ
aiua-7778	141	4	limitations	limitation	NOUN
aiua-7778	141	5	in	in	ADP
aiua-7778	141	6	our	our	PRON
aiua-7778	141	7	study	study	NOUN
aiua-7778	141	8	.	.	PUNCT
aiua-7778	142	1	firstly	firstly	ADV
aiua-7778	142	2	,	,	PUNCT
aiua-7778	142	3	our	our	PRON
aiua-7778	142	4	data	datum	NOUN
aiua-7778	142	5	derived	derive	VERB
aiua-7778	142	6	from	from	ADP
aiua-7778	142	7	retrospective	retrospective	ADJ
aiua-7778	142	8	cohort	cohort	NOUN
aiua-7778	142	9	.	.	PUNCT
aiua-7778	143	1	the	the	DET
aiua-7778	143	2	next	next	ADJ
aiua-7778	143	3	,	,	PUNCT
aiua-7778	143	4	we	we	PRON
aiua-7778	143	5	could	could	AUX
aiua-7778	143	6	not	not	PART
aiua-7778	143	7	evaluate	evaluate	VERB
aiua-7778	143	8	the	the	DET
aiua-7778	143	9	factors	factor	NOUN
aiua-7778	143	10	,	,	PUNCT
aiua-7778	143	11	such	such	ADJ
aiua-7778	143	12	as	as	ADP
aiua-7778	143	13	body	body	NOUN
aiua-7778	143	14	mass	mass	PROPN
aiua-7778	143	15	index	index	NOUN
aiua-7778	143	16	,	,	PUNCT
aiua-7778	143	17	smoking	smoking	NOUN
aiua-7778	143	18	,	,	PUNCT
aiua-7778	143	19	metabolic	metabolic	NOUN
aiua-7778	143	20	syndrome	syndrome	NOUN
aiua-7778	143	21	which	which	PRON
aiua-7778	143	22	may	may	AUX
aiua-7778	143	23	be	be	AUX
aiua-7778	143	24	associated	associate	VERB
aiua-7778	143	25	with	with	ADP
aiua-7778	143	26	the	the	DET
aiua-7778	143	27	inflammatory	inflammatory	ADJ
aiua-7778	143	28	response	response	NOUN
aiua-7778	143	29	.	.	PUNCT
aiua-7778	144	1	also	also	ADV
aiua-7778	144	2	the	the	DET
aiua-7778	144	3	number	number	NOUN
aiua-7778	144	4	of	of	ADP
aiua-7778	144	5	patients	patient	NOUN
aiua-7778	144	6	was	be	AUX
aiua-7778	144	7	relatively	relatively	ADV
aiua-7778	144	8	low	low	ADJ
aiua-7778	144	9	.	.	PUNCT
aiua-7778	145	1	especially	especially	ADV
aiua-7778	145	2	,	,	PUNCT
aiua-7778	145	3	the	the	DET
aiua-7778	145	4	low	low	ADJ
aiua-7778	145	5	number	number	NOUN
aiua-7778	145	6	of	of	ADP
aiua-7778	145	7	the	the	DET
aiua-7778	145	8	patients	patient	NOUN
aiua-7778	145	9	with	with	ADP
aiua-7778	145	10	prostatitis	prostatitis	NOUN
aiua-7778	145	11	inhibited	inhibit	VERB
aiua-7778	145	12	some	some	DET
aiua-7778	145	13	analysis	analysis	NOUN
aiua-7778	145	14	.	.	PUNCT
aiua-7778	146	1	however	however	ADV
aiua-7778	146	2	we	we	PRON
aiua-7778	146	3	think	think	VERB
aiua-7778	146	4	that	that	SCONJ
aiua-7778	146	5	,	,	PUNCT
aiua-7778	146	6	regarding	regard	VERB
aiua-7778	146	7	our	our	PRON
aiua-7778	146	8	limited	limited	ADJ
aiua-7778	146	9	data	datum	NOUN
aiua-7778	146	10	,	,	PUNCT
aiua-7778	146	11	asymptomatic	asymptomatic	ADJ
aiua-7778	146	12	prostatitis	prostatitis	NOUN
aiua-7778	146	13	does	do	AUX
aiua-7778	146	14	not	not	PART
aiua-7778	146	15	effect	effect	VERB
aiua-7778	146	16	cbc	cbc	NOUN
aiua-7778	146	17	parameters	parameter	NOUN
aiua-7778	146	18	.	.	PUNCT
aiua-7778	147	1	furthermore	furthermore	ADV
aiua-7778	147	2	,	,	PUNCT
aiua-7778	147	3	the	the	DET
aiua-7778	147	4	initial	initial	ADJ
aiua-7778	147	5	pbx	pbx	PROPN
aiua-7778	147	6	may	may	AUX
aiua-7778	147	7	miss	miss	VERB
aiua-7778	147	8	cancer	cancer	NOUN
aiua-7778	147	9	in	in	ADP
aiua-7778	147	10	some	some	DET
aiua-7778	147	11	men	man	NOUN
aiua-7778	147	12	and	and	CCONJ
aiua-7778	147	13	20	20	NUM
aiua-7778	147	14	%	%	NOUN
aiua-7778	147	15	of	of	ADP
aiua-7778	147	16	men	man	NOUN
aiua-7778	147	17	may	may	AUX
aiua-7778	147	18	be	be	AUX
aiua-7778	147	19	diagnosed	diagnose	VERB
aiua-7778	147	20	as	as	ADP
aiua-7778	147	21	pca	pca	NOUN
aiua-7778	147	22	in	in	ADP
aiua-7778	147	23	repeated	repeat	VERB
aiua-7778	147	24	biopsy	biopsy	NOUN
aiua-7778	147	25	(	(	PUNCT
aiua-7778	147	26	20	20	NUM
aiua-7778	147	27	)	)	PUNCT
aiua-7778	147	28	.	.	PUNCT
aiua-7778	148	1	conclusions	conclusion	NOUN
aiua-7778	148	2	regarding	regard	VERB
aiua-7778	148	3	our	our	PRON
aiua-7778	148	4	data	data	PROPN
aiua-7778	148	5	lmr	lmr	PROPN
aiua-7778	148	6	value	value	NOUN
aiua-7778	148	7	is	be	AUX
aiua-7778	148	8	a	a	DET
aiua-7778	148	9	useful	useful	ADJ
aiua-7778	148	10	tool	tool	NOUN
aiua-7778	148	11	at	at	ADP
aiua-7778	148	12	detecting	detect	VERB
aiua-7778	148	13	pca	pca	NOUN
aiua-7778	148	14	especially	especially	ADV
aiua-7778	148	15	in	in	ADP
aiua-7778	148	16	patients	patient	NOUN
aiua-7778	148	17	with	with	ADP
aiua-7778	148	18	psa	psa	NOUN
aiua-7778	148	19	value	value	NOUN
aiua-7778	148	20	between	between	ADP
aiua-7778	148	21	4	4	NUM
aiua-7778	148	22	and	and	CCONJ
aiua-7778	148	23	10	10	NUM
aiua-7778	148	24	ng	ng	PROPN
aiua-7778	148	25	/	/	SYM
aiua-7778	148	26	dl	dl	PROPN
aiua-7778	148	27	.	.	PUNCT
aiua-7778	149	1	the	the	DET
aiua-7778	149	2	combination	combination	NOUN
aiua-7778	149	3	of	of	ADP
aiua-7778	149	4	free	free	ADJ
aiua-7778	149	5	/	/	SYM
aiua-7778	149	6	total	total	ADJ
aiua-7778	149	7	psa	psa	NOUN
aiua-7778	149	8	ratio	ratio	NOUN
aiua-7778	149	9	and	and	CCONJ
aiua-7778	149	10	lmr	lmr	PROPN
aiua-7778	149	11	improves	improve	VERB
aiua-7778	149	12	the	the	DET
aiua-7778	149	13	diagnostic	diagnostic	ADJ
aiua-7778	149	14	accuracy	accuracy	NOUN
aiua-7778	149	15	more	more	ADJ
aiua-7778	149	16	than	than	ADP
aiua-7778	149	17	the	the	DET
aiua-7778	149	18	use	use	NOUN
aiua-7778	149	19	of	of	ADP
aiua-7778	149	20	free	free	ADJ
aiua-7778	149	21	/	/	SYM
aiua-7778	149	22	total	total	ADJ
aiua-7778	149	23	psa	psa	NOUN
aiua-7778	149	24	ratio	ratio	NOUN
aiua-7778	149	25	alone	alone	ADV
aiua-7778	149	26	.	.	PUNCT
aiua-7778	150	1	this	this	DET
aiua-7778	150	2	model	model	NOUN
aiua-7778	150	3	can	can	AUX
aiua-7778	150	4	assist	assist	VERB
aiua-7778	150	5	urologists	urologist	NOUN
aiua-7778	150	6	in	in	ADP
aiua-7778	150	7	deciding	decide	VERB
aiua-7778	150	8	whether	whether	SCONJ
aiua-7778	150	9	prostate	prostate	NOUN
aiua-7778	150	10	biopsy	biopsy	NOUN
aiua-7778	150	11	is	be	AUX
aiua-7778	150	12	advisable	advisable	ADJ
aiua-7778	150	13	.	.	PUNCT
aiua-7778	151	1	references	reference	NOUN
aiua-7778	151	2	1	1	NUM
aiua-7778	151	3	.	.	PUNCT
aiua-7778	151	4	ferlay	ferlay	PROPN
aiua-7778	151	5	j	j	PROPN
aiua-7778	151	6	,	,	PUNCT
aiua-7778	151	7	soerjomataram	soerjomataram	PROPN
aiua-7778	151	8	i	i	PROPN
aiua-7778	151	9	,	,	PUNCT
aiua-7778	151	10	dikshit	dikshit	PROPN
aiua-7778	151	11	r	r	PROPN
aiua-7778	151	12	,	,	PUNCT
aiua-7778	151	13	et	et	PROPN
aiua-7778	151	14	al	al	PROPN
aiua-7778	151	15	.	.	PUNCT
aiua-7778	151	16	cancer	cancer	NOUN
aiua-7778	151	17	incidence	incidence	NOUN
aiua-7778	151	18	and	and	CCONJ
aiua-7778	151	19	mortality	mortality	NOUN
aiua-7778	151	20	worldwide	worldwide	ADV
aiua-7778	151	21	:	:	PUNCT
aiua-7778	151	22	sources	source	NOUN
aiua-7778	151	23	,	,	PUNCT
aiua-7778	151	24	methods	method	NOUN
aiua-7778	151	25	and	and	CCONJ
aiua-7778	151	26	major	major	ADJ
aiua-7778	151	27	patterns	pattern	NOUN
aiua-7778	151	28	in	in	ADP
aiua-7778	151	29	globocan	globocan	PROPN
aiua-7778	151	30	2012	2012	NUM
aiua-7778	151	31	.	.	PUNCT
aiua-7778	152	1	int	int	NOUN
aiua-7778	152	2	j	j	PROPN
aiua-7778	152	3	cancer	cancer	NOUN
aiua-7778	152	4	.	.	PUNCT
aiua-7778	153	1	2015	2015	NUM
aiua-7778	153	2	;	;	PUNCT
aiua-7778	153	3	136	136	NUM
aiua-7778	153	4	:	:	PUNCT
aiua-7778	153	5	e359	e359	NUM
aiua-7778	153	6	-	-	SYM
aiua-7778	153	7	86	86	NUM
aiua-7778	153	8	.	.	PUNCT
aiua-7778	154	1	2	2	X
aiua-7778	154	2	.	.	PUNCT
aiua-7778	154	3	arnold	arnold	PROPN
aiua-7778	154	4	m	m	PROPN
aiua-7778	154	5	,	,	PUNCT
aiua-7778	154	6	karim	karim	PROPN
aiua-7778	154	7	-	-	PUNCT
aiua-7778	154	8	kos	kos	PROPN
aiua-7778	154	9	he	he	PRON
aiua-7778	154	10	,	,	PUNCT
aiua-7778	154	11	coebergh	coebergh	PROPN
aiua-7778	154	12	jw	jw	PROPN
aiua-7778	154	13	,	,	PUNCT
aiua-7778	154	14	et	et	PROPN
aiua-7778	154	15	al	al	PROPN
aiua-7778	154	16	.	.	PUNCT
aiua-7778	155	1	recent	recent	ADJ
aiua-7778	155	2	trends	trend	NOUN
aiua-7778	155	3	in	in	ADP
aiua-7778	155	4	incidence	incidence	NOUN
aiua-7778	155	5	of	of	ADP
aiua-7778	155	6	five	five	NUM
aiua-7778	155	7	common	common	ADJ
aiua-7778	155	8	cancers	cancer	NOUN
aiua-7778	155	9	in	in	ADP
aiua-7778	155	10	26	26	NUM
aiua-7778	155	11	european	european	ADJ
aiua-7778	155	12	countries	country	NOUN
aiua-7778	155	13	since	since	SCONJ
aiua-7778	155	14	1988	1988	NUM
aiua-7778	155	15	:	:	PUNCT
aiua-7778	155	16	analysis	analysis	NOUN
aiua-7778	155	17	of	of	ADP
aiua-7778	155	18	the	the	DET
aiua-7778	155	19	european	european	ADJ
aiua-7778	155	20	cancer	cancer	NOUN
aiua-7778	155	21	observatory	observatory	NOUN
aiua-7778	155	22	.	.	PUNCT
aiua-7778	156	1	eur	eur	PROPN
aiua-7778	156	2	j	j	PROPN
aiua-7778	156	3	cancer	cancer	NOUN
aiua-7778	156	4	.	.	PUNCT
aiua-7778	157	1	2015	2015	NUM
aiua-7778	157	2	;	;	PUNCT
aiua-7778	157	3	51:116487	51:116487	NUM
aiua-7778	157	4	.	.	NOUN
aiua-7778	158	1	3	3	NUM
aiua-7778	158	2	.	.	X
aiua-7778	158	3	salman	salman	PROPN
aiua-7778	158	4	jw	jw	PROPN
aiua-7778	158	5	,	,	PUNCT
aiua-7778	158	6	schoots	schoot	VERB
aiua-7778	158	7	ig	ig	PROPN
aiua-7778	158	8	,	,	PUNCT
aiua-7778	158	9	carlsson	carlsson	PROPN
aiua-7778	158	10	sv	sv	PROPN
aiua-7778	158	11	,	,	PUNCT
aiua-7778	158	12	et	et	PROPN
aiua-7778	158	13	al	al	PROPN
aiua-7778	158	14	.	.	PROPN
aiua-7778	158	15	prostate	prostate	NOUN
aiua-7778	158	16	specific	specific	ADJ
aiua-7778	158	17	antigen	antigen	NOUN
aiua-7778	158	18	as	as	ADP
aiua-7778	158	19	a	a	DET
aiua-7778	158	20	tumor	tumor	NOUN
aiua-7778	158	21	marker	marker	NOUN
aiua-7778	158	22	in	in	ADP
aiua-7778	158	23	prostate	prostate	NOUN
aiua-7778	158	24	cancer	cancer	NOUN
aiua-7778	158	25	:	:	PUNCT
aiua-7778	158	26	biochemical	biochemical	ADJ
aiua-7778	158	27	and	and	CCONJ
aiua-7778	158	28	clinical	clinical	ADJ
aiua-7778	158	29	aspects.adv	aspects.adv	NOUN
aiua-7778	158	30	exp	exp	PRON
aiua-7778	158	31	med	med	ADJ
aiua-7778	158	32	biol	biol	NOUN
aiua-7778	158	33	.	.	PUNCT
aiua-7778	159	1	2015	2015	NUM
aiua-7778	159	2	;	;	PUNCT
aiua-7778	159	3	867:93	867:93	NUM
aiua-7778	159	4	-	-	SYM
aiua-7778	159	5	114	114	NUM
aiua-7778	159	6	.	.	PUNCT
aiua-7778	160	1	4	4	X
aiua-7778	160	2	.	.	X
aiua-7778	160	3	ganeswaran	ganeswaran	PROPN
aiua-7778	160	4	d	d	PROPN
aiua-7778	160	5	,	,	PUNCT
aiua-7778	160	6	sweeney	sweeney	PROPN
aiua-7778	160	7	c	c	PROPN
aiua-7778	160	8	,	,	PUNCT
aiua-7778	160	9	yousif	yousif	PROPN
aiua-7778	160	10	f	f	PROPN
aiua-7778	160	11	,	,	PUNCT
aiua-7778	160	12	et	et	PROPN
aiua-7778	160	13	al	al	PROPN
aiua-7778	160	14	.	.	PUNCT
aiua-7778	161	1	population	population	NOUN
aiua-7778	161	2	-	-	PUNCT
aiua-7778	161	3	based	base	VERB
aiua-7778	161	4	linkage	linkage	NOUN
aiua-7778	161	5	of	of	ADP
aiua-7778	161	6	health	health	NOUN
aiua-7778	161	7	records	record	NOUN
aiua-7778	161	8	to	to	PART
aiua-7778	161	9	detect	detect	VERB
aiua-7778	161	10	urological	urological	ADJ
aiua-7778	161	11	complications	complication	NOUN
aiua-7778	161	12	and	and	CCONJ
aiua-7778	161	13	hospitalisation	hospitalisation	NOUN
aiua-7778	161	14	following	follow	VERB
aiua-7778	161	15	transrectal	transrectal	ADJ
aiua-7778	161	16	ultrasound	ultrasound	NOUN
aiua-7778	161	17	-	-	PUNCT
aiua-7778	161	18	guided	guide	VERB
aiua-7778	161	19	biopsies	biopsy	NOUN
aiua-7778	161	20	in	in	ADP
aiua-7778	161	21	men	man	NOUN
aiua-7778	161	22	suspected	suspect	VERB
aiua-7778	161	23	of	of	ADP
aiua-7778	161	24	prostate	prostate	NOUN
aiua-7778	161	25	cancer	cancer	NOUN
aiua-7778	161	26	.	.	PUNCT
aiua-7778	162	1	world	world	PROPN
aiua-7778	162	2	j	j	PROPN
aiua-7778	162	3	urol	urol	PROPN
aiua-7778	162	4	.	.	PUNCT
aiua-7778	162	5	2012	2012	NUM
aiua-7778	162	6	;	;	PUNCT
aiua-7778	162	7	32:309	32:309	NUM
aiua-7778	162	8	-	-	SYM
aiua-7778	162	9	15	15	NUM
aiua-7778	162	10	.	.	NOUN
aiua-7778	163	1	5	5	NUM
aiua-7778	163	2	.	.	X
aiua-7778	163	3	heidenreich	heidenreich	PRON
aiua-7778	163	4	a	a	PRON
aiua-7778	163	5	,	,	PUNCT
aiua-7778	163	6	bolla	bolla	PROPN
aiua-7778	163	7	m	m	PROPN
aiua-7778	163	8	,	,	PUNCT
aiua-7778	163	9	joniau	joniau	PROPN
aiua-7778	163	10	s	s	PROPN
aiua-7778	163	11	,	,	PUNCT
aiua-7778	163	12	et	et	PROPN
aiua-7778	163	13	al	al	PROPN
aiua-7778	163	14	.	.	PUNCT
aiua-7778	164	1	guidelines	guideline	NOUN
aiua-7778	164	2	on	on	ADP
aiua-7778	164	3	prostate	prostate	NOUN
aiua-7778	164	4	cancer	cancer	NOUN
aiua-7778	164	5	.	.	PUNCT
aiua-7778	165	1	update	update	NOUN
aiua-7778	165	2	.	.	PUNCT
aiua-7778	166	1	2011	2011	NUM
aiua-7778	166	2	;	;	PUNCT
aiua-7778	166	3	53:31	53:31	NUM
aiua-7778	166	4	-	-	SYM
aiua-7778	166	5	45	45	NUM
aiua-7778	166	6	.	.	NOUN
aiua-7778	167	1	6	6	NUM
aiua-7778	167	2	.	.	PUNCT
aiua-7778	168	1	nishijima	nishijima	PROPN
aiua-7778	168	2	tf	tf	PROPN
aiua-7778	168	3	,	,	PUNCT
aiua-7778	168	4	muss	muss	PROPN
aiua-7778	168	5	hb	hb	PROPN
aiua-7778	168	6	,	,	PUNCT
aiua-7778	168	7	shachar	shachar	PROPN
aiua-7778	168	8	ss	ss	PROPN
aiua-7778	168	9	,	,	PUNCT
aiua-7778	168	10	et	et	PROPN
aiua-7778	168	11	al	al	PROPN
aiua-7778	168	12	.	.	PROPN
aiua-7778	169	1	prognostic	prognostic	ADJ
aiua-7778	169	2	value	value	NOUN
aiua-7778	169	3	of	of	ADP
aiua-7778	169	4	lymphocyte	lymphocyte	NOUN
aiua-7778	169	5	-	-	PUNCT
aiua-7778	169	6	to	to	ADP
aiua-7778	169	7	-	-	PUNCT
aiua-7778	169	8	monocyte	monocyte	NOUN
aiua-7778	169	9	ratio	ratio	NOUN
aiua-7778	169	10	in	in	ADP
aiua-7778	169	11	patients	patient	NOUN
aiua-7778	169	12	with	with	ADP
aiua-7778	169	13	solid	solid	ADJ
aiua-7778	169	14	tumors	tumor	NOUN
aiua-7778	169	15	:	:	PUNCT
aiua-7778	169	16	a	a	DET
aiua-7778	169	17	systematic	systematic	ADJ
aiua-7778	169	18	review	review	NOUN
aiua-7778	169	19	and	and	CCONJ
aiua-7778	169	20	meta	meta	ADJ
aiua-7778	169	21	-	-	PUNCT
aiua-7778	169	22	analysis	analysis	NOUN
aiua-7778	169	23	.	.	PUNCT
aiua-7778	170	1	cancer	cancer	NOUN
aiua-7778	170	2	treat	treat	PROPN
aiua-7778	170	3	rev	rev	VERB
aiua-7778	170	4	.	.	PROPN
aiua-7778	170	5	2015	2015	NUM
aiua-7778	170	6	;	;	PUNCT
aiua-7778	170	7	41:971	41:971	NUM
aiua-7778	170	8	-	-	SYM
aiua-7778	170	9	8	8	NUM
aiua-7778	170	10	.	.	X
aiua-7778	171	1	7	7	X
aiua-7778	171	2	.	.	X
aiua-7778	171	3	templeton	templeton	PROPN
aiua-7778	171	4	aj	aj	PROPN
aiua-7778	171	5	,	,	PUNCT
aiua-7778	171	6	ace	ace	VERB
aiua-7778	171	7	o	o	PROPN
aiua-7778	171	8	,	,	PUNCT
aiua-7778	171	9	mcnamara	mcnamara	PROPN
aiua-7778	171	10	mg	mg	PROPN
aiua-7778	171	11	,	,	PUNCT
aiua-7778	171	12	et	et	PROPN
aiua-7778	171	13	al	al	PROPN
aiua-7778	171	14	.	.	PUNCT
aiua-7778	172	1	prognostic	prognostic	ADJ
aiua-7778	172	2	role	role	NOUN
aiua-7778	172	3	of	of	ADP
aiua-7778	172	4	platelet	platelet	NOUN
aiua-7778	172	5	to	to	ADP
aiua-7778	172	6	lymphocyte	lymphocyte	ADJ
aiua-7778	172	7	ratio	ratio	NOUN
aiua-7778	172	8	in	in	ADP
aiua-7778	172	9	solid	solid	ADJ
aiua-7778	172	10	tumors	tumor	NOUN
aiua-7778	172	11	:	:	PUNCT
aiua-7778	172	12	a	a	DET
aiua-7778	172	13	systematic	systematic	ADJ
aiua-7778	172	14	review	review	NOUN
aiua-7778	172	15	and	and	CCONJ
aiua-7778	172	16	meta	meta	ADJ
aiua-7778	172	17	-	-	PUNCT
aiua-7778	172	18	analysis	analysis	NOUN
aiua-7778	172	19	.	.	PUNCT
aiua-7778	173	1	cancer	cancer	NOUN
aiua-7778	173	2	epidemiol	epidemiol	PROPN
aiua-7778	173	3	biomarkers	biomarkers	PROPN
aiua-7778	173	4	prev	prev	X
aiua-7778	173	5	.	.	PUNCT
aiua-7778	174	1	2014	2014	NUM
aiua-7778	174	2	;	;	PUNCT
aiua-7778	174	3	23:1204	23:1204	NUM
aiua-7778	174	4	-	-	SYM
aiua-7778	174	5	12	12	NUM
aiua-7778	174	6	.	.	NOUN
aiua-7778	175	1	8	8	NUM
aiua-7778	175	2	.	.	PUNCT
aiua-7778	175	3	templeton	templeton	PROPN
aiua-7778	175	4	aj	aj	PROPN
aiua-7778	175	5	,	,	PUNCT
aiua-7778	175	6	mcnamara	mcnamara	PROPN
aiua-7778	175	7	mg	mg	PROPN
aiua-7778	175	8	,	,	PUNCT
aiua-7778	175	9	šeruga	šeruga	PROPN
aiua-7778	175	10	b	b	PROPN
aiua-7778	175	11	,	,	PUNCT
aiua-7778	175	12	et	et	PROPN
aiua-7778	175	13	al	al	PROPN
aiua-7778	175	14	.	.	PUNCT
aiua-7778	176	1	prognostic	prognostic	ADJ
aiua-7778	176	2	role	role	NOUN
aiua-7778	176	3	of	of	ADP
aiua-7778	176	4	neutrophil	neutrophil	ADJ
aiua-7778	176	5	-	-	PUNCT
aiua-7778	176	6	to	to	ADP
aiua-7778	176	7	-	-	PUNCT
aiua-7778	176	8	lymphocyte	lymphocyte	ADJ
aiua-7778	176	9	ratio	ratio	NOUN
aiua-7778	176	10	in	in	ADP
aiua-7778	176	11	solid	solid	ADJ
aiua-7778	176	12	tumors	tumor	NOUN
aiua-7778	176	13	:	:	PUNCT
aiua-7778	176	14	a	a	DET
aiua-7778	176	15	systematic	systematic	ADJ
aiua-7778	176	16	review	review	NOUN
aiua-7778	176	17	and	and	CCONJ
aiua-7778	176	18	meta	meta	ADJ
aiua-7778	176	19	-	-	PUNCT
aiua-7778	176	20	analysis	analysis	NOUN
aiua-7778	176	21	.	.	PUNCT
aiua-7778	177	1	j	j	PROPN
aiua-7778	177	2	natl	natl	PROPN
aiua-7778	177	3	cancer	cancer	PROPN
aiua-7778	177	4	inst	inst	PROPN
aiua-7778	177	5	.	.	PUNCT
aiua-7778	177	6	2014	2014	NUM
aiua-7778	177	7	;	;	PUNCT
aiua-7778	177	8	106	106	NUM
aiua-7778	177	9	:	:	PUNCT
aiua-7778	177	10	dju124	dju124	NOUN
aiua-7778	177	11	.	.	PUNCT
aiua-7778	178	1	9	9	X
aiua-7778	178	2	.	.	X
aiua-7778	178	3	gu	gu	NOUN
aiua-7778	178	4	x	x	PROPN
aiua-7778	178	5	,	,	PUNCT
aiua-7778	178	6	gao	gao	PROPN
aiua-7778	178	7	x	x	PROPN
aiua-7778	178	8	,	,	PUNCT
aiua-7778	178	9	li	li	PROPN
aiua-7778	178	10	x	x	PROPN
aiua-7778	178	11	,	,	PUNCT
aiua-7778	178	12	et	et	PROPN
aiua-7778	178	13	al	al	PROPN
aiua-7778	178	14	.	.	PROPN
aiua-7778	179	1	prognostic	prognostic	ADJ
aiua-7778	179	2	significance	significance	NOUN
aiua-7778	179	3	of	of	ADP
aiua-7778	179	4	neutrophil	neutrophil	ADJ
aiua-7778	179	5	-	-	PUNCT
aiua-7778	179	6	tolymphocyte	tolymphocyte	NOUN
aiua-7778	179	7	ratio	ratio	NOUN
aiua-7778	179	8	in	in	ADP
aiua-7778	179	9	prostate	prostate	NOUN
aiua-7778	179	10	cancer	cancer	NOUN
aiua-7778	179	11	:	:	PUNCT
aiua-7778	179	12	evidence	evidence	NOUN
aiua-7778	179	13	from	from	ADP
aiua-7778	179	14	16,266	16,266	NUM
aiua-7778	179	15	patients	patient	NOUN
aiua-7778	179	16	.	.	PUNCT
aiua-7778	180	1	sci	sci	PROPN
aiua-7778	180	2	rep	rep	PROPN
aiua-7778	180	3	.	.	PROPN
aiua-7778	180	4	2016	2016	NUM
aiua-7778	180	5	;	;	PUNCT
aiua-7778	180	6	6:22089	6:22089	NUM
aiua-7778	180	7	.	.	X
aiua-7778	181	1	10	10	NUM
aiua-7778	181	2	.	.	PUNCT
aiua-7778	182	1	kawahara	kawahara	PROPN
aiua-7778	182	2	t	t	PROPN
aiua-7778	182	3	,	,	PUNCT
aiua-7778	182	4	yokomizo	yokomizo	PROPN
aiua-7778	182	5	y	y	PROPN
aiua-7778	182	6	,	,	PUNCT
aiua-7778	182	7	ito	ito	PROPN
aiua-7778	182	8	y	y	PROPN
aiua-7778	182	9	,	,	PUNCT
aiua-7778	182	10	et	et	PROPN
aiua-7778	182	11	al	al	PROPN
aiua-7778	182	12	.	.	PUNCT
aiua-7778	182	13	pretreatment	pretreatment	PROPN
aiua-7778	182	14	neutrophillymphocyte	neutrophillymphocyte	PROPN
aiua-7778	182	15	ratio	ratio	NOUN
aiua-7778	182	16	predicts	predict	VERB
aiua-7778	182	17	the	the	DET
aiua-7778	182	18	prognosis	prognosis	NOUN
aiua-7778	182	19	in	in	ADP
aiua-7778	182	20	patients	patient	NOUN
aiua-7778	182	21	with	with	ADP
aiua-7778	182	22	metastatic	metastatic	ADJ
aiua-7778	182	23	prostate	prostate	NOUN
aiua-7778	182	24	cancer	cancer	NOUN
aiua-7778	182	25	.	.	PUNCT
aiua-7778	183	1	bmc	bmc	NOUN
aiua-7778	183	2	cancer	cancer	NOUN
aiua-7778	183	3	.	.	PUNCT
aiua-7778	184	1	2016	2016	NUM
aiua-7778	184	2	;	;	PUNCT
aiua-7778	184	3	16:111	16:111	NUM
aiua-7778	184	4	.	.	PUNCT
aiua-7778	185	1	11	11	NUM
aiua-7778	185	2	.	.	PUNCT
aiua-7778	186	1	kawahara	kawahara	PROPN
aiua-7778	186	2	t	t	PROPN
aiua-7778	186	3	,	,	PUNCT
aiua-7778	186	4	ishiguro	ishiguro	PROPN
aiua-7778	186	5	h	h	PROPN
aiua-7778	186	6	,	,	PUNCT
aiua-7778	186	7	hoshino	hoshino	PROPN
aiua-7778	186	8	k	k	PROPN
aiua-7778	186	9	,	,	PUNCT
aiua-7778	186	10	et	et	PROPN
aiua-7778	186	11	al	al	PROPN
aiua-7778	186	12	.	.	PUNCT
aiua-7778	187	1	analysis	analysis	NOUN
aiua-7778	187	2	of	of	ADP
aiua-7778	187	3	nsaid	nsaid	PROPN
aiua-7778	187	4	activated	activate	VERB
aiua-7778	187	5	gene	gene	NOUN
aiua-7778	187	6	1	1	NUM
aiua-7778	187	7	expression	expression	NOUN
aiua-7778	187	8	in	in	ADP
aiua-7778	187	9	prostate	prostate	NOUN
aiua-7778	187	10	cancer	cancer	NOUN
aiua-7778	187	11	.	.	PUNCT
aiua-7778	188	1	urologia	urologia	PROPN
aiua-7778	188	2	internationalis	internationalis	PROPN
aiua-7778	188	3	.	.	PUNCT
aiua-7778	189	1	2010	2010	NUM
aiua-7778	189	2	;	;	PUNCT
aiua-7778	189	3	84:198	84:198	NUM
aiua-7778	189	4	-	-	SYM
aiua-7778	189	5	202	202	NUM
aiua-7778	189	6	.	.	PUNCT
aiua-7778	190	1	caglayan_stesura	caglayan_stesura	NOUN
aiua-7778	190	2	seveso	seveso	NOUN
aiua-7778	190	3	10/01/19	10/01/19	PROPN
aiua-7778	190	4	16:08	16:08	NUM
aiua-7778	190	5	pagina	pagina	NOUN
aiua-7778	190	6	274	274	NUM
aiua-7778	190	7	275archivio	275archivio	PROPN
aiua-7778	190	8	italiano	italiano	NOUN
aiua-7778	190	9	di	di	NOUN
aiua-7778	190	10	urologia	urologia	PROPN
aiua-7778	190	11	e	e	PROPN
aiua-7778	190	12	andrologia	andrologia	NOUN
aiua-7778	190	13	2018	2018	NUM
aiua-7778	190	14	;	;	PUNCT
aiua-7778	190	15	90	90	NUM
aiua-7778	190	16	,	,	PUNCT
aiua-7778	190	17	4	4	NUM
aiua-7778	190	18	lymphocyte	lymphocyte	NOUN
aiua-7778	190	19	-	-	PUNCT
aiua-7778	190	20	to	to	ADP
aiua-7778	190	21	-	-	PUNCT
aiua-7778	190	22	monocyte	monocyte	NOUN
aiua-7778	190	23	ratio	ratio	NOUN
aiua-7778	190	24	is	be	AUX
aiua-7778	190	25	a	a	DET
aiua-7778	190	26	valuable	valuable	ADJ
aiua-7778	190	27	marker	marker	NOUN
aiua-7778	190	28	to	to	PART
aiua-7778	190	29	predict	predict	VERB
aiua-7778	190	30	prostate	prostate	NOUN
aiua-7778	190	31	cancer	cancer	NOUN
aiua-7778	190	32	in	in	ADP
aiua-7778	190	33	patients	patient	NOUN
aiua-7778	190	34	with	with	ADP
aiua-7778	190	35	prostate	prostate	NOUN
aiua-7778	190	36	specific	specific	ADJ
aiua-7778	190	37	antigen	antigen	NOUN
aiua-7778	190	38	between	between	ADP
aiua-7778	190	39	4	4	NUM
aiua-7778	190	40	and	and	CCONJ
aiua-7778	190	41	10	10	NUM
aiua-7778	190	42	ng	ng	PROPN
aiua-7778	190	43	/	/	SYM
aiua-7778	190	44	dl	dl	PROPN
aiua-7778	190	45	.	.	PROPN
aiua-7778	190	46	12	12	NUM
aiua-7778	190	47	.	.	PUNCT
aiua-7778	191	1	ishiguro	ishiguro	PROPN
aiua-7778	191	2	h	h	PROPN
aiua-7778	191	3	,	,	PUNCT
aiua-7778	191	4	kawahara	kawahara	PROPN
aiua-7778	191	5	t.	t.	PROPN
aiua-7778	191	6	nonsteroidal	nonsteroidal	NOUN
aiua-7778	191	7	anti	anti	ADJ
aiua-7778	191	8	-	-	ADJ
aiua-7778	191	9	inflammatory	inflammatory	ADJ
aiua-7778	191	10	drugs	drug	NOUN
aiua-7778	191	11	and	and	CCONJ
aiua-7778	191	12	prostatic	prostatic	ADJ
aiua-7778	191	13	diseases	disease	NOUN
aiua-7778	191	14	.	.	PUNCT
aiua-7778	191	15	biomed	biome	VERB
aiua-7778	191	16	research	research	NOUN
aiua-7778	191	17	international	international	PROPN
aiua-7778	191	18	.	.	PUNCT
aiua-7778	191	19	2014	2014	NUM
aiua-7778	191	20	;	;	PUNCT
aiua-7778	191	21	2014:436123	2014:436123	NUM
aiua-7778	191	22	.	.	NOUN
aiua-7778	191	23	13	13	NUM
aiua-7778	191	24	.	.	PUNCT
aiua-7778	192	1	koosha	koosha	PROPN
aiua-7778	192	2	kamali	kamali	PROPN
aiua-7778	192	3	,	,	PUNCT
aiua-7778	192	4	mojtaba	mojtaba	NOUN
aiua-7778	192	5	ashrafi	ashrafi	PROPN
aiua-7778	192	6	,	,	PUNCT
aiua-7778	192	7	pejman	pejman	NOUN
aiua-7778	192	8	shadpour	shadpour	PROPN
aiua-7778	192	9	,	,	PUNCT
aiua-7778	192	10	et	et	PROPN
aiua-7778	192	11	al	al	PROPN
aiua-7778	192	12	.	.	PUNCT
aiua-7778	193	1	the	the	DET
aiua-7778	193	2	role	role	NOUN
aiua-7778	193	3	of	of	ADP
aiua-7778	193	4	blood	blood	NOUN
aiua-7778	193	5	neutrophil	neutrophil	ADJ
aiua-7778	193	6	count	count	NOUN
aiua-7778	193	7	and	and	CCONJ
aiua-7778	193	8	the	the	DET
aiua-7778	193	9	neutrophil	neutrophil	NOUN
aiua-7778	193	10	-	-	PUNCT
aiua-7778	193	11	to	to	ADP
aiua-7778	193	12	-	-	PUNCT
aiua-7778	193	13	lymphocyte	lymphocyte	NOUN
aiua-7778	193	14	ratio	ratio	NOUN
aiua-7778	193	15	as	as	ADP
aiua-7778	193	16	a	a	DET
aiua-7778	193	17	predictive	predictive	ADJ
aiua-7778	193	18	factor	factor	NOUN
aiua-7778	193	19	for	for	ADP
aiua-7778	193	20	prostate	prostate	NOUN
aiua-7778	193	21	biopsy	biopsy	NOUN
aiua-7778	193	22	results	result	NOUN
aiua-7778	193	23	.	.	PUNCT
aiua-7778	194	1	urologia	urologia	PROPN
aiua-7778	194	2	.	.	PUNCT
aiua-7778	195	1	2018	2018	NUM
aiua-7778	195	2	apr	apr	VERB
aiua-7778	195	3	1:391560318766822	1:391560318766822	NUM
aiua-7778	195	4	.	.	PUNCT
aiua-7778	196	1	14	14	NUM
aiua-7778	196	2	.	.	PUNCT
aiua-7778	197	1	jong	jong	PROPN
aiua-7778	197	2	jin	jin	PROPN
aiua-7778	197	3	oh	oh	INTJ
aiua-7778	197	4	,	,	PUNCT
aiua-7778	197	5	ohsung	ohsung	PROPN
aiua-7778	197	6	kwon	kwon	PROPN
aiua-7778	197	7	,	,	PUNCT
aiua-7778	197	8	jung	jung	PROPN
aiua-7778	197	9	keun	keun	PROPN
aiua-7778	197	10	lee	lee	PROPN
aiua-7778	197	11	,	,	PUNCT
aiua-7778	197	12	et	et	PROPN
aiua-7778	197	13	al	al	PROPN
aiua-7778	197	14	.	.	PROPN
aiua-7778	197	15	association	association	PROPN
aiua-7778	197	16	of	of	ADP
aiua-7778	197	17	the	the	DET
aiua-7778	197	18	neutrophil	neutrophil	NOUN
aiua-7778	197	19	-	-	PUNCT
aiua-7778	197	20	to	to	ADP
aiua-7778	197	21	-	-	PUNCT
aiua-7778	197	22	lymphocyte	lymphocyte	ADJ
aiua-7778	197	23	ratio	ratio	NOUN
aiua-7778	197	24	and	and	CCONJ
aiua-7778	197	25	prostate	prostate	NOUN
aiua-7778	197	26	cancer	cancer	NOUN
aiua-7778	197	27	detection	detection	NOUN
aiua-7778	197	28	rates	rate	NOUN
aiua-7778	197	29	in	in	ADP
aiua-7778	197	30	patients	patient	NOUN
aiua-7778	197	31	via	via	ADP
aiua-7778	197	32	contemporary	contemporary	ADJ
aiua-7778	197	33	multi	multi	ADJ
aiua-7778	197	34	-	-	ADJ
aiua-7778	197	35	core	core	ADJ
aiua-7778	197	36	prostate	prostate	NOUN
aiua-7778	197	37	biopsy	biopsy	NOUN
aiua-7778	197	38	.	.	PUNCT
aiua-7778	198	1	hongasian	hongasian	PROPN
aiua-7778	198	2	j	j	PROPN
aiua-7778	198	3	androl	androl	PROPN
aiua-7778	198	4	.	.	PROPN
aiua-7778	198	5	2016	2016	NUM
aiua-7778	198	6	;	;	PUNCT
aiua-7778	198	7	18:937	18:937	NUM
aiua-7778	198	8	-	-	SYM
aiua-7778	198	9	941	941	NUM
aiua-7778	198	10	.	.	NOUN
aiua-7778	198	11	15	15	NUM
aiua-7778	198	12	.	.	PUNCT
aiua-7778	199	1	takashi	takashi	PROPN
aiua-7778	199	2	kawahara	kawahara	PROPN
aiua-7778	199	3	,	,	PUNCT
aiua-7778	199	4	sachi	sachi	PROPN
aiua-7778	199	5	fukui1	fukui1	PROPN
aiua-7778	199	6	,	,	PUNCT
aiua-7778	199	7	kentaro	kentaro	PROPN
aiua-7778	199	8	sakamaki	sakamaki	PROPN
aiua-7778	199	9	,	,	PUNCT
aiua-7778	199	10	et	et	PROPN
aiua-7778	199	11	al	al	PROPN
aiua-7778	199	12	.	.	PROPN
aiua-7778	200	1	neutrophil	neutrophil	PROPN
aiua-7778	200	2	-	-	PUNCT
aiua-7778	200	3	to	to	ADP
aiua-7778	200	4	-	-	PUNCT
aiua-7778	200	5	lymphocyte	lymphocyte	NOUN
aiua-7778	200	6	ratio	ratio	NOUN
aiua-7778	200	7	predicts	predict	VERB
aiua-7778	200	8	prostatic	prostatic	ADJ
aiua-7778	200	9	carcinoma	carcinoma	NOUN
aiua-7778	200	10	in	in	ADP
aiua-7778	200	11	men	man	NOUN
aiua-7778	200	12	undergoing	undergo	VERB
aiua-7778	200	13	needle	needle	NOUN
aiua-7778	200	14	biopsy	biopsy	NOUN
aiua-7778	200	15	.	.	PUNCT
aiua-7778	201	1	oncotarget	oncotarget	NOUN
aiua-7778	201	2	2015	2015	NUM
aiua-7778	201	3	;	;	PUNCT
aiua-7778	201	4	6:32169	6:32169	NUM
aiua-7778	201	5	-	-	SYM
aiua-7778	201	6	76	76	NUM
aiua-7778	201	7	.	.	PUNCT
aiua-7778	202	1	16	16	NUM
aiua-7778	202	2	.	.	PUNCT
aiua-7778	203	1	tian	tian	PROPN
aiua-7778	203	2	-	-	PUNCT
aiua-7778	203	3	bao	bao	PROPN
aiua-7778	203	4	huang	huang	PROPN
aiua-7778	203	5	,	,	PUNCT
aiua-7778	203	6	shi	shi	PROPN
aiua-7778	203	7	-	-	PUNCT
aiua-7778	203	8	yu	yu	PROPN
aiua-7778	203	9	mao	mao	PROPN
aiua-7778	203	10	,	,	PUNCT
aiua-7778	203	11	sheng	sheng	PROPN
aiua-7778	203	12	-	-	PUNCT
aiua-7778	203	13	ming	ming	PROPN
aiua-7778	203	14	lu	lu	PROPN
aiua-7778	203	15	,	,	PUNCT
aiua-7778	203	16	et	et	PROPN
aiua-7778	203	17	al	al	PROPN
aiua-7778	203	18	.	.	PROPN
aiua-7778	203	19	predictive	predictive	ADJ
aiua-7778	203	20	value	value	NOUN
aiua-7778	203	21	of	of	ADP
aiua-7778	203	22	neutrophil	neutrophil	ADJ
aiua-7778	203	23	-	-	PUNCT
aiua-7778	203	24	to	to	ADP
aiua-7778	203	25	-	-	PUNCT
aiua-7778	203	26	lymphocyte	lymphocyte	ADJ
aiua-7778	203	27	ratio	ratio	NOUN
aiua-7778	203	28	in	in	ADP
aiua-7778	203	29	diagnosis	diagnosis	NOUN
aiua-7778	203	30	of	of	ADP
aiua-7778	203	31	prostate	prostate	NOUN
aiua-7778	203	32	cancer	cancer	NOUN
aiua-7778	203	33	among	among	ADP
aiua-7778	203	34	menwho	menwho	NOUN
aiua-7778	203	35	underwent	underwent	NOUN
aiua-7778	203	36	template	template	NOUN
aiua-7778	203	37	-	-	PUNCT
aiua-7778	203	38	guided	guide	VERB
aiua-7778	203	39	prostate	prostate	NOUN
aiua-7778	203	40	biopsy	biopsy	NOUN
aiua-7778	203	41	.	.	PUNCT
aiua-7778	204	1	medicine	medicine	NOUN
aiua-7778	204	2	2016	2016	NUM
aiua-7778	204	3	;	;	PUNCT
aiua-7778	204	4	95:44(e5307	95:44(e5307	NUM
aiua-7778	204	5	)	)	PUNCT
aiua-7778	204	6	.	.	PUNCT
aiua-7778	205	1	17	17	NUM
aiua-7778	205	2	.	.	PUNCT
aiua-7778	205	3	gokce	gokce	PROPN
aiua-7778	205	4	mi	mi	PROPN
aiua-7778	205	5	,	,	PUNCT
aiua-7778	205	6	hamidi	hamidi	NOUN
aiua-7778	205	7	n	n	CCONJ
aiua-7778	205	8	,	,	PUNCT
aiua-7778	205	9	suer	suer	PROPN
aiua-7778	205	10	e	e	PROPN
aiua-7778	205	11	,	,	PUNCT
aiua-7778	205	12	et	et	PROPN
aiua-7778	205	13	al	al	PROPN
aiua-7778	205	14	.	.	PUNCT
aiua-7778	205	15	evaluation	evaluation	NOUN
aiua-7778	205	16	of	of	ADP
aiua-7778	205	17	neutrophil	neutrophil	ADJ
aiua-7778	205	18	-	-	PUNCT
aiua-7778	205	19	tolymphocyte	tolymphocyte	NOUN
aiua-7778	205	20	ratio	ratio	NOUN
aiua-7778	205	21	prior	prior	ADV
aiua-7778	205	22	to	to	ADP
aiua-7778	205	23	prostate	prostate	NOUN
aiua-7778	205	24	biopsy	biopsy	NOUN
aiua-7778	205	25	to	to	PART
aiua-7778	205	26	predict	predict	VERB
aiua-7778	205	27	biopsy	biopsy	NOUN
aiua-7778	205	28	histology	histology	NOUN
aiua-7778	205	29	:	:	PUNCT
aiua-7778	205	30	results	result	NOUN
aiua-7778	205	31	of	of	ADP
aiua-7778	205	32	1836	1836	NUM
aiua-7778	205	33	patients	patient	NOUN
aiua-7778	205	34	.	.	PUNCT
aiua-7778	206	1	can	can	AUX
aiua-7778	206	2	urol	urol	VERB
aiua-7778	206	3	assoc	assoc	PROPN
aiua-7778	206	4	j.	j.	PROPN
aiua-7778	206	5	2015	2015	NUM
aiua-7778	206	6	;	;	PUNCT
aiua-7778	206	7	9	9	NUM
aiua-7778	206	8	:	:	PUNCT
aiua-7778	206	9	e761	e761	PROPN
aiua-7778	206	10	-	-	PUNCT
aiua-7778	206	11	e765	e765	PROPN
aiua-7778	206	12	.	.	PROPN
aiua-7778	206	13	18	18	NUM
aiua-7778	206	14	.	.	PUNCT
aiua-7778	207	1	kaynar	kaynar	PROPN
aiua-7778	207	2	m	m	PROPN
aiua-7778	207	3	,	,	PUNCT
aiua-7778	207	4	yıldırım	yıldırım	VERB
aiua-7778	207	5	me	i	PRON
aiua-7778	207	6	,	,	PUNCT
aiua-7778	207	7	gul	gul	PROPN
aiua-7778	207	8	m	m	PROPN
aiua-7778	207	9	,	,	PUNCT
aiua-7778	207	10	et	et	PROPN
aiua-7778	207	11	al	al	PROPN
aiua-7778	207	12	.	.	PUNCT
aiua-7778	207	13	benign	benign	ADJ
aiua-7778	207	14	prostatic	prostatic	ADJ
aiua-7778	207	15	hyperplasia	hyperplasia	NOUN
aiua-7778	207	16	and	and	CCONJ
aiua-7778	207	17	prostate	prostate	NOUN
aiua-7778	207	18	cancer	cancer	NOUN
aiua-7778	207	19	differentiation	differentiation	NOUN
aiua-7778	207	20	via	via	ADP
aiua-7778	207	21	platelet	platelet	NOUN
aiua-7778	207	22	to	to	ADP
aiua-7778	207	23	lymphocyte	lymphocyte	ADJ
aiua-7778	207	24	ratio	ratio	NOUN
aiua-7778	207	25	.	.	PUNCT
aiua-7778	208	1	cancer	cancer	NOUN
aiua-7778	208	2	biomark	biomark	NOUN
aiua-7778	208	3	.	.	PUNCT
aiua-7778	209	1	2015	2015	NUM
aiua-7778	209	2	;	;	PUNCT
aiua-7778	209	3	13:317	13:317	NUM
aiua-7778	209	4	-	-	SYM
aiua-7778	209	5	23	23	NUM
aiua-7778	209	6	.	.	PUNCT
aiua-7778	210	1	19	19	NUM
aiua-7778	210	2	.	.	PUNCT
aiua-7778	211	1	ozgur	ozgur	PROPN
aiua-7778	211	2	haki	haki	PROPN
aiua-7778	211	3	yuksel	yuksel	PROPN
aiua-7778	211	4	,	,	PUNCT
aiua-7778	211	5	ahmet	ahmet	PROPN
aiua-7778	211	6	urkmez	urkmez	NOUN
aiua-7778	211	7	,	,	PUNCT
aiua-7778	211	8	serkan	serkan	PROPN
aiua-7778	211	9	akan	akan	PROPN
aiua-7778	211	10	,	,	PUNCT
aiua-7778	211	11	et	et	PROPN
aiua-7778	211	12	al	al	PROPN
aiua-7778	211	13	.	.	PROPN
aiua-7778	212	1	predictive	predictive	ADJ
aiua-7778	212	2	value	value	NOUN
aiua-7778	212	3	of	of	ADP
aiua-7778	212	4	the	the	DET
aiua-7778	212	5	platelet	platelet	NOUN
aiua-7778	212	6	-	-	PUNCT
aiua-7778	212	7	to	to	ADP
aiua-7778	212	8	-	-	PUNCT
aiua-7778	212	9	lymphocyte	lymphocyte	ADJ
aiua-7778	212	10	ratio	ratio	NOUN
aiua-7778	212	11	in	in	ADP
aiua-7778	212	12	diagnosis	diagnosis	NOUN
aiua-7778	212	13	of	of	ADP
aiua-7778	212	14	prostate	prostate	NOUN
aiua-7778	212	15	cancer	cancer	NOUN
aiua-7778	212	16	.	.	PUNCT
aiua-7778	213	1	asian	asian	PROPN
aiua-7778	213	2	pac	pac	PROPN
aiua-7778	213	3	j	j	PROPN
aiua-7778	213	4	cancer	cancer	NOUN
aiua-7778	213	5	prev	prev	NOUN
aiua-7778	213	6	.	.	PROPN
aiua-7778	213	7	2015	2015	NUM
aiua-7778	213	8	;	;	PUNCT
aiua-7778	213	9	16:6407	16:6407	NUM
aiua-7778	213	10	-	-	SYM
aiua-7778	213	11	6412	6412	NUM
aiua-7778	213	12	.	.	PUNCT
aiua-7778	214	1	20	20	NUM
aiua-7778	214	2	.	.	X
aiua-7778	215	1	ploussard	ploussard	PROPN
aiua-7778	215	2	g	g	PROPN
aiua-7778	215	3	,	,	PUNCT
aiua-7778	215	4	nicolaiew	nicolaiew	PROPN
aiua-7778	215	5	n	n	CCONJ
aiua-7778	215	6	,	,	PUNCT
aiua-7778	215	7	marchand	marchand	PROPN
aiua-7778	215	8	c	c	PROPN
aiua-7778	215	9	,	,	PUNCT
aiua-7778	215	10	et	et	PROPN
aiua-7778	215	11	al	al	PROPN
aiua-7778	215	12	.	.	PROPN
aiua-7778	215	13	risk	risk	NOUN
aiua-7778	215	14	of	of	ADP
aiua-7778	215	15	repeat	repeat	NOUN
aiua-7778	215	16	biopsy	biopsy	NOUN
aiua-7778	215	17	and	and	CCONJ
aiua-7778	215	18	prostate	prostate	NOUN
aiua-7778	215	19	cancer	cancer	NOUN
aiua-7778	215	20	detection	detection	NOUN
aiua-7778	215	21	after	after	ADP
aiua-7778	215	22	an	an	DET
aiua-7778	215	23	initial	initial	ADJ
aiua-7778	215	24	extended	extend	VERB
aiua-7778	215	25	negative	negative	ADJ
aiua-7778	215	26	biopsy	biopsy	NOUN
aiua-7778	215	27	:	:	PUNCT
aiua-7778	215	28	longitudinal	longitudinal	ADJ
aiua-7778	215	29	follow	follow	NOUN
aiua-7778	215	30	-	-	PUNCT
aiua-7778	215	31	up	up	NOUN
aiua-7778	215	32	from	from	ADP
aiua-7778	215	33	a	a	DET
aiua-7778	215	34	prospective	prospective	ADJ
aiua-7778	215	35	trial	trial	NOUN
aiua-7778	215	36	.	.	PUNCT
aiua-7778	216	1	bju	bju	NOUN
aiua-7778	216	2	int	int	PROPN
aiua-7778	216	3	.	.	PUNCT
aiua-7778	217	1	2013	2013	NUM
aiua-7778	217	2	;	;	PUNCT
aiua-7778	217	3	111:988	111:988	PROPN
aiua-7778	217	4	-	-	SYM
aiua-7778	217	5	996	996	NUM
aiua-7778	217	6	.	.	PUNCT
aiua-7778	218	1	correspondence	correspondence	NOUN
aiua-7778	218	2	volkan	volkan	NOUN
aiua-7778	218	3	caglayan	caglayan	PROPN
aiua-7778	218	4	volkantuysuz@hotmail.com	volkantuysuz@hotmail.com	PUNCT
aiua-7778	219	1	efe	efe	PROPN
aiua-7778	219	2	onen	onen	PROPN
aiua-7778	219	3	efe17@yahoo.com	efe17@yahoo.com	PROPN
aiua-7778	219	4	sinan	sinan	PROPN
aiua-7778	219	5	avci	avci	PROPN
aiua-7778	219	6	sinavci@yahoo.com	sinavci@yahoo.com	PROPN
aiua-7778	220	1	murat	murat	PROPN
aiua-7778	220	2	sambel	sambel	PROPN
aiua-7778	220	3	muratsambel@hotmail.com	muratsambel@hotmail.com	PROPN
aiua-7778	221	1	metin	metin	PROPN
aiua-7778	221	2	kilic	kilic	PROPN
aiua-7778	221	3	kilicmetin@yahoo.com	kilicmetin@yahoo.com	PROPN
aiua-7778	222	1	sedat	sedat	PROPN
aiua-7778	222	2	oner	oner	PROPN
aiua-7778	222	3	sedatoner@yahoo.com	sedatoner@yahoo.com	PROPN
aiua-7778	223	1	mustafa	mustafa	PROPN
aiua-7778	223	2	murat	murat	PROPN
aiua-7778	223	3	aydos	aydos	PROPN
aiua-7778	223	4	mudos16@hotmail.com	mudos16@hotmail.com	X
aiua-7778	223	5	halil	halil	PROPN
aiua-7778	223	6	emre	emre	PROPN
aiua-7778	223	7	yıldız	yıldız	PROPN
aiua-7778	223	8	halilemreyldz@gmail.com	halilemreyldz@gmail.com	PROPN
aiua-7778	224	1	university	university	PROPN
aiua-7778	224	2	of	of	ADP
aiua-7778	224	3	health	health	PROPN
aiua-7778	224	4	sciences	sciences	PROPN
aiua-7778	224	5	,	,	PUNCT
aiua-7778	224	6	bursa	bursa	NOUN
aiua-7778	224	7	yuksek	yuksek	PROPN
aiua-7778	224	8	ihtisas	ihtisa	VERB
aiua-7778	224	9	training	training	NOUN
aiua-7778	224	10	and	and	CCONJ
aiua-7778	224	11	research	research	NOUN
aiua-7778	224	12	hospital	hospital	NOUN
aiua-7778	224	13	,	,	PUNCT
aiua-7778	224	14	bursa	bursa	NOUN
aiua-7778	224	15	,	,	PUNCT
aiua-7778	224	16	turkey	turkey	PROPN
aiua-7778	224	17	caglayan_stesura	caglayan_stesura	NOUN
aiua-7778	224	18	seveso	seveso	NOUN
aiua-7778	224	19	10/01/19	10/01/19	PROPN
aiua-7778	224	20	16:08	16:08	NUM
aiua-7778	224	21	pagina	pagina	NOUN
aiua-7778	224	22	275	275	NUM